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ABSTRACT 
 
             This thesis presents the application of diffusion weighted imaging 
(DWI) and relaxometry MRI studies in three organs in the abdomen, the 
kidney, colon and liver.  
            These methods are first applied at 1.5 Tesla in healthy volunteers and 
patients with Cardiorenal Syndrome (CRS), a clinical condition in which 
cardiac and renal dysfunctions (RD) coexist. Diffusion parameters are 
determined using the mono-exponential ADC, bi-exponential IVIM, stretched-
exponential and Kurtosis models, as well as diffusion tensor imaging (DTI) in 
order to assess pathophysiology and structural changes in the kidney. 
Complementary longitudinal relaxation time (T1) mapping and PC-MRI flow 
measures are collected for comparison with diffusion parameters.  
               The assessment of the colonic content using T1 measures as a 
biomarker of water absorption and health is presented in the second study. The 
main objective of the study was to determine the robustness of bi-exponential 
model in the fitting of T1 in the colonic contents of ascending colon. T1 
measurements of colonic content are made at different positions in the 
ascending colon, before and after a liquid challenge. The reliability of T1 
measurements of colonic content were compared across observers. The 
heterogeneity in the measurements was evaluated by considering different ROI 
sizes and locations. 	
               The final study is the assessment of liver function associated with 
Chronic Liver Disease (CLD) using DWI and T1 measurement at 1.5 T and a 
comparison with histological measures. the Measurements of T1 and diffusion 
parameters (ADC and IVIM) to stratify fibrosis stage in liver disease are 
combined with T2* measurement of iron accumulation. The repeatability and 
reproducibility of this protocol is then tested in the healthy liver using MRI at 
3T for the assessment of structural and haemodynamic changes for future 
studies, with an evaluation of the choice of b-values to inform fitting of the bi-
exponential (IVIM) model provided.  
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Chapter 1  
      
Introduction 
 
              Magnetic resonance imaging (MRI) also known as Nuclear magnetic 
resonance (NMR) imaging is a non-invasive imaging technique firstly 
discovered independently by Felix Bloch [1] and Edward Purcell in 1946 [2]. 
In 2003, Peter Mansfield [3] and Paul Lauterbur [4] were recognised with the 
Nobel Prize for Physiology or Medicine for their separate contributions to MRI 
in gradient imaging and echo-planar imaging. MRI has long been used in the 
fields of physics and chemistry to study molecular structure and diffusion. In 
clinical imaging, the main use of MRI is to image anatomy and pathology of 
the body and to investigate organ function. MRI uses the combination of a high 
magnetic field coupled with the transmission and detection of radio waves to 
produce images of the body from the MR signal. Moreover, MRI offers a wide 
range of techniques and physical parameters to sensitise the image to. This 
thesis is focussed on using MRI in abdominal imaging applications and clinical 
studies. Many studies in different areas of research, both basic experimental 
medicine and clinical applications, have been widely performed on abdominal 
organs of humans and animals. The main focus in this thesis is the study of 
pathophysiology in the kidney, colon and liver using measures of diffusion 
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weighted imaging (DWI) and longitudinal relaxation time (T1) mapping. DWI 
is an imaging technique that describes the diffusion of water molecules in 
tissues. In organ tissue, the movement of water molecules can be restricted by 
boundaries such as membranes and macromolecules, and it can be dependent 
on changes in tissue structure, for example due to fibrosis or inflammation. 
Longitudinal relaxation time (T1) measures consider the water content in the 
tissue. The properties and amount of water in tissue can alter dramatically with 
disease and injury. For example, inflammation is associated with accumulation 
of water in the intracellular and extracellular space, due to cell swelling and 
interstitial oedema, respectively, so that prolonged T1values are expected. 
Furthermore, interstitial collagen deposition due to fibrosis may allow water to 
accumulate in the enlarged interstitial space. Thus, longitudinal T1 relaxation 
time values in tissue and their alteration in disease are predicted to relate to the 
diffusion of water molecules in tissues. 
1.1 Thesis Overview 
This thesis is structured into seven chapters. The first three chapters include an 
overview of the thesis and MRI principles and methods. Chapters 4, 5, and 6 
are then the experimental chapters of this thesis. In each, a description of the 
anatomy, function, and physiology of organ studied (kidney, colon, and liver - 
Chapters 4, 5 and 6 respectively) are given at the beginning of the chapter, 
followed by the experimental study.  
Chapter 2 introduces the background theory of magnetic resonance imaging. 
The fundamental concepts of NMR physics are outlined, and MRI sequences 
used in these studies are introduced.  
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Chapter 3 describes diffusion of water molecules and the characteristics of the 
tissues. Diffusion Weighted Imaging (DWI) and its application in the 
assessment of abdominal are introduced. The concept of intravoxel incoherent 
motion (IVIM) is outlined. Mono-exponential and bi-exponential models are 
introduced, and Diffusion tensor imaging (DTI) outlined.   
In Chapter 4, firstly an overview of kidney disease and the application of DWI 
to the assessment of the kidney disease are highlighted. The main focus in this 
chapter is to use MR diffusion to assess the kidney in patients with Cardiorenal 
Syndrome (CRS) using a 1.5 Tesla MRI scanner. The data are compared to 
healthy volunteers (HV) in order to assess pathophysiology change. 
Longitudinal relaxation time measures and phase contrast blood flow are also 
implemented to this study. Diffusion and directionality in the kidney using DTI 
in healthy volunteers and patients with CRS also are assessed.  
The aim of the work in Chapter 5 is to determine whether robust biexponential 
fitting of T1 measurement can be carried out on the colonic contents in order to 
characterise the chyme within the ascending colon (AC) as a marker of water 
absorption and health. In conjunction to this, the properties of the colonic 
contents at different positions in the AC of healthy volunteers after liquid 
challenge are characterised. Then, the reliability of the T1 measurement of 
colonic contents are assessed. Finally, the heterogeneity of the measurements 
in the ascending colon (AC) are investigated by considering different ROI sizes 
and locations in different physiological situations. 
In Chapter 6, the definition of fibrosis in the liver is described. The application 
of DWI and longitudinal relaxometry measures in the liver are highlighted. In 
this chapter, chronic liver disease (CLD) at different stages of liver fibrosis is 
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assessed using ADC and IVIM parameters, and T1 measures collected at 1.5 
Tesla. For a better signal-to-noise ratio (SNR), the reproducibility of the 
healthy liver is investigated using 3 Tesla MRI. Diffusion parameters, 
relaxometry parameter, phase contrast parameters, and liver volume are 
assessed in two session of scanning for a future patient study.  
Finally, Chapter 7 provides a general summary of results from three 
experimental chapters, and outlines directions of future research. 
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Chapter 2   
Magnetic Resonance Imaging Concepts 
 
2.1 Introduction 
This chapter presents the basic principles of Magnetic Resonance Imaging 
(MRI). Firstly, the basic theory of nuclear magnetic resonance (NMR) and the 
interaction of spins with magnetic fields are described. The relaxation of the 
spin system is then explained. Following this, sections describe the effect of 
gradients on the spin, and the techniques used to produce an MR image. The 
pulse sequences that were employed specifically in the studies in this thesis are 
then overviewed. Finally, the main components of MR scanner are 
summarised.  
 
2.2 Basic Principles of Magnetic Resonance Imaging 
2.2.1 Nuclear magnetic resonance  
An atom is a fundamental unit of matter that consists of a nucleus and 
negatively charged electrons.  The nucleus consists of positively charged 
protons and electrically neutral neutrons. Spin is a basic property of many 
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atomic nuclei. Nuclei that have an odd number of protons and neutrons possess 
a net nuclear spin or spin angular momentum, I, while nuclei that have even 
number of protons and neutrons have no net spin. These can be described as a 
charged sphere spinning about its axis, this gives rise to a current loop that 
creates a magnetic dipole moment, µ (Figure 2.1). 
 
  
 Figure 2.1:  A spinning charged particle generates a magnetic dipole moment, µ. 
 
The relation between I and µ is described by: 
!	 = 	γ%																																																			(2.1)	 
 
where γ is the gyromagnetic ratio, a property of the nucleus. The gyromagnetic 
ratio can be positive or negative, with µ and I aligned parallel to each other if γ 
is positive or anti-parallel if γ is negative. Since, hydrogen-1 (H1) is the most 
abundant element in human body, MRI signals are typically generated from H1 
which has one proton that has a relatively large magnetic dipole moment and 
high gyromagnetic ratio, with γ of 42.5 MHz/T. The particle and wave 
behaviour of the protons in the magnetic field can be accurately described by 
µ 
+ 
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quantum mechanics principles. However, in this thesis, MRI principles will be 
mainly explained by the classical model, a more intuitive approach compared 
to the quantum model. 
 
2.2.2 Interaction of spins with main magnetic fields (B0) 
In the absence of an external magnetic field, all the spins are oriented randomly 
forming no net bulk magnetization (M = 0).  In the presence of an external 
magnetic field (B = B0k), a nuclear magnetic moment will experience a torque 
and precess about the direction of the external magnetic field (Figure 2.2), with 
the torque being given by rate of change of the spin angular momentum, I, as 
described in Equation (2.2). 
+ = 	!	×- = 	dIdt																																													(2.2) 
 
 
Figure 2.2: In the presence of external magnetic field B0, a spinning particle precesses 
around B0 direction at the Lamor frequency. 
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Protons precess around the direction of external magnetic field, B = B0k, at a 
frequency given by the Larmor equation:  
ω2 	= 	γ	B2																																																					(2.3)                                            
 
The magnetic moments of the spin align so that they precess around an axis 
parallel (low energy state) or antiparallel (high energy state) to the direction of 
B0. In thermal equilibrium, there are more spins in the low energy state than the 
high energy state. This results in an excess of spins parallel to B0 creating a net 
magnetization, M (Figure 2.3).  
 
 
Figure 2.3: (a) Spins are randomly oriented in the absence of an external magnetic 
field B0. (b) Spins align parallel and antiparallel in a magnetic field B0, with more 
spins in the low spin state generating a net magnetisation, M. 
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2.2.3 Interaction with oscillating electromagnetic field (B1) 
In the external magnetic field, B = B0k, which is along the z-axis of the 
Cartesian coordinate system, the net magnetisation M0 at equilibrium is along 
the z-axis (Figure 2.4). 
 
Figure 2.4:  The net magnetisation of spins M0 at equilibrium produced in the presence 
of B0. 
 
This magnetisation is perturbed from the equilibrium state in order to produce a 
detectable NMR signal. To do this, an oscillating radiofrequency (RF) pulse of 
magnetic field B1(t) is applied. The RF pulse is tuned to the same frequency as 
the Larmor frequency, ɷ0 to excite the spins and rotate the net magnetization 
vector M though a flip angle, α, dependent on the B1 amplitude and its 
duration. The B1 field is much smaller than the B0 and perpendicular to the 
main magnetic field. 
In order to illustrate the effects of an RF pulse and relaxation mechanisms, we 
can choose to study the system in one of two frames of reference: the stationary 
or the rotating frame of reference. In the stationary frame of reference, defined 
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in Cartesian coordinates (x, y, z), the frame is fixed and the B1(t) RF pulse is 
applied along the x-axis. Hence, the net magnetization vector M rotates about 
the x-axis and combined with the Larmor frequency about the z-axis, the leads 
to a spiral motion as the magnetisation vector moves from the z-axis toward the 
transverse plane (x-y plane), as shown in (Figure 2.5 (a)). In a rotation frame of 
reference precessing at the Larmor frequency, defined in Cartesian coordinates 
(x’, y’, z), the x-y plane rotates at the same direction as the spin system. Hence, 
the B1 is stationary along x’-axis and rotation of the magnetization the 
transverse plane can be simplified as shown in Figure 2.5(b).  
 
 
Figure 2.5:  When an RF pulse is applied, the bulk magnetization M rotates from z-
axis towards the transverse plane. The motion of M is shown in blue in (a) the 
stationary frame and (b) the rotating frame. Note in this illustration a 900 RF pulse is 
used with the resulting magnetisation vector along the y-axis (green). 
 
A fictitious field of amplitude -ɷRF/γ must be applied in order to transform the 
system to the rotating frame. The motion of the magnetization M can be 
described mathematically as [1] d5dt = γ5	× B2 − 789γ : + B<= 																								(2.4) 
(a) (b) 
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The combination of B0k and B1i produces an effective magnetic field, Beff, 
which can be written as: d5dt = γ5	×-?@@																																														(2.5) 
In the condition of being on-resonance, ɷRF = ɷ0,  B0  and ωBC/γ component 
will cancel out and |Beff|=|B1|. Therefore, the motion of M0 will be to precess 
about the B1 axis at a flip angle, α which is determined by both the amplitude 
of B1 and duration, tp of the RF pulse: α = 	γB<FG																																																(2.6) 
A different RF pulse amplitude or duration can be applied to rotate the 
magnetization through different flip angles. For example, a 90° RF pulse will 
tip the magnetization through 90° from the z-axis to the x’-y’ plane, to produce 
maximum transverse magnetization, Mt. A 180° RF pulse inverts the 
magnetization to lie along the z-axis and hence no transverse component is 
produced.  
The transverse magnetization is responsible for the induction of an MR signal 
in the receiver coil. Following the cessation of the RF pulse, the spins rapidly 
dephase to return to thermal equilibrium. The transverse magnetization which 
is detected as the MR signal, decays exponentially to zero (Figure 2.6) and 
generates what is called a free induction decay (FID). 
 
Magnetic Resonance Imaging Concepts 
 
 
 
13 
 
Figure 2.6:  Free Induction Decay (FID). The signal decays exponentially to zero due 
to spins dephasing. This is shown for a signal which is on-resonance (red) and off-
resonance (blue). 
2.2.4 Relaxation Mechanisms 
An RF pulse is used to excite the spins and flip the magnetization from the 
equilibrium condition into the transverse plane. Following a 900 RF pulse, all 
spins are in phase and the spin populations are equated between the low energy 
spin-up and high energy spin-down states. When the RF pulse is switched off, 
the magnetization slowly returns to its equilibrium state such that M0 is aligned 
with B0, and the spins dephase such that they are randomly distributed. This 
mechanism is called relaxation. There are two mechanisms for relaxation: the 
spin-lattice and spin-spin relaxation. In spin-lattice or longitudinal (T1) 
relaxation, the spins loose the energy obtained from an RF pulse by 
transferring it to their surrounding lattice. This process causes the recovery of 
longitudinal magnetization back to the equilibrium state. For spin-spin or 
transverse (T2) relaxation, the interaction between individual spins causes the 
spins to exchange energy with neighbouring spins causing dephasing and the 
decay of transverse magnetization. The T1 and T2 relaxation processes can be 
Magnetic Resonance Imaging Concepts 
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described mathematically by the Bloch equations [2]. The longitudinal 
magnetisation can be described by: dMJdt = −	 MK −	M2T< 																																								(2.7) 
whilst the transverse magnetisation is given by the coupled Bloch equations [3] dMNdt = −	MNTO + 	γPQR2																																	(2.8. a) dMUdt = −	MUTO − 	γPVR2																																	(2.8. b) 
For a 90° RF pulse, where the initial longitudinal magnetization following the 
RF pulse is zero [Mz(0)= 0], the solution to Equation 2.7 is given by a 
saturation recovery described by: 
MK t = 	M2 1 − eY Z[\ 																															(2.9)	 
The longitudinal relaxation time (T1) characterizes the time for the longitudinal 
magnetization to return to equilibrium along the B0k direction. The T1 value is 
reduced when the exchange of energy is increased by randomly fluctuation 
magnetic fields caused by the motion of surrounding magnetic dipoles. The T1 
value increases with magnetic field strength, B0, due to the greater energy 
exchange that is required at higher frequencies.  
Following a 900 RF pulse, with initial y-component of transverse 
magnetization is assumed to be equal to the equilibrium magnetization, My(0)= 
M0,  the solutions to equation (2.8.a) and (2.8.b) are 
MN t = 	M2	sin	ω2t	. aY bcd 																								 (2.10.a) 
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MU t = 	M2 cos72 t	. aY Z[d 																					(2.10. b) 
The combined transverse magnetization component (Mxy) then can be 
simplified to 
MNU t = 	M2 aY Z[d 																																					(2.11) 
T2 relaxation is caused by the spins exchanging energy with neighbouring 
spins. The energy exchange is caused by the magnetic fields of each spin 
interacting with its neighbour. This causes the precessional frequency of each 
spin to change slightly and results in dephasing of spins. Since the spins’ 
interactions are random, the dephasing is an exponential decay process. The 
magnetization as a function of time, Mz(t) and Mxy(t), due to the T1 and T2 
relaxation are shown in Figure 2.7. 
 
     
Figure 2.7: When a 900 RF pulse is turned off, the longitudinal magnetization will 
recover with a T1 relaxation time (a) and the transverse magnetization decays with the 
T2 relaxation time (b). 
 
The transverse relaxation is also influenced by inhomogeneity of the external 
magnetic field. This causes each spin to experience a slightly different 
(a) (b) 
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magnetic field strength. Hence, the spins at different locations precess at 
different Larmor frequencies. The dephasing of spin due to inhomogeneity of 
magnetic field increases the rate of transverse relaxation and results in an 
apparent transverse relaxation time termed T2*, which is given by 1TO∗ = 1TO + 1TOi 																																											(2.12) 
where T2 is spin-spin relaxation time and T2’ is relaxation time due to magnetic 
field inhomogeneity. Figure 2.8 shows a comparison of transverse 
magnetization as a function of time due to T2 and T2* relaxation. Note that the 
T2* of a tissue is always shorter than the T2. The T2’ component of the 
transverse magnetization decay can be removed with the application of a spin 
echo pulse sequence, this will be described further in Section 2.2.6.1.   
 
Figure 2.8: The transverse magnetization with T2* decays which is faster than T2 due 
to additional inhomogeneity of the external magnetic field. 
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2.2.5 The effect of a magnetic field gradient 
Since all spins precess at approximately the same resonance frequency, ɷ0, in 
the presence of B0, the signal generated from different positions along the z-
axis cannot be distinguished. Thus, to generate a distinct signal from a certain 
location, a linear gradient magnetic field Gi is applied in addition to B0, as so 
that the field at position r is given by:   
Bj r = 	B2 + l=. m																																																	(2.13) 
This additional gradient field introduces a slightly different external magnetic 
field strength to be experienced at each spatial position in the direction in 
which a gradient is applied. Hence, the spins will precess at different Larmor 
frequencies corresponding to the magnetic field strength at each spatial 
position. 
2.2.5.1 Slice selective   
In order to excite spins in a certain range of positions, a slice selective gradient 
[4] , Gz is turned on in the z-direction at the same time as when a RF excitation 
pulse is transmitted (Figure 2.9). The RF pulse is applied with a bandwidth 
(∆ɷ) which coincides with the range of Larmor frequencies of the spins in the 
predefined slice. The bandwidth and gradient strength determine the slice 
thickness (∆z), with 
∆z = ∆ωγGK 																																																(2.14) 
The slice thickness can be made thinner by reducing the bandwidth of the RF 
pulse or by increasing the strength of slice selection gradient (Figure 2.10). To 
achieve a slice excitation with a rectangular profile, the Fourier transform of 
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the RF pulse must be rectangular. This requires an RF pulse with sinc shaped 
modulation to excite a sharp edged slice. For practical implementation of an 
RF pulse it is necessary to limit the pulse length, and so typically a five lobe 
sinc function is used. This approximation of sharp edged slice is only correct 
for small pulse angles, for larger flip angles it is usually necessary to use some 
form of iterative method to optimise pulses.  Multiple slices can then be excited 
by applying RF pulses with varying central frequency and matched 
bandwidths, hence each RF pulse excites a range of frequencies for a different 
slice.  A gap between the consecutive slice can be applied to avoid slice 
overlapping.  
 
Figure 2.9:  An example MRI pulse sequence, showing one of the most common 
acquisitions used in MRI today known as spin-warp imaging [5]. Slice selective 
excitation is performed by applying an RF pulse at the same time as a slice selective 
gradient Gz (dashed line box). The frequency range (bandwidth, Δω) of the RF pulse 
must be tuned to the Larmor frequency of the spins under the applied gradient. The 
frequency encoding gradient Gx and phase encoding gradient Gy are applied to obtain 
spatial information of the signal in the x-y plane.   
α° 
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Figure 2.10:  The slice thickness is determined by the bandwidth of RF pulse, Δω, and 
the gradient field strength, Gz. A narrower RF pulse bandwidth Δω (a), or a larger  
gradient field strength Gz (blues versus red line) (b), decreases the slice thickness, Δz.  
 
2.2.5.2 Frequency and phase encoding 
A frequency encoding or readout gradient Gx is applied after slice selection to 
obtain spatial information in the in-plane x-direction (Figure 2.9). A positive 
Gx gradient is applied during the time when the echo is received by the 
Δω 
Δz 
ω 
z 
(a) 
Δω 
Δz 
z 
ω 
(b) 
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detector. When Gx is turned on, the spins in x-direction will experience a 
different strength of magnetic field and thus precess with different frequencies. 
Notice also that a negative gradient is applied before the positive gradient, such 
that an echo is formed at the centre of the positive gradient. Without the 
negative gradient, we can only acquire the full range of positive spatial 
frequencies to sample k-space. 
In order to obtain spatial information in the y-direction, a phase encoding 
gradient Gy is applied after slice selection (Figure 2.9) and prior to the positive 
frequency encoding, Gx. When Gy is turned on, the spins in the y-direction 
precess with difference frequencies dependent on y position. Once Gy is turned 
off, all the spins precess with same frequency but out of phase with each other. 
In other words, the y-gradient encodes spatial position into the phase of the 
magnetization. Thus the MRI signal in a 2-D image results from distinct 
frequency and phase information, with the y-gradient setting up a spatially 
dependent phase distribution that remains fixed during the frequency encoding 
process under which data acquisition takes place. The spatial information in the 
x- and y-direction define k space.  
 
2.2.5.3 k-space. 
The MRI signals generated using pulse sequences are digitally sampled and 
stored in a 2D or 3D raw data matrix called k-space [6] (Figure 2.11 (a)).  
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Figure 2.11:  An example of (a) k-space and its respective (b) MRI image. 
  
The raw data matrix is generally placed in kx and ky dimensions representing 
the frequency and phase encoding direction respectively. k-space is filled line 
by line dependent on the phase encoding steps, with the points in the x-
direction sampled during frequency encoding. The phase gradient strength is 
changed for each repetition, thus it is the phase encoding matrix that defines 
the scan time. Spatial frequencies are expressed by: 
kN = 	γGNtN																																														(2.15)  kU = 	γGUtU																																													(2.16) 
where kx and ky  are the spatial frequency in x- and y-directions respectively, 
and Gx and Gy are the gradient strengths, while tx and ty are the sampling times. 
The centre of k-space (kx and ky =0) corresponds to low spatial frequency 
terms and the outer part corresponds to high spatial frequency information. 
Hence, the relative signal intensity and contrast in an image is determined by 
(a) (b) 
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signal at the centre of k-space, whilst image sharpness is determined by the 
outer parts of the k-space.  
 
 
Figure 2.12:  Steps in MR image formation from k-space to image space. 
       
The unit interval of spatial frequencies (∆kx and ∆ky) is inversely proportional 
to the field of view (FOV) of an image, 
∆kN = 	 1FOVN 																																												(2.17) 
∆kU = 	 1FOVU 																																											(2.18) 
Since, the k-space position is a function of the gradient field strength and its 
duration. The amplitude of frequency encoding (FE) (or read-out) gradient GFE 
and the sampling period ∆tx determine the spatial unit frequency interval, ∆kx. 
The phase encoding (PE) gradient amplitude GPE and gradient duration tGy 
determines the sampling period ∆ky along the y-direction (Figure 2.12).  
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FOVN = 	 1∆kN = 	 2πγGCv∆tN 																																			(2.19) 
 
FOVU = 	 1∆kU = 	 2πγGwvtxU 																																			(2.20) 
The 2D k-space data trajectory is defined by the phase and frequency encoding 
polarity as shown in Figure 2.13. The trajectory of k-space begins at the origin 
before the phase encoding is switched on. When a phase encoding gradient, Gy 
with positive lobe is applied the trajectory will move upward along the ky 
direction. The read-out gradient with a positive lobe is then turned on during 
the data acquisition, such that k-space is filled in the positive kx direction.  
 
 
Figure 2.13: Trajectory of k-space filling in the positive y and x direction defined by 
phase (Gy) and frequency encoding (Gx) polarity. 
 
k-space data is converted to image space using a Fourier transformation. The 
result of the Fourier transformation contains real (R) and imaginary (I) parts, 
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and magnitude (M) and phase image can be constructed from the real and 
imaginary parts. In order to speed-up the signal acquisition while retaining the 
tissue contrast, a partial coverage of k-space acquisition can be employed.  
 
2.2.6 Creating an echo 
There are two techniques that can be used to generate echoes in MRI: either a 
spin echo or a gradient echo. In a spin echo, at a given time after a 900 RF 
excitation pulse a 1800 RF pulse is applied to refocus the spins and generate an 
echo. In a gradient echo, gradient reversal on frequency encoded axis is used 
after an excitation RF pulse to forms the echo. 
 
2.2.6.1 Spin echo 
Spins dephase naturally after a 90° RF pulse is turned of (Figure 2.14). The 
rate of dephasing depends on the T2*, a combination of T2 and external 
magnetic field inhomogeneties. In a spin-echo (SE) technique,  a 180° RF 
pulse is applied, this flips the spins by 180° and reverses the phase angle. The 
spins continue to then precess at the same frequency and direction as before, 
and rephase to produce an echo. At the echo time, TE, the signal will reach a 
maximum value, which is determined by the T2 spin-spin interaction of the 
tissue. Hence, the use of 180° RF pulse in a spin echo sequence is to regain the 
signal lost due to magnetic field inhomogeneities but not from T2. 
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Figure2.14:  Spin echo sequence. The spins are in phase initially just after a 900 RF 
pulse is turned off and then dephase naturally due to the T2* relaxation. The spins 
dephasing are reversed by a 1800 RF pulse and start to rephase. An echo is formed and 
the spins start to dephase again. The amplitude of the echo is determined by the T2 of 
the tissue. 
 
2.2.6.2 Gradient echo 
In a gradient echo sequences, an RF pulse normally with a flip angle, α less 
than 900 is used to excite the spins. (Figure 2.15). A small flip angle, α allows 
a very short repetition time (TR) to be used while retaining the tissue contrast. 
Hence, the scan time can be made much shorter compared to the spin echo 
technique. After the excitation, the magnetization is flipped from its 
equilibrium state towards the transverse plane.  An RF pulse creates transverse 
magnetisation (Mxy) while retaining part of the longitudinal magnetization 
(Mz). A refocusing gradient comprising a read-out gradient of two opposing 
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polarities is then used. The negative lobe of this gradient dephases the spins in 
the transverse plane intentionally and thus eliminates the FID. The positive 
lobe of the gradient will then rephase the spins. Hence, the FID signal is 
regained and an echo is generated at an echo time TE. The area of the positive 
lobe is double that of the area of the negative lobe. In contrast with spin echo 
formation, the positive gradient only compensates for the dephasing spins 
caused by the negative gradient lobe but not caused by magnetic field 
inhomogeneity or spin-spin interactions. Thus, the amplitude of the signal is 
determined by T2* relaxation time. 
 
Figure 2.15:  Gradient echo sequence. The negative lobe of gradient field dephases the 
spins and a positive lobe of gradient rephase the spins to form a gradient echo signal.  
 
T2* 
α° 
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2.2.7 Echo planar imaging  
Echo planar imaging (EPI) is one of the fastest MRI pulse sequences. This 
technique was introduced by Sir Peter Mansfield in 1977 [7]. EPI is a 
technique that utilizes the transverse magnetization maximally to produce a 2D 
image in only a few tens of milliseconds. This fast MRI technique is used in 
diffusion weighted imaging (DWI), perfusion imaging and functional MRI 
(fMRI).  
An EPI sequence can be performed as a blipped or non-blipped technique. In a 
non-blipped EPI, the phase encoding gradient starts with a pre-phasing gradient 
lobe and constant phase encoding gradient throughout the entire readout echo 
train (Figure 2.16). The pre-phasing lobe determines the initial k-space position 
along the phase encoding direction (y-direction). The combination of a phase 
encoding, Gy (Figure 2.16(a) and a constant gradient Gx (Figure 2.16 (b) 
produce a zigzag k-space trajectory as shown in Figure 2.16 (d). However, this 
causes artefacts during Fourier transformation compared with conventional k-
space trajectory. Because of this problem, a blipped phase encoding was 
introduced and is most routinely used (Figure 2.16 (c)). In the blipped scheme, 
Ny phase encoding blip gradients of the same polarity are applied throughout 
the readout echo train gradient, with each blip turned on before the acquisition 
of an echo. Prior to the train of blip gradient pulses, a negative phase encoding 
lobe of area equal to half the total area of the Ny blips is applied. This sequence 
produces a k-space trajectory as shown in Figure 2.16(e).  
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Figure 2.16:  A single-shot non-blipped EPI (a and b) and blipped EPI (a and c) 
produce k-space trajectories (d and e respectively)). A pre-phasing lobe (black) 
determine the initial k-space position. 
 
EPI can be applied as a single or multi-shot technique. Single-shot EPI was the 
first EPI technique used. By using this technique, the entire data acquisition for 
each slice is acquired from a single RF pulse. This is accomplished by rapidly 
reversing the readout gradients to produce a series of gradient echoes that are 
used to form an image. In such a manner, the whole of k-space can be sampled 
under the envelope of a single FID. In the multishot technique, multiple RF 
excitations are required to form an image; k-space is divided into several 
segments. The echoes generated from each excitation are filled sequentially in 
different segments of k-space. Multi-shot EPI is more susceptible to motion 
artefact due to long image acquisition compared to single shot EPI. 
(d) (e) 
(a) 
(b) 
(c) 
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The main advantage of EPI is it is a very fast MRI technique. However, it is 
prone to a variety of artefacts. The most common artefact in EPI is the Nyquist 
ghost caused by eddy currents, imperfect gradients, field inhomogeneity, or a 
mismatch between the timing of the odd and even echoes. This artefact can 
lead to signal amplitude modulation, phase inconsistency, or displacement of k-
space. This artefact can be reduced by using a reference scan acquired using a 
single-shot acquisition without phase encoding gradient. Another common 
artefact in EPI is caused by chemical shift. This artefact is observed along the 
phase encoding direction due to the presences of phase error propagation. It 
can be reduced by using fat suppression. Image distortion is produced in 
regions with off-resonance effects due to the very low bandwidth in the phase 
encoding direction. This artefact can be minimized by decreasing the echo 
spacing or the echo train length as in multi-shot EPI. EPI can be performed in 
combination with a spin echo or gradient echo technique. Three common EPI 
pulse sequences are spin echo (SE)-EPI, gradient echo (GE)-EPI and inversion 
recovery (IR)-EPI which are used in this thesis. 
 
2.2.7.1 SE-EPI 
A 2D SE-EPI pulse sequence consists of two selective RF pulses, one 
excitation pulse with a typical flip angle of 90° and a 180°refocusing RF pulse. 
These pulses generate a spin echo, as explained in Section 2.2.6.1 and shown in 
Figure 2.17. The pre-phasing lobe of the phase encoding and frequency 
encoding are often applied between the 90° RF pulse and 180° RF pulse to 
produce a time efficient sequence. The echoes are produced at different TEs, 
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but the echo time, TE, of the sequence is defined as the effective TE, TEeff  
when the ky origin (ky = 0)  is acquired.   
 
Figure 2.17:  Timing diagram of a spin echo (SE) EPI sequence. 
 
2.2.7.2 GE-EPI 
In gradient echo (GE) EPI, a 90° RF excitation pulse is used because the TR of 
EPI is longer than a conventional GE scheme. The combination of phase 
encoding and frequency encoding gradients produce a series of gradient echoes 
(Figure 2.18). The amplitude of the echoes is determined by the FID envelope.  
As in the SE-EPI sequence, in GE-EPI each k-space line along the phase 
encoding direction is acquired at a different TE, and the effective TE, TEeff, 
corresponds to the central of k-space line, which predominantly determines the 
image contrast. 
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Figure 2.18: Timing diagram of a gradient echo (GE) EPI pulse sequence. 
 
2.2.8 Turbo Field Echo (TFE) 
 A turbo field echo (TFE) is based on a spoiled gradient echo imaging 
technique (Figure 2.19). Fast low angle shot (FLASH) [8], is the most 
commonly used gradient spoiled gradient-echo MRI-sequence in abdominal 
imaging. By applying one or more pre-pulses followed by a delay prior to a 
series of k-space sampling, a lower RF pulse angle and shorter repetition time 
in the imaging sequence can be used to produce acceptable signal-to-noise ratio 
images. This type of pulse sequence is used for Phase Contrast Imaging, see 
Section 2.2.11. FLASH combines a low-flip angle radio-frequency excitation  a 
90° 
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rapid repetition of the basic sequence which is usually much shorter than the 
typical T1 relaxation time of the tissue. 
 
 
Figure 2.19:  A Turbo Field Echo (TFE). 
2.2.9 Balance fast field echo (bFFE) sequences 
Balance fast field echo (bFFE) is the pulse sequence name used by Philips for a 
fully rewound GE sequence, this sequence is used for abdominal imaging in 
this thesis. The sequence is also known as true-fast imaging with steady 
precession (true-FISP) on the Siemens platform, and FIESTA on the GE 
system [3]. The technique employs balanced, rewind gradients in all three 
orthogonal directions as shown in Figure 2.20. A bFFE pulse sequence uses a 
higher flip angle, and provides greater signal than a FLASH spoiled GE 
sequence, but often at an expense of reduced tissue contrast. In the bFFE 
α° 
Magnetic Resonance Imaging Concepts 
 
 
 
33 
technique, reversing the sign of the gradient lobes, or sometimes only the phase 
encoding gradient, refocuses the transverse magnetisation, and the resulting 
signal contains a FID which is enhanced with an echo containing coherent 
transverse magnetization components. 
At a TR longer than the T2 of the tissue, there is not much difference between 
rewound (bFFE) and spoiled (FLASH) GE sequences. In general, a rewound 
GE is excellent for imaging of fluid and solid structures in rapid imaging, since 
the signals are relatively independent of TR. The main drawbacks of a rewound 
GE sequence is it is sensitive to motion and flow, which destroy the steady 
state transverse coherence. The main limitation of this pulse sequence is that it 
requires high performance gradient technology to obtain good shimming and 
very short TE. Images can become degraded with banding artefacts (spaced 
inversely proportional to the filed homogeneity) if this is not accomplished. 
 
Figure 2.20:  A balanced Fast Field Echo (bFFE) pulse sequence. 
 
α° α° 
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2.2.10    Relaxometry    
2.2.10.1 Measurement of longitudinal relaxation time, T1 
Longitudinal (T1) relaxation time can be measured using an inversion recovery 
(IR) pulse sequence [9] (Figure 2.21). This technique employs an inversion RF 
pulse 1800INV before the excitation pulse. This 1800INV inverts the equilibrium 
magnetization from positive z-axis to the negative z-axis. The time between the 
inversion and excitation pulses is known as the inversion time (TI). A delay of 
TI allows the magnetization to recover in the z-direction from -M0 back to M0, 
with the time constant of the recovery determined by the T1 of the tissue 
(Figure 2.21). After the inversion time, a 90° RF excitation pulse is applied to 
flip the longitudinal magnetization, Mz, into the transverse plane to generate an 
FID. The amplitude of the magnetization flipped into the transverse plane 
depends on the amplitude of Mz recovered during the TI period. T1 relaxation 
time can be estimated by acquiring a series of images at different TI values, 
where each image will have different signal intensity depending on the TI. For 
a very long TR e.g. TR > 5 x T1, the equation for longitudinal magnetization 
can be described by 
 
MK = 	M2 	 1 − 2	exp −TIT< 																													(2.21) 
 
A fast imaging technique, such as gradient echo or spin echo EPI, is often used 
as the readout scheme for an inversion recovery sequence to shorten the 
imaging time for collection of images at multiple TI values.  
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Figure 2.21:  Inversion recovery spin echo pulse sequence. 
  
2.2.10.2 Measurement of transverse relaxation time, T2 and 
T2* 
The transverse relaxation times of T2 and T2* can be measured by repeating SE 
and GE pulse sequences respectively at different TE values. The transverse 
relaxation time (T2 and T2*) can be evaluated fitting images to the following 
equation  
MK = 	M2 	 	exp −TETO 																																		(2.22) 
(where T2 for a SE sequence can be interchanged for T2* for a GE sequence) 
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2.2.11   Phase contrast flow imaging 
Phase-contrast (PC) imaging is used to measure the change in the phase of 
transverse magnetization of spins which are moving in the direction of a 
magnetic field gradient. The technique is commonly performed using a 
gradient echo sequence with additional bipolar flow encoding gradients to 
create a linear relationship between the blood velocity and the phase of MR 
signal. Using this technique, moving spins result in a phase shift in the MR 
signal, while for stationary spins the phase is not shifted. In the presence of a 
magnetic field gradient, G of duration, T, the phase shift for spins moving at a 
constant velocity, v, is given by 
ϕ = 	γ	 Gvt. dt																			[2 																				(2.23. ~) 
 
ϕ =	12 γvGTO																																													(2.23. b) 
 
where γ is the gyromagnetic ratio. This results in a gradient moment, m1. The 
phase shift of moving spins with velocity v is then given by 
ϕ = 	γm<v																																																(2.23. c) 
and is thus proportional to the blood’s velocity. 
In phase contrast imaging, two images are acquired, each using a different 
gradient first moment to sensitize to flow in a particular direction. The 
acquisition is repeated with the polarity of the bipolar pulse reversed in order to 
estimate the velocities from the phase difference of the two images. The phase 
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difference between two images is related to the difference in the two gradient 
moments, Δm1, of the two bipolar pulses. ∆ϕ = 	γv. ∆m<																																								(2.24. d) 
The velocity can then be calculated from 
Ä = 	 ∆ϕγ∆m< 																																																(2.25) 
There is a maximum velocity, venc, that can be assessed because the inherent 
phase differences is limited by π. 
ÄÅÇÉ = 	 ÑÖ∆Ü< 																																												(2.26) 
 If the actual velocity is higher than the venc value, then the velocity of those 
spins will alias. 
 
2.3 Instrumentation 
Figure 2.22 shows a schematic diagram of an MR system. The most important 
components of an MR system are: the main magnet and shim coils, the gradient 
coils and the radiofrequency (RF) coils. 
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 Figure 2.22:  Schematic diagram of an MR scanner. 
 
2.3.1 Main magnet 
The main magnet is the most prominent component in any MR system. Any 
MR scanner is characterized by the field strength of the main magnet, which is 
defined in Tesla (T). In this thesis, all experiments were performed using a 1.5 
or 3T Achieva, Philips Healthcare, Best, NL system. In any MRI experiments, 
the magnetic field produced by the main magnet is required to be homogeneous 
and to have good temporal stability. Field inhomogeneities produce line 
broadening and image distortions because of the varying frequency offset at 
different position, while temporal variations produce image blurring. To 
produce a very strong and homogeneous magnetic field, MR scanners employ 
superconducting magnets (Figure 2.23). The coil of the magnet must be able to 
support large electric currents without requiring an external power supply. In 
the Philips system, the superconducting coils are made of Niobium-Titanium 
Magnetic Resonance Imaging Concepts 
 
 
 
39 
(Nb-Ti) alloy with critical temperature around 10K. In order to maintain the 
superconductivity condition, a cooling system consisting of liquid helium is 
used and it is maintained with water and air cooled chillers (Figure 2.23).  
 
 
 
Figure 2.23:  Schematic diagram of main magnet. Liquid helium is used to cool the 
magnet. 
 
2.3.2 Shim coils 
To ensure that the main magnetic field is as homogeneous as possible, a set of 
shim coils are located in the bore of the magnet. There are two types of shim 
system used in MRI: passive and active shims. Passive shimming involves 
placing ferromagnetic material in the bore of an MRI scanner. Active 
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shimming is performed by using coils located inside the bore. The coils can 
produce a spatially varying magnetic field that can be adjusted for each subject. 
Active shimming is performed after a subject or sample is placed in the bore. 
In an MRI scanner, such as the Philips system, the shimming procedure is 
included in the protocol setup process.  
 
2.3.3 Gradient coils 
Gradients coils are an important component of an MR scanner. They consist of 
large resistive, low inductance coils wound on a cylindrical surface and water 
cooled to prevent overheating. Gradient coils are shielded to avoid eddy 
currents being produced in the bore. The gradient system is used to 
intentionally vary the magnetic field homogeneity across a field of view. 
Hence, the Larmor frequency will vary as function of position thus performing 
slice selection and spatial encoding. Other applications of the gradient coils 
include sensitizing MR signals in diffusion weighted imaging (DWI) and phase 
contrast imaging, and as spoilers to destroy transverse magnetization in some 
pulse sequences. 
 
2.3.4 Radiofrequency (RF) coils 
Radiofrequency coils are used for both the transmission and reception of RF 
signals.  There are different types of RF coils used in an MRI system. The body 
coil is the largest coil which is a fixed component of the magnet system. It can 
be used for both transmission and reception. However, to maximize the signal 
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to noise (SNR), usually, a local receive coil is used. Since SNR decreases with 
the distance from the receiver coil element, r (i.e. SNR α 1/r2), the receive coils 
should be positioned as close as possible to the area of the subject to be 
investigated to maximise signal detection. Normally, these types of coils are 
small and flexible. In this thesis, both a 5-element and 16-element body receive 
coil are used. 
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Chapter 3  
Assessing diffusion using Magnetic Resonance 
Imaging 
 
3.1 Introduction 
       Diffusion Weighted Imaging (DWI) exploits the random motion of water 
molecules, with the signal intensity of the acquired images being dependent on 
the self-diffusion of the excited spins. This molecular motion depends on the 
microscopic structure and organization of biological tissues; the extent of tissue 
cellularity and the presence of intact cell membranes determine the impedance 
of the diffusion of water molecules.  Hence, DWI can be used to assess various 
pathological changes in tissues. In this chapter, I present the basic principles of 
DWI that are used in the qualitative and quantitative interpretation of diffusion 
weighted images [1, 2]. Firstly, the basic principles of diffusion and the 
properties of water molecule movement in tissues is described. The technique 
of DWI is then explained, and the application of DWI to assess diffusion of 
water molecules in the tissue of abdominal organs is described. The influence 
of perfusion on the measurement of diffusion in tissue is described in the 
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Intravoxel Incoherent Motion (IVIM) model. The effect of the choice of b-
values on the resultant quantitative DWI images is explained, and the different 
mathematical models used to determine diffusion and perfusion parameters are 
introduced. Finally, the theory of Diffusion Tensor Imaging (DTI) is outlined.  
3.2 Diffusion of water molecules in tissue 
3.2.1 Brownian motion 
     Diffusion is a process by which matter is transported from one part of a 
system to another without requiring bulk motion as a result of random 
molecular motion, this is also called Brownian motion (Figure 3.1). Molecules 
spread out to move freely in all directions from an area of high to low 
concentration, a phenomenon described by Fick’s Law. 
 
 
Figure 3.1:  Illustration of the random movement of three molecules in pure liquid 
starting from the centre (blue dot). This random movement is termed Brownian 
motion. 
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3.2.1.1 Fick’s Laws 
Fick’s first Law relates the diffuse flux (J) to any difference in particle 
concentration (C) through the relationship 
! = 	−D ∂C∂x 																																																												(3.1) 
 
where D is diffusion coefficient and x is the position. The flux tends from a 
region of high concentration to low concentration with a magnitude 
proportional to the concentration gradient. Fick’s second Law predicts how 
diffusion causes the concentration to change with time:    
∂C∂t = D ∂/C∂x/ 																																																					(3.2) 
 
3.2.2 Diffusion in Tissue Microstructure    
         In pure water, molecules move freely in all directions from high to low 
concentration. However, water diffusion in the human body is complicated 
because its movement is limited by the interaction with natural barriers, such as 
cell membranes and macromolecules. In biological tissue, water molecules also 
diffuse in blood capillaries and vessels.  
       There are three types of cellular space in human tissue: extracellular space, 
intracellular space and intravascular space, as shown in Figure 3.2. Restricted 
water movement in the tissue is dependent on the tissue cellularity and the 
integrity of cell membranes. The movement of water molecules is more 
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restricted in tissue with high cellular density compared to tissues with low 
cellular density, as the low cellular density environment provides a large space 
for water molecules to move freely. Water molecules in intravascular space 
experience a greater diffusion distance compared to those in the extracellular 
because of blood flow. The different degree of movement of water molecules 
in all space contributes to the measured MR signal [3, 4]. 
 
 
Figure 3.2:  Model of the diffusion of water molecules in biological tissue (a) 
Intravascular space: water molecules diffuse in the capillary with blood flow, f. A 
tissue can be described by the volume fraction f (not shown in figure) of water flowing 
and diffusion in capillaries. (b) Extracellular space: water molecules move freely in 
large spaces but will bounce back from a membrane wall whilst the movement of 
water molecules is restricted between two cells. (c) Intracellular space: water diffuses 
in the cell and moves out of the intracellular space. 
 
      Water molecules can either diffuse equally in all directions, which is 
known as isotropic diffusion, or they can diffuse preferentially along a 
particular direction or axis, which is known as anisotropic diffusion. Figure 3.3 
illustrates the movement of water molecules from one position to another 
position in intracellular and extracellular space, showing the different types of 
barriers. Isotropic diffusion occurs if there are no barriers to diffusion (e.g. in a 
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pure liquid) or if the barriers are randomly oriented. Anisotropic diffusion 
occurs when there are barriers that impede diffusion in certain directions while 
favouring movement of water along others. Thus the directionality of water 
diffusion can be used as an indirect marker of the degree of tissue 
microstructure.  
          Because of this physical phenomenon, there must be enough time for the 
diffusion molecules to sample the environment of the tissue. At the limit of 
very short diffusion times, the molecules do not have time to experience any 
barriers; hence measurement of their diffusion does not give any indication of 
their environment. If there is sufficient time for the water molecules to interact 
with their surroundings, such as the cellular components in tissue that reduce 
the distance travelled, structure can be inferred by measuring the molecular 
displacement in multiple directions. In this case, at some point, the molecular 
mean squared displacement may not increase further, even when using longer 
diffusion times, since the structure does not permit the molecules to travel 
further. Measurement of intracellular water diffusion in living tissue and 
quantitative interpretation of diffusion data are challenged by the complexity of 
tissue microstructure, the contribution of both intracellular and extracellular 
water to the diffusion signal, and the exchange of water between these spaces. 
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3.3 Measurement of water molecules using Diffusion Weighted 
imaging (DWI) 
     Diffusion Weighted Imaging (DWI) is a MRI technique that is sensitive to 
Brownian molecular motion. The MR signal is dependent on the diffusive 
mobility of the water molecule in certain tissues. The degree of water diffusion 
is typically characterized by the Apparent Diffusion Coefficient (ADC) which 
is measured in units of mm²/s; the term ‘apparent’ is used because the intrinsic 
water molecules not only collide with other molecules but also reflect from 
impermeable barriers or move into intracellular and extracellular in the tissue 
microstructure.  
 
Figure 3.3:  Illustration of the diffusion of water molecules (red) in tissue started at 
origin (blue). The directionality of molecules can be classified as (a) isotropic and (b) 
anisotropic. In isotropic diffusion the movement is random in all directions, while in 
anisotropic diffusion the movement is in a preferred direction due to restriction by the 
barriers. 
(a) (b) 
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3.3.1 The effect of perfusion on diffusion parameters 
      In biological tissue, other movement sources aside from diffusion may 
contribute to the ADC value, such as microcirculation or perfusion in a pseudo-
random capillary system. Water molecules flow in the blood stream and change 
direction between each capillary segment in the tissue. This movement of 
blood in the microvascular contributes to the diffusion MRI result. On a 
microscopic scale, water molecule movement in blood capillaries can be 
described as a pseudo-diffusion process. The segments of blood capillaries are 
distributed in space in a pseudo-random manner and the overall movement of 
water molecules mimic a random walk [5], Figure 3.4. This concept is known 
as Intravoxel Incoherent Motion (IVIM). The IVIM model is characterised by 
the pure molecular diffusion coefficient (D), the pseudo-diffusion coefficient 
(D*) which reflects the velocity of capillary blood and perfusion-related 
pseudo-diffusion, and the perfusion fraction (f) which reflects the fraction of 
flowing blood that can be distinguish in a voxel (Section 3.4.2). 
 
 
 
 
 
 
 
 
(a) (b) 
Figure 3.4:  Basic principle of Intravoxel Incoherent Motion (IVIM). (a) Illustration 
of blood flow, fb in microvasculature. (b) The motion of water molecules (red and 
blue dots) in flowing blood in the capillary network may mimic a random walk 
shown by red and blue lines. D* represents the pseudo-diffusion coefficient, which is 
associated with the blood perfusion as it changes capillary segments, x, several times 
during the diffusion time, t. Perfusion can be considered as incoherent motion due to 
the pseudo-random orientation of microvascular at the voxel level. 
fb 
D* 
t 
x 
fb 
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Theoretically, the ADC value is equal to D when diffusion is the only type of 
motion in the tissue [6], (e.g. for pure water) [7]. Recently, DWI has been used 
increasingly in the investigation of the characterization of diffusion parameters 
(properties) in abdominal organs [7-9]. The ADC is dependent on capillary 
perfusion and water diffusion in the extracellular space [10]. The effect of 
perfusion on the ADC value can provide information concerning 
microstructure changes in abdominal organs [7, 11]. The ADC values of the 
liver [7, 11], kidney [7, 12], spleen, pancreas, and muscle (ADC: 0.86, 1.55, 
0.88, 1.02, and 1.09 x 10-3 mm2/s respectively) are significantly higher than 
their corresponding D values (D: 0.72, 1.38, 0.8, and 0.69 x 10-3 mm2/s 
respectively) due to the effect of perfusion [7]. However, in the gallbladder 
(ADC: 2.81 x 10-3 mm2/s, D: 2.82 x 10-3 mm2/s) and cysts [5] (ADC: 3.01 and 
D: 3.03 x 10-3 mm2/s) the ADC and D value are approximately equal because 
diffusion is the only type of molecular motion. In the kidney, ADC values are 
high compared to other abdominal organs due to the high water content and 
blood supply of the kidney [10]. In the liver, ADC values have been shown to 
be significantly reduced in the cirrhotic (ADC: 1.23 x 10-3 mm2/s) liver 
compared to a healthy liver (ADC: 1.39 x 10-3 mm2/s) [7]. Lesions in the liver 
give rise to a variation in ADC (1.10-1.56 x 10-3 mm2/s), D (1.02-1.31 x 10-3 
mm2/s), and f (0.15-0.35 x 10-3 mm2/s) values [5].  
 
3.3.2 Diffusion Weighted Imaging (DWI) pulse sequence 
 A Diffusion Weighted Imaging (DWI) pulse sequence is shown in Figure 3.5 
and 3.6 for a spin echo (SE) EPI acquisition. In the presence of magnetic field 
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gradients, the effect of diffusion on spins (water molecules) can be described in 
terms of the phase shift ∆ф of the transverse magnetization in the rotating 
frame. In Figure 3.5, a pair of diffusion gradients is applied to quantify 
diffusion. The two lobes have the same polarity and are placed either side of a 
1800 refocusing RF pulse (in contrast, in a gradient echo (GE) pulse sequence 
the two lobes must have opposite polarity). The first diffusion gradient Gd is 
positioned between the 90⁰ pulse and refocusing 180⁰ RF pulse. The 90⁰ RF 
pulse creates coherent transverse magnetization of spins such that all spins are 
in phase. Spins at position x are then dephased by the first diffusion gradient, 
resulting in a phase shift ф1 = γδGdx. For stationary signals, this phase shift 
will be reversed by the 180⁰ RF pulse, and the second diffusion gradient 
rephases the spins back with identical phase. However, the phase that is 
acquired from the dephasing and rephasing process is different for diffusing 
molecules, because such spins move between the two diffusion gradients, from 
x to x’, thus each single spin experiences a different effect of magnetic field at 
the time of the second diffusion gradient (t1+∆+δ). The net phase shift 
following this pulse will be ∆ ф= γδGd(x’-x). This resulting phase shift is 
observed as signal attenuation, which is a measure of the molecular diffusion.  
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The sensitivity of a DWI sequence to water motion can be modified by 
changing the properties of the diffusion gradient - the gradient strength 
amplitude Gd, the duration of each gradient pulse δ, and the time interval 
separating the paired gradient pulses Δ, Figure 3.5. The effect of gradient 
strength and timing can be described by the diffusion b-value (of units s/mm²). 
For rectangular diffusion lobes, the b-value can be calculated from: 
b = 	γ/G/δ/ ∆ − δ3 																																														(3.3) 
Figure 3.5:  Schematic diagram of a DWI pulse sequence. The three circles illustrate 
each proton with different states of transverse magnetization in the rotating frame 
during diffusion which begins at different positions, x. Before the diffusion gradient is 
applied, all spins have the same frequency and phase. The first diffusion gradient Gd 
causes the spins to dephase (black arrow direction). A spin moving in the direction of 
the magnetic field gradient Gd has a different phase shift compared to a non-moving 
spin. Ф1 represents the phase shift caused by the application of diffusion gradient, Gd. 
A spin echo forms at a time t = TE following the application of a 90⁰ RF pulse with 
net dephasing of ∆ф.	
Spin echo 
δ 
Δ 
Dephasing Diffusing Attenuated Signal Rephasing Signal 
90ᵒ 
180ᵒ 
TE 
Gd Gd 
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for which (∆-δ/3) is referred to as the diffusion time, which is controlled by the 
time between the two diffusion-sensitizing gradients. If trapezoidal diffusion 
gradients are applied with slope τ,  the b-value can be calculated from:  
b = 	γ/G/ δ/ ∆ − δ3 + τ930 − δπ/6 																																	(3.4) 
The resultant signal attenuation of the MR signal is defined as the ratio (S/S0) 
of the measured signal S at given b-values, to the original signal without the 
influence of the diffusion gradient, S0. The signal attenuation is related to the 
apparent diffusion coefficient (ADC) [5] by 
S = 	 S?. e ABCDE 																																															(3.5)          
DWI typically uses a fast single-shot echo-planar imaging (EPI) readout 
sequence. This provides the advantage that it overcomes bulk motion problems 
in tissues, but can limit the acquired slice number as well as the spatial 
resolution [13]. Most frequently a DWI spin-echo echo planar imaging (SE-
EPI) sequence is implemented (Figure 3.6). 
A sufficient SNR is particularly demanding in DWI, since the SNR in DW 
images is reduced by the relatively long echo time TE [14] required for high b-
values. Reducing the echo time, limits the achievable b-values, but leads to a 
reduced T2 dependence and an increase in the signal-to-noise ratio (SNR). 
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3.3.3 The effect of b-value of diffusion parameter estimates 
       In DWI, the choice of b-value is very important in the quantitative analysis 
of diffusion parameters. Theoretically, the attenuation of signal intensity with 
increasingly b-values occurs exponentially in tissues. A DWI image can thus 
be formed from a minimum of two b-values (e.g. typical values include b=0 
s/mm² and a second b-value of 500 - 1000 s/mm²). The tissue can then be 
characterized by observing the relative signal intensity in the DWI at the higher 
b-value to b=0 s/mm². The greater the b-value used, the greater the degree of 
attenuated signal from water molecules in tissues [3]. For example, at a given 
b-value the signal intensity of a cyst is lower than a tumour because water 
diffusion is less restricted. However, the signal intensity also depends on the T2 
Figure 3.6:  A DWI single-shot spin-echo EPI pulse sequence. Dotted lines indicate 
that the diffusion gradient Gd can be applied in any direction. GSS, GPE and GFE 
represent the slice select, phase encoding and frequency encoding gradients 
respectively. 
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relaxation time, the signal in a DWI image will remain high in areas with a 
very long T2 and can be mistaken for restricted diffusion. This is called the “T2 
shine-through” effect, and can be reduced by using a shorter TE and larger b-
values [4].   
        The relation between signal intensity and b-value is shown in the 
logarithm plot in Figure 3.7. A faster rate of signal decay occurs at low b-
values in the liver due to the contribution from both diffusion and perfusion, 
and its relatively high blood volume fraction [15]. At low b-values, the 
intravoxel spin dephasing caused by the pseudorandom blood flow in the 
presence of a diffusion gradient will contribute more to signal attenuation. 
During the latter part of the signal decay, the attenuation is mainly a 
consequence of molecular water diffusion which is supressed by the large 
diffusion gradient [15]. Moreover, IVIM has different sensitivity to vessel 
types according to the b-value that is used. At very low b values, signal from 
large vessels with rapid flow attenuates quickly, while at larger b values (>200 
s/mm²) smaller vessels with slower flow may still contribute to the IVIM signal 
[16]. 
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Figure 3.7 :  The logarithm plot of relative signal intensity (ln S/Sₒ) versus b-value for  
liver and kidney. There is an initial steeper decrease in signal at low b-values (b< 50 
s/mm² -dashed arrow) for the liver compared to the kidney. At high b-values, the 
signal for the both liver and kidney decrease more gradually 
 
3.4 Mathematical Models for Quantification of DWI  
3.4.1 Apparent Diffusion Coefficient monoexponential model 
The simplest model is to calculate the apparent diffusion coefficient (ADC) 
from DW images. This is given by the mono-exponential function,  
S = 	 S?e AB.GHI 																																											(3.6) 
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where S is the signal intensity at a given diffusion gradient b-value, S0 is the 
signal intensity without a diffusion gradient (b=0 s/mm²), and ADC is apparent 
diffusion coefficient (mm²/s) of the tissue. Figure 3.8(a) shows the attenuation 
of signal intensity with increasing b-value, alternatively this can be described 
by plotting the logarithm of signal intensity versus b-value (Figure 3.8 (b). 
However, the ADC model describes only one fraction of water molecules 
within an image voxel. 
 
                 
Figure 3.8:  (a) Monoexponential curve of relative signal intensity (S/S0) versus b-
value showing the attenuation of signal intensity with increasing b-value. (b) 
Logarithm of relative signal intensity (S/S0) versus b-values plot describes ADC value 
from a linear gradient. 
 
3.4.2 Intravoxel Incoherent Motion (IVIM) biexponential 
Model 
Intravoxel Incoherent Motion (IVIM) [5] quantifies the diffusion and perfusion 
effects to combine the motion of water in cellular space and the 
microcirculation of blood in capillaries. The signal variation, S, at a given b-
value can be expressed in the IVIM equation: 
S/
S 0
b-value
(a)
ln
 S
/S
 0
b-value 
(b)
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S = S? 1 − f . K AB.H + f. K AB. HLH∗ 																									(3.7) 
where S is the mean signal intensity at a given b-value, f is the perfusion 
fraction of the diffusion related to microcirculation, D (mm²/s) is the diffusion 
coefficient representing the true diffusion of water molecules and D* (mm²/s) 
is the pseudo-diffusion coefficient related to the perfusion in the 
microcirculation in the voxel. The perfusion fraction f is involved in perfusion 
in blood capillaries, and the volume fraction (1-f) is involved in diffusion only. 
The effect of perfusion is dominant at low b-values (b=<50 s/mm²) and can be 
excluded when high b-values (b>400s/mm²) are applied. Figure 3.9 shows the 
attenuation of signal intensity with increasing b-values for a biexponential 
model in the presence of incoherent motion other than diffusion [5, 17]. 
 
Figure 3.9: Biexponential curve showing an initial rapid attenuation of signal intensity 
at low b-values due to the perfusion fraction (f). 
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3.4.3 Stretched-Exponential Model 
The stretched-exponential function was developed to describe diffusion-related 
signal decay as a continuous distribution of sources decaying at different rates 
[18]. To describe the behaviour of the attenuation analytically as a function of 
b-value, the stretched exponential model is given by 
S = 	 S?. K A B	O	HHI P 																																								(3.8) 
where α is the stretch parameter which characterizes the deviation of the signal 
attenuation from monoexponential behaviour, and is limited to values between 
0 and 1. DDC is the distributed diffusion coefficient which is derived from 
fitting the stretched-exponential function to the data and can be used to 
measure mean intravoxel diffusion rate in the presence of heterogeneity of 
diffusion. A value of α that of close to 1 indicates high homogeneity in 
apparent diffusion and hence a monoexponential attenuation curve (α close to 0 
indicates heterogeneity). Lower values of α result from monoexponential 
behaviour caused by the addition of multiple separable proton pools within the 
voxel.  
 
3.4.4 Kurtosis Model 
         The kurtosis method provides a specific measurement of tissue structure 
such as cellular compartments and membranes, by quantifying the degree to 
which water diffusion is non-Gaussian. The model is described by 
S = 	 S? K ABHRSSLTUBVHRSSVWRSS 																														(3.9)                                
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where Kapp is the apparent diffusional Kurtosis and Dapp is apparent Diffusion 
Coefficient. In order to obtain Kapp with a reasonable degree of precision, large 
b-values must typically be employed in DWI [19]. In the brain, maximum b-
values of 2000 s/mm² are needed, and from this, maps of diffusional kurtosis 
and apparent diffusion coefficient can be generated. 
 
3.4.5 Analysis method in obtaining the diffusion parameters 
       Many studies have compared the diffusion parameters of the 
monoexponential model of ADC with the biexponential IVIM to estimate D, 
D* and f values [20-22]. The monoexponential ADC model fits the DWI data 
least well, but is the most robust against low SNR. Analysis of in-vivo DWI 
measurement shows that the biexponential model is the preferred analysis 
method [20] under the precondition of sufficient SNR. For example, 
monoexponential ADC and biexponential IVIM models have been compared in 
normal and malignant prostate tissue and normal rectal wall tissue [22]. The 
ADC was significantly higher than the corresponding diffusion coefficient D 
from the biexponential model. The biexponential was the best model 
describing the data when low b-values were included in the calculation. [21]. 
       The stretch-exponential model assumes that there is no prior information 
about the number of  intravoxel proton pools, since this model contains one 
less free parameter than the biexponential model [18]. The relation between the 
diffusion coefficient and the effect of the model sensitivity on the magnitude of 
the applied diffusion gradient was investigated in rat brain cortex, this model 
can also measure the heterogeneity in water diffusion. New types of contrast 
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were observed with this model, but caution must be taken in selecting b-values 
in order to match the diffusion coefficient in the samples. Another observation 
was that both DDC and ADC were affected by the heterogeneity of diffusion 
rate in the voxel, the values of DDC being higher when the intravoxel diffusion 
rate was fast and homogeneous.  
        The Kurtosis method has been proven to be useful in neurologic diseases, 
such as multiple sclerosis and epilepsy and in the investigation of abnormalities 
in tissues with isotropic structure such as grey matter [19]. Diffusional kurtosis 
decreases rapidly if the maximum b-values are reduced substantially below 200 
s/mm². A principle advantage of the diffusional kurtosis model compared with 
the ADC is that it is a specific measure of tissue structure (e.g. cellular 
compartments and membranes). The ADC is not only affected by the diffusion 
structure but influenced by other factors, such as the concentration of 
macromolecules.  
3.5 The limitation in DWI in abdominal imaging 
     One major problem in applying DWI for clinical applications in the body is 
respiratory motion. To overcome this problem, two main acquisition strategies 
can be implemented in DWI applied in the body: breath-holding and free-
breathing. Breath-holding allows a target volume in the abdomen (e.g. liver, 
kidney, pancreas and gallbladder) to be measured. However, the number of b-
value images that can be acquired over the duration of a breath-hold are 
limited, giving poor SNR and greater sensitivity to pulsatile and susceptibility 
artefacts [4].  Free-breathing spin-echo EPI based DWI is a technique that is 
frequently used in the abdomen. Most typically free-breathing data is collected 
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with respiratory triggering. This technique allows the use of multiple and high 
b-values, improving SNR and contrast-to-noise ratio (CNR). However, the 
image acquisition time for free-breathing is long and it will depend on the 
coverage and the number of b-values used. Interestingly, one study has shown 
that respiratory-triggered DWI of the liver is less reproducible than breath-hold 
and free-breathing DWI [10]. In contrast, others have shown the reproducibility 
of DWI of the kidney to be promising with a free-breathing technique [23] and 
that the best image quality and reproducibility is obtained by applying 
respiratory triggering [24], with images of diffusion anisotropy showing 
significant improvement when compared to those collected using conventional 
breath-hold acquisition [25]. Multiple breath-hold acquisitions are possible but 
this is highly demanding for the subject, and can prove difficult in a clinical 
setting. Thus, the use of respiratory triggered acquisition is preferred in a 
clinical setting as it requires less patient cooperation. This is the method was 
used in Chapters 4 and 6. 
3.6 Diffusion Tensor Imaging (DTI) 
     The mobility of water molecules in organized tissue is not necessarily the 
same in all directions but can occur in one of three ways (i) bulk flow, (ii) 
isotropic diffusion where motion is random and (iii) restricted diffusion where 
random motion is constrained by physical barriers. In the kidney, whose 
function is to transport water, renal structures such as vessel, tubules and 
collecting ducts are oriented in a radial fashion, resulting in anisotropic 
diffusion properties [12] . 
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        In a DWI scheme, the diffusion gradients can be applied in at least six 
directions yielding a diffusion tensor image (DTI) to obtain information on the 
orientation of water molecule diffusion. In anisotropic tissues, ADC will vary 
depending on the direction in which it is measured. DTI provides further 
information on the degree of diffusion anisotropy in the tissue’s microstructure. 
To measure the ADC values in an anisotropic tissue all tensor components and 
an unweighted (b=0) image are required. The diffusion properties can then be 
described mathematically by a tensor which has nine matrix values (3x3), each 
corresponding to a gradient orientation and a cell orientation (equation (3.10)). 
D = 	 DOO		DOY		DOZDOY		DYY		DYZDOZ		DYZ		DZZ 																																													(3.10) 
The diffusion tensor results in a three-dimension (3D) ellipsoid. The physical 
process of diffusion causes water molecules to move out from a central point, 
and gradually reach in the surface of an ellipsoid if the medium is anisotropic 
(Figure3.10 (b)) and in the surface of a sphere for an isotropic medium (Figure 
3.10 (a)). The ellipsoid has three principle primary axes which describe its 
length, width and depth properties. These are determined by the eigenvectors 
(v1,v2 and v3) and eigenvalues (λ1, λ2, and λ3) that describe the orientation and 
magnitude of diffusion along the principle axes (Figure 3.10). All three of these 
are perpendicular to each other and cross at the centre point of the ellipsoid. 
The diffusivity along the principle axis, λ1 is also called the longitudinal 
diffusivity or the axial diffusivity (AD). The diffusivities in the two minor axes 
(λ2 and λ3) are often averaged to provide a measure of radial diffusivity (RD) 
(Equation (3.11)). Mean diffusivity (MD) is a scalar measure of the total 
diffusion within a voxel (Equation (3.12)). The other parameter involved in 
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diffusion anisotropy measurements is the fractional anisotropy (FA) (Equation 
(3.13)), an index scaled from 0 (isotropic: no preferred direction) to 1 (full 
anisotropy: only one direction).  
 
 
 
 
 
 
 
 
 
 
		RD = λ/ + λ92 																																																							(3.11) 
MD = λ^ + λ/ + λ93 																																													(3.12) 
FA	 = 	 3	 λ^ − MD / +	 λ/ − MD /		 + 	 λ9 − MD /2	 λ^/ + λ// + λ9/ 																(3.13) 
 
DTI has been applied to renal tissue in a small number of studies [25-27] to 
measure anisotropic diffusion in the kidney. FA has been shown to be low in 
the renal cortex suggesting that diffusion in the renal cortex can be coherent in 
v1 
v2 v3 
v1 
v2 
v3 
(a) (b) 
Figure 3.10:  Three principle directions are coincident with the eigenvector of 
D, v1,v2, and v3 in (a) an isotropic medium which has spherical diffusion 
ellipsoid and (b) in an anisotropic medium which has a prolate or oblate 
diffusion ellipsoid. 
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direction but relatively isotropic in magnitude [25]. In contrast, recent studies 
have shown that the directionality of diffusion (FA) is higher in the renal 
medulla than in the cortex  [24, 28, 29], which probably reflects the radial 
arrangement  of tubules, vessels, and collecting ducts and blood vessel [26, 30, 
31], suggesting a coherent flow along the axial direction and restricted 
diffusion in the radial direction. DTI has also been used in the liver [13], and 
results show that the liver has a near isotropic diffusion. DTI has detected 
progressive changes in water diffusivities and diffusion anisotropy in tissues 
with liver fibrosis [32]. 
      In addition, the impact of renal blood flow on FA values of kidneys has 
been reported [28]. In the human kidney, a significant correlation between 
renal ADC and blood flow in renal artery [33] has also been demonstrated, 
with ADC of renal cortex being significantly higher at maximal than minimal 
blood flow [28]. The potential influence of pulsatile blood flow on ADC and 
FA values has to be considered when interpreting DWI and DTI data. 
However, whilst the measured ADC values are highly dependent on the choice 
of b-values [24], FA values are not, suggesting that FA is a more stable 
parameter than ADC [10]. Moreover, IVIM and DTI methodology can be 
combined to distinguish structural from flow effects [34].  
This chapter has presented an overview of diffusion imaging which will be 
applied in Chapters 4 and 6. 
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Chapter 4    
The application of MRI measures to study 
Kidney Disease 
 
 
4.1 Introduction 
This chapter describes the application of diffusion imaging and longitudinal 
(T1) relaxation mapping to assess the changes that occur in patients with 
Cardiorenal Syndrome (CRS).  
A description of kidney structure and function is first provided, and the 
underlying pathophysiology of CRS is outlined. This is followed by a brief 
review of the current applications of diffusion imaging and T1 measurements in 
the study of kidney disease. Diffusion imaging, longitudinal relaxation time 
measures and phase contrast blood flow are then applied to the study of CRS 
patients at 1.5 Tesla. Diffusion weighted imaging (DWI) parameters are 
estimated using multiple models and are compared, and diffusion tensor 
imaging (DTI) is used to assess orientation dependent diffusivity in the kidney.  
This work was presented as an oral presentation at the Intl. Soc. Mag. Reson. 
Med., Utah, 2013, p22. Components of the work presented in this chapter and 
The application of MRI measures to study Kidney Disease 72 
related data from this study have been published in ‘The pathophysiology of the 
chronic Cardiorenal Syndrome: a magnetic resonance imaging study’, 
Breidthardt T, Cox EF, Squire I, Odudu A, Omar NF, Eldehni MT, Francis ST, 
McIntyre CW, Eur Radiol. 2015 Jun;25(6):1684-91.  
 
4.2 Kidney structure and function 
       The kidneys reside against the back muscles in the upper abdominal cavity 
and are located in the region of the thoracic (T12) and lumbar vertebrae (L3), 
as shown in Figure 4.1. The right kidney is lower than the left kidney to 
accommodate the liver. The kidneys receive blood from the aorta via the renal 
arteries and return blood to the inferior vena cava via the renal veins. Urine is 
formed in the kidney and passed by a pair of ureters to the uterine bladder, 
where it is stored until it can be released through the urethra. There are a large 
number of blood vessels which run through the kidney and supply a vast 
network of capillaries.  
 
Figure 4.1:  Location of the kidneys as viewed from the back. Image adapted from 
http://philschatz.com/anatomy-book/contents/m46429.html) 
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        Figure 4.2 shows the kidney’s anatomy and structure. The kidney has two 
distinct regions, the medulla and cortex. The medulla is composed of tubules, 
collecting ducts and blood vessels which are grouped together to form renal 
pyramids and is subdivided into the outer and inner medulla, with the inner 
medulla being furthest from the cortex. The tip of the medullary pyramid forms 
a renal papilla. The hilum is the medial aspect of each kidney, where the ureter, 
blood vessels, nerves, and lymphatic vessels enter or leave the kidney. 
 
Figure 4.2:  Diagram showing kidney anatomy and structure. (Image adapted from 
Renal Physiology and Body Fluids, Chapter 22, Kidney Function by George A. 
Tanner) 
        
          The nephron is the basic structure and functional unit of the kidney, there 
are about one million nephrons per kidney and they provide an enormous 
surface area for the exchange of materials. Each nephron is composed of six 
regions as shown in Figure 4.3. These are the renal capsule, containing the 
glomerulus and surrounded by the Bowman’s capsule; the proximal convoluted 
tubule; the descending limb of the loop of Henle; the ascending limb of the 
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loop of Henle; the distal convoluted tubule; and the collecting duct. There are 
two types of nephron, cortical nephrons located in the cortex which contain a 
short loop of Henle, and the juxtomedullary nephrons which have renal 
corpuscles close to the junction of the cortex and medulla. 
 
 
Figure 4.3:  Components of the nephron and the three processes of ultrafiltration, 
selective reabsorption and secretion performed in the kidney. (Image modified from 
Renal Physiology and Body Fluids, Chapter 22, Kidney Function by George A. 
Tanner) 
 
        The processes that are performed by the nephron are ultrafiltration, 
selective reabsorption, and secretion, with the transportation of substances 
being either by active or passive processes. All small molecules (i.e. water, 
glucose, and urea) are filtered out of the blood plasma in the glomerulus and 
produce a filtrate in the Bowman’s capsule which passes into the tubule of the 
nephron. Blood pressure forces fluid from blood in the glomerulus into the 
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Bowman's capsule. The Bowman's capsule is permeable to water and small 
solutes and is involved in nonselective filtration. The filtrate contains salts, 
glucose, amino acids, vitamins, urea, and other small molecules. All substances 
useful to the body to maintain the water and salt composition of body fluids are 
removed from the filtrate and reabsorbed into the blood capillaries which 
surround the kidney tubules. The processes performed by nephrons are 
described in Figure 4.3, and are (1) In the proximal tubule, NaCl, glucose, 
amino acids, K+, HCO3¯, and water diffuse into the tissue. This process helps 
maintain pH (HCO3¯) in the kidney. At the same time, H+ and NH3 are secreted 
into filtrate; (2) In the descending loop of Henle, water is reabsorbed into the 
tissue and filtrate becomes more concentrated; (3) In the thick and thin 
ascending loop of Henle, only NaCl is reabsorbed because the wall of the 
ascending loop of Henle is impermeable to water; (4) In the distal tubule, 
NaCl, water, and HCO3¯ are reabsorbed, while K+ is secreted into filtrate. In 
order to control pH in the tissue, H+ is secreted into the filtrate and HCO3¯ is 
reabsorbed; (5) In the collecting duct, urea and water is carried though the 
medulla to the pelvis and NaCl is actively reabsorbed. Finally, urine is excreted 
into a minor calyx by each renal papilla, which then flows into the renal pelvis 
and exits the kidney through the ureters.  
Figure 4.4 shows the vessels involved in the blood circulation in the kidney. A 
single renal artery supplies blood to each kidney and branches into interlobar 
arteries, which pass toward the cortex between the kidney lobes. The interlobar 
arteries branch to form arcuate arteries at the junction of the cortex and give 
rise to smaller cortical radial arteries. The cortical radial arteries extend to form 
afferent arterioles and gives rise to glomerulus, followed by efferent arterioles. 
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Finally, the efferent arteriole divides into peritubular capillaries, which 
surround the kidney tubules and vasa recta, which are straight and long 
capillaries. Some vasa recta reach deep into the inner medulla. The descending 
and ascending vasa recta are grouped in vascular bundles in the outer medulla. 
This arrangement provides a medium to exchange substances between blood 
flowing into and out of the medulla. 
 
 
       The glomerular filtration rate (GFR) is the rate at which plasma is filtered 
by the kidney glomeruli. GFR is typically used to evaluate kidney function, and 
can be measured from iohexol or inulin clearance measurements, or estimated 
from a blood test.  
         The kidney plays an important role in the human body in maintaining the 
body fluid composition at a stable internal environment by excreting 
substances (waste products, foreign compounds, including useful substances) 
Figure 4.4: Vessel supply to the kidney and flow of blood in the 
kidney. 
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in the urine. It also regulates the concentration of electrolytes in blood plasma, 
such as, Na+, K+, Ca²+, Mg²+, Cl¯, bicarbonate (HCO3¯), phosphate, and 
sulphate. The kidney plays a major role in balancing acid-base in the body by 
excreting H+ when there is excess acid, or HCO3¯ when there is excess base. 
The kidney regulates blood volume by controlling Na+ and the amount of water 
excreted. It excretes nitrogenous compounds such as urea, uric acid, ammonia, 
and creatinine. It also helps to regulate blood pressure by adjusting Na+ 
excretion and producing various substances, such as renin, that can affect blood 
pressure and remove drugs and foreign or toxic compounds. If there is a 
problem with the kidney, it will manifest in kidney disease in the form of 
Chronic Kidney Disease (CKD) or Acute Kidney Injury (AKI). 
4.3 Kidney Disease 
       Chronic kidney disease (CKD), also known as chronic renal disease, is a 
gradual reduction in kidney function over a period of time. The common 
causes of CKD are diabetes, high blood pressure and ageing. Untreated or 
poorly treated high blood pressure can lead not only to CKD but heart attack 
and stroke. CKD can be diagnosed using a blood test to assess creatinine level. 
Higher levels of creatinine indicate a lower GFR, where the kidney’s capability 
to excrete waste products is decreased. CKD is classified as abnormalities in 
kidney function or structure present for more than 3 months in which GFR is 
less than 60 ml/min on at least 2 occasions. All GFR values are normalized to 
an average body surface area of 1.73m2.  
      CKD can lead to acute kidney injury (AKI) where there is loss of kidney 
function that leads to complete kidney failure. Alternatively, AKI commonly 
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results as a complication of other serious illnesses such as heart failure, liver 
disease or diabetes. Often the cause of AKI is a reduction of blood flow to the 
kidneys, caused by low blood volume, weak heart pumping, inflammation, 
blockage in blood vessels to the kidney, or certain medicines that affect the 
blood supply to the kidney or cause a reaction in the kidney itself. 
Glomerulonephritis, damage of glomeruli inside the kidney, can also cause 
AKI to occur.  
Cardiorenal Syndrome (CRS) describes the clinical condition in which cardiac 
and renal dysfunctions coexist. Despite its clinical importance, the 
pathophysiology of chronic cardiorenal syndrome (CRS) is currently not fully 
understood [1]. Renal dysfunction (RDF) is common in patients with heart 
failure (HF), where it has consistently been shown to be one of the strongest 
predictors of morbidity and all-cause mortality in patients with heart failure [2-
6].  
30% of all heart failure patients have a history of chronic renal failure 
according to the Acute Decompensated Heart Failure National Registry 
(ADHERE) [7] and 30% of stable heart failure outpatients with symptoms 
exceeding New York Heart Association (NYHA) Class 2 have been reported to 
have severe renal impairment (i.e. an eGFR below 30 ml/min)[8]. According to 
a recent meta-analysis including over 80,000 chronic heart failure patients, 
mortality worsens incrementally across a range of renal function, with a 7 % 
increase  in the risk of mortality for every 10 ml/min decrease in eGFR [6].   
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4.4 Assessment of kidney disease using Diffusion Imaging 
        Early detection of kidney disease is important to help prevent the 
progression of kidney disease to kidney failure. Clinically, the type and 
severity of renal pathology in CKD can be identified using a renal biopsy, 
which involves removing a small sample of kidney tissue. However, there are 
risks associated with this, which may cause complication and even death in 
patients. Diffusion weighted imaging (DWI) provides a non-invasive imaging 
method to potentially diagnose CKD and AKI. The role of the kidney in water 
filtration makes it an interesting organ to investigate using DWI, as diffusion 
provides an indicator of water molecule movement in tissues. In the healthy 
kidney, there is a higher ADC in the medulla than cortex (for example, 
measures of 2.84 x 10-3 mm2/s in the medulla versus 2.55 x 10-3 mm2/s in the 
cortex) reflecting the greater water diffusion per unit tissue mass in the medulla 
than the cortex. CKD is characterized by loss of nephrons and fibrosis, which 
causes a reduction of water transport function, thus restricting the water 
molecules movement. 
A number of groups have performed DWI in the kidney to investigate 
the clinical importance of diffusion parameters in the assessment of renal 
pathology. Recently, Li et al. investigated the clinical potential of DWI (using 
two b-values of 0 and 800 s/mm2) at 1.5 Tesla to assess renal pathology of 
CKD [9]. Three groups of CKD patients were classified according to the 
severity of renal pathology (mild, moderate, and severe). ADC was measured 
in the renal cortex and compared with pathology score, eGFR, serum creatinine 
(SCr), and age. Results showed that ADC correlated negatively with pathology 
score and gradually decreased across all groups (mild, moderate, severe 
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impairment, and controls with ADC values of 2.05, 1.93, 1.75, and 2.06 x 10-3 
mm2/s respectively). The difference in ADC between all groups was 
significant, suggesting that ADC may reflect the severity of renal pathology 
and could serve as a non-invasive and effective index for guiding therapy and 
follow-up in CKD. A relationship between ADC and pathology type such as 
glomerulosclerosis, tubular atrophy, and interstitial fibrosis was also observed, 
although the ADC did not significantly differ with renal pathology.  
Renal function has also been prospectively evaluated using DWI to 
detect early stage CKD [10]. Patients were grouped into five stages according 
to the K/DOQI CKD (kidney disease outcome quality initiative) classification 
and eGFR. At all except the first stage of CKD, ADC values in the kidney were 
significantly lower than in healthy subjects. A negative correlation between 
ADC and SCr was found in CKD patients. The reduction of ADC suggested to 
be likely due to tubular atrophy, interstitial fibrosis, cellular infiltration, and 
scarring of glomeruli [10] which restricts the movement of free water in the 
extravascular extracellular space. There was also a moderate negative 
correlation between ADC and age, likely a result of the ageing kidney being 
characterized by a decrease in renal blood flow and GFR, as a result of 
glomerulosclerosis. Carbone et al. [11] also assessed renal function and 
morphology. They showed a good correlation (p=<0.01, R=-0.79) between 
ADC and GFR, suggesting ADC to be a good parameter for determining renal 
damage [11]. 
          Renal fibrosis is one indicator of pathological change in the kidney, and 
is the final common abnormality of CKD. The presence of fibrosis in the 
kidney could determine early treatment and prognosis of the patient. Previous 
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studies have shown the potential of DWI as a sensitive non-invasive biomarker 
to detect the presence of fibrosis in CKD [12, 13]. Zhao et al. [12] assessed 
renal fibrosis in CKD patients using ADC, and correlated with histopathology 
to assess type of fibrotic lesion and fibrosis score, as well as SCr and eGFR. 
Renal ADC was found to correlate significantly with the histological measure 
of fibrosis (p<0.05, R=-0.78). During renal fibrosis, there is a higher cell 
density, including fibroblasts in the interstitial space, which can decrease the 
extracellular water fraction and increase the intracellular water fraction [13], 
leading to a lower ADC. In addition, collagen deposition in the kidney may 
contribute to reduced water motion and lower ADC values [14]. 
       In an animal model of unilateral ureteral obstruction (UUO), a surgical 
procedure to obstruct the urinary flow which results in renal fibrosis 
approximately after 1 week, the change in renal histopathology due to 
fibrosis[13] was correlated with DWI. ADC was measured in the cortex and 
medulla of the kidney, a decrease in ADC due to fibrosis was shown which 
was associated with an increased number of fibroblasts. 
         DWI was also found to be useful in determining the presence and severity 
of acute and chronic renal change after AKI. One of the factors that lead to 
AKI is renal ischemia reperfusion which is associated with tissue oedema, 
inflammatory cell infiltration, and subsequent development of interstitial renal 
fibrosis and tubular atrophy. Heuper et. al. [15] used DWI to characterize acute 
and chronic pathology after unilateral (moderate and severe) AKI was induced 
in mice. Renal histology and immunohistochemistry were performed to 
determine inflammatory cell infiltration with monocytes/macrophages, T-
lymphocytes, and dendritic cells, as well as the degree of interstitial fibrosis 4 
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weeks after AKI. They showed that ADC in the medulla was reduced 
significantly after AKI, and that ADC was associated with the severity of AKI, 
inflammatory cell infiltration and interstitial renal fibrosis at 4 weeks after 
AKI. They also demonstrated a significant loss of kidney volume after AKI. 
      ADC values have also been compared between CKD and AKI [16, 17]. 
Namimoto et al. [17] showed that in CKD and AKI, the ADC value in the 
kidney in both medulla and cortex were significantly lower than for a normal 
healthy kidney, and that the ADC was lower in AKI than CKD. There is a 
decrease in renal perfusion pressure and glomerular plasma flow in AKI, this 
may have led to the reduction in ADC in both the cortex and medulla. It was 
also shown that ADC values in the cortex were a more sensitive indicator of 
renal dysfunction than those in the medulla, with the ADC of the medulla 
showing a lower correlation with SCr level. 
       Macarini et al. [18] assessed ADC measurements in the evaluation of 
benign renal abnormalities. Healthy volunteers were studied along with 
patients who were divided into seven groups; cyst, CKD, AKI, chronic 
pyelonephritis, hydronephrosis, medullary sponge kidney, lupic nephropathy 
and hypertensive nephrosclerosis. In AKI patients, patients had reduced kidney 
size (<10 cm in length) and a thinned cortex, and again lower ADC values than 
in CKD.  
     In addition to DWI, diffusion tensor imaging (DTI) has been used to analyse 
tissue anisotropy to provide additional information on diffusion direction. The 
degree of diffusion related tissue anisotropy has recently been used to assess 
renal impairment and pathology stage in patients with chronic 
glomerulonephritis [18], the most common cause of end-stage renal disease. 
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This study found ADC values in the cortex and medulla decreased with 
increasing pathology stage, and there was a significant difference in FA 
between pathology stages. A significant negative correlation was found 
between the percentage of glomerulosclerosis and FA in the renal cortex, and 
degree of tubulointerstitial fibrosis and FA in the medulla.  
     DTI has also been used to evaluate pathological change and renal damage in 
patients with normal or high eGFR, and renal diseases which cause chronic 
renal dysfynction [19].  Kidney impairment in CKD was assessed and DTI data 
correlated with biopsy to investigate the type of structural changes than can 
alter diffusion parameters, comparing pathology type and score, such as 
glomerular lesion and tubulointerstitial injury (including interstitial fibrosis, 
tubule atrophy and cellular infiltration). FA values in renal parenchymal 
patients were significantly lower than in controls, suggested the differences to 
be caused by water molecules that are radially transported from vessel, tubules, 
and collecting ducts to the renal pelvis. The FA of renal parenchyma was 
reduced at all CKD stages, showing that early stage CKD can be detected using 
DTI, when no significant difference in ADC of cortex or medulla is apparent 
between patients and healthy subjects. FA in the cortex and medulla were 
highly correlated with eGFR, suggesting FA is more sensitive than ADC for 
detecting functional change in CKD. Perfusion and flow effects contribute to 
ADC values, whereas FA values depend on the transportation of water 
molecules in tubules [20, 21]. From comparison with biopsy and pathology 
score, it was suggested that the reduction in FA was caused by the removal of 
partial water molecule directionality diffusion along tubules in the cortex and 
medulla by tubular atrophy. Furthermore, they suggested that cellular damage 
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was related to tubular atrophy and glomerular lesion, which might influence the 
direction of diffusion. In a DTI study, the structural complexity in the kidney 
of CKD patients was shown to be lost as the disease advanced, resulting in a 
reduced number of fibre tracts [22].  
4.5 Using MRI in the study of Cardiorenal Syndrome (CRS) 
        Cardiorenal Syndrome (CRS) describes the clinical condition in which 
cardiac and renal dysfunctions coexist. The pathophysiology of CRS is 
currently not well understood [1], particularly as to whether renal dysfunction 
is caused by changes in tissue structure (i.e. fibrosis) or haemodynamics. 
Traditionally renal dysfunction (RDF) in heart failure (HF) has been thought to 
be primarily caused by low cardiac output and/or depleted intravascular 
volume. Recently, haemodynamic factors including the adequacy of renal 
perfusion [2], the degree of venous congestion [23] as well as shared cardio-
renal risk factors [1] and drug effects [24] are thought to contribute to renal 
dysfunction in heart failure.  
This chapter aims to (i) estimate  diffusion weighted imaging (DWI) 
parameters (ADC, D, D* and f) in the kidney of patients with CRS compared 
to healthy volunteers (HV), in order to assess pathophysiology changes, and 
compare DWI measures to complementary measures of renal parenchyma 
structure using longitudinal (T1) relaxation time mapping and haemodynamics 
using renal blood flow; (ii) compare diffusion parameters estimated with ADC 
[25], IVIM [26], stretched exponential (DDC and α) [27], and kurtosis (Dapp 
and Kapp)  [28] models;  (iii) assess diffusion directionality (FA and MD) in the 
kidney using DTI in patients with CRS and healthy volunteers.  
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4.5.1 Subject demographics  
       In total, 36 subjects participated in this study and at the time of enrolment 
all participants underwent an initial clinical assessment including clinical 
history, physical examination, blood tests, and bioimpedance analysis as well 
as cardiac and renal MRI. The subjects were divided into four groups of 10 
subjects per group, which consisted of two healthy volunteer groups with no 
history of renal dysfunction (Groups 1 and 2) separated by age and eGFR 
(Figure 4.5), and two heart failure (HF) patient groups (Groups 3 and 4) 
separated by renal dysfunction (RDF) status and thus eGFR. Group 2 and 
Group 3 had similar eGFR but were separated by HF diagnosis. Group 1 
comprised 10 younger volunteers aged less than 40 years old (age range 24-37 
years, eGFR 101 ± 17 mL/min, cardiac output (CO) 5.6 ± 1.3 L) and Group 2 
comprised 10 volunteers aged over 50 years (age range 53-72 years, eGFR 75 
± 16 mL/min, cardiac output (CO) 5.3 ± 1.0 L). Group 3 comprised 7 HF 
patients without RDF with eGFR > 60 ml/min (age range 57-82 years, eGFR 
73 ± 8 mL/min, cardiac output (CO) 4.5 ± 0.5 L) (1 subject discarded due to 
poor DWI data). Group 4 consist of 6 HF patients with RDF with eGFR <60 
ml/min (age range 62-78 years, eGFR 38 ±11 mL/min, cardiac output (CO) 4.7 
± 1.3 L) (2 subjects discarded due to poor DWI data). eGFR was calculated 
using the abbreviated Modification of Diet in Renal Disease Study (MDRD) 
equation [29]. Impaired renal function was defined as eGFR < 60 ml/min. 
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Heart failure patients were recruited during routine visits to the outpatient heart 
failure clinics at the Royal Derby Hospital and the University Hospitals of 
Leicester. Healthy volunteers were approached through the local clinical 
research healthy volunteer programme. Patients under 18 years of age, those 
undergoing renal replacement therapy or having any contraindications to MRI 
were excluded. Furthermore, heart failure patients with known primary renal 
disease, experiencing an acute deterioration of heart failure symptoms or 
having undergone changes in heart failure medications (diuretics, betablockers, 
RAAS-blocking agents) in the month preceding the study were excluded. Heart 
failure patients with renal dysfunction were judged as having Cardiorenal 
Syndrome Type 2 by their treating physician [1]. The study was carried out 
according to the principles of the Declaration of Helsinki and was approved by 
the local ethics committee. Written informed consent was obtained from all 
participating patients. 
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Figure 4.5: Estimated GFR (eGFR) for each of the groups. Group 1 and 2 are 
younger (< 40 years) and older (> 50 years) healthy volunteers, Group 3 and 4 are HF 
patients without and with RDF respectively. 
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4.5.2 MRI methods 
This study was performed on a 1.5 Tesla MR scanner (Achieva Philips 
Healthcare Systems, Netherlands) with a body transmit coil and 16-channel 
SENSE torso receive coil. Coronal and transverse localisers were acquired to 
plan the position of slices for the T1, DWI and phase contrast (PC)-MRI 
measures. 
Phase contrast-MRI 
Phase contrast (PC) MRI with through-plane velocity encoding and VCG 
gating was used to measure the mean area, velocity, and flux in the renal 
arteries (RA), renal veins (RV), and the ascending aorta (AO). A turbo field 
echo (TFE) technique was used with the following imaging parameters: slice 
thickness 6 mm; 15 phases per cardiac cycle (30 for AO); repetition time 
(TR)/echo time (TE) 6.9/3.7 ms; flip angle (FA) 25°; sensitivity encoding 
(SENSE) factor 3; number of excitations 2; reconstructed resolution 1.17×1.17 
mm2; the TFE factor depended on the subjects’ heart rate (range 4-6); velocity 
encoding (VENC) 100/50/200 cm/s for RA/RV/AO respectively. 
 
Renal longitudinal (T1) relaxation time  
 A modified respiratory-triggered inversion-recovery (IR) sequence was used 
to measure the longitudinal relaxation time (T1) in the renal cortex and 
medulla. Contiguous coronal-oblique slices were positioned through the long 
axis of the kidney whilst avoiding the aorta. Nine inversion times (TI) were 
acquired (100-900 ms in 100 ms steps). The acquisition was performed twice 
with the order of slice acquisition reversed (ascend and descend slice order) to 
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increase dynamic range, resulting in slices being acquired at 18 TI values 
ranging from 100 to 1512 ms) using a balanced fast field echo (bFFE) readout 
scheme (TE/TR=1.69/3.4 ms, FA=60°, SENSE factor 2, and a temporal 
spacing between slices of Td= 153 ms). Each inversion time (TI) was collected 
in the same point in the respiratory cycle by introducing an additional delay TV 
following the respiratory trigger and prior to the TI. Data were collected with a 
FOV of 288 x 324 mm and voxel size 3x3x5 mm, 10 slices. Scan times for the 
acquisition of the T1 relaxometry data ranged from 2-3 minutes, dependent on 
the duration of the subject’s respiratory cycle. 
 
Diffusion Weighted/Tensor Imaging (DWI/DTI)  
 Respiratory triggered spin-echo Diffusion Weighted Imaging (SE-DWI) was 
performed using a SE-EPI readout and imaging parameters with matched FOV 
and voxel size to the T1 data (FOV of 288 x 324 mm, 10 coronal-oblique slices, 
3x3x5 mm voxel size, TE/TR = 71/3200 ms). Ten b-values (b = 0, 50, 100, 
150, 200, 250, 300, 500, 750, 800 s/mm²) were collected in 6 orthogonal 
directions, with one average collected at each b-value. 
 
4.5.3 MRI data analysis 
Phase contrast-MRI  
Scanner manufacturer’s software (Q-flow, Philips Healthcare, Best, NL 
Systems) was used to calculate mean vessel area, velocity and flux of blood 
flow (ml/s) over the cardiac cycle, across the vessel. 
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Volume  
Individual total kidney volume was measured using Analyze® 9.0 software 
(Biomedical Imaging Resource, Mayo Foundation, Rochester, MN). Each 
kidney was segmented by thresholding each slice in the transverse bTFE 
localiser, and the volume summed across all slices. This was repeated on the 
coronal bTFE localiser. The two values were checked for consistency and, 
subsequently, each direction was averaged. To calculate global kidney 
perfusion, renal artery flux was divided by the corresponding kidney volume. 
 
T1 relaxation time mapping  
Data from the 18 TI values were fit on a voxel-by-voxel basis to Equation (4.1) 
to generate T1 and M0 maps using a least squares non-linear curve fitting 
algorithm in Matlab® (The MathWorks Inc., Natick, MA).  
M = 	M$ 	 1 − 2exp +,-,. 																																						(4.1) 
Slices were inspected for any residual motion at each slice, and were excluded 
before fitting. An ROI was then drawn on the right and left kidney for each 
slice to create a binary mask of the kidney, Figure 4.6 (a). This mask was 
applied to the T1 map to obtain a T1 histogram, and the cortex and medulla 
were segmented by signal intensity thresholding of the T1 map, as shown in 
Figure 4.6. For the cortex and medulla mask the mean T1 value was calculated. 
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Figure 4.6: Binary mask (a) applied to the T1 map (b) at each slice to create a T1 
histogram (c). The cortex and medulla for both right and left kidney were segmented 
by signal intensity thresholding according to the range of T1 values in the histogram 
thus creating a cortex (d) and medulla (e) mask for each slice. Note the vessels are 
removed by this segmentation. 
                                  
Diffusion Weighted Imaging (DWI) parameter estimation 
All images were inspected for poor image quality due to motion, any b-values 
displaying such effects were discarded before fitting. The signal intensity for 
each b-value was averaged across the six directions to form an averaged b-
value time series (Figure 4.7). 
(a) (b) 
(c) 
(d) (e) 
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The mask of cortex and medulla (Figure 4.6) was applied to the average DWI 
images at each slice for each b-values (0, 50, 100, 150, 200, 250, 300, 500, 
750, 800 s/mm²) to compute the mean signal intensity. This mean signal 
intensity was fit to (i) mono-exponential ADC model (Equation (3.6)), (ii) bi-
exponential fitted IVIM model (Equation (3.7)), (iii) stretched-exponential 
model (Equation (3.8)) and (iv) kurtosis model (Equation (3.9)) at the ten b-
values using a ‘least-square’ fit written in Matlab to obtain values of (i) ADC, 
(ii) D, D*, and f, (iii) DDC and α, and (iv) Dapp and Kapp for the cortex and 
medulla. To generate ADC, D, D*, f, DDC, α, Dapp and Kapp maps, the 
averaged data images were fitted on a voxel-by-voxel basis to all models. 
Assessment of accuracy of ADC and IVIM parameters 
To assess the error in fitted ADC and IVIM parameters, a mono-exponential 
(ADC) and bi-exponential (D, D*, and f) DWI signal were simulated, and the 
fitted diffusion parameters of ADC, D, D*, and f calculated. Simulations were 
performed in MATLAB (R2010a; MathWorks Inc, Natick, MA, USA). Data 
  250           300           500          750           800         
  0           50           100          150          200           b-value         
Figure 4.7: Average DWI images at each b value (s/mm2). The signal intensity can be 
seen to decrease with increasing b-value.   
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were simulated using a mono-exponential ADC model (Equation (3.6) in 
Chapter 3)) and a bi-exponential model (IVIM) (Equation (3.7) in Chapter 3) 
using published values of ADC, D, D*, and f [30], as shown in Table 4.2. Data 
was simulated for the b-value implemented in the experimental data, and noise 
added using random numbers generated in Matlab multiplied by 1/ signal to 
noise ratio (SNR), where SNR was taken to be 50. Fitted parameters were 
determined using a Monte-Carlo technique with 1000 repeats. The signal 
simulated from the one compartment (mono-exponential) model was fitted to a 
mono-exponential equation to predicted ADCmono. The signal for IVIM was 
fitted to a bi-exponential equation to estimate D, D* and f, and also to a 
monoexponential equation to obtain ADCIVIM. For ADCmono, D, D* , f and D*f, 
accuracy (%) and stdev (%) in fitted parameters were computed, together with 
that of D*f.  
 
Diffusion Tensor Imaging (DTI) parameter estimation 
The DTI data was analyzed in FSL (fMRIB, Oxford). Diffusion measurements 
along the six directions were calculated, which correspond to the diffusion 
tensor, and from these eigenvalue (λ1, λ2, and λ3) maps, fractional anisotropy 
(FA) maps, and mean diffusivity (MD) maps were calculated. The mask of the 
cortex and medulla was applied to these maps to obtain a mean value of MD, 
FA, and eigenvalues (λ1, λ2, and λ3). λ1 was defined as the axial diffusivity 
(AD), and radial diffusivity (RD) was calculated from the average of λ2 and λ3, 
Equation (3.11) in Chapter 3. 
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Statistical analysis 
 Statistical analysis was performed using SPSS (version 21.0, IBM SPSS 
Statistics, USA). The mean and standard deviation (SD) of MR parameters of 
ADC, D, D*, f, DDC, α, Dapp and Kapp and T1 values for both the cortex and 
medulla were computed. D*f, defined as flow [31], was also calculated for the 
cortex and medulla. Paired tests were performed to compare between measured 
parameters in the cortex and medulla in all groups. Independent paired tests 
were made to compare parameters between groups, specifically testing Group 1 
versus 2, Group 2 versus 3, and Group 3 versus 4 for both the cortex and 
medulla. The relationship of diffusion parameters ADC, D, D*, f, DDC,α, Dapp 
and Kapp, D*f, T1 and renal artery flow with eGFR was tested using a Pearson 
correlation. For DTI data, a paired test was used to evaluate the difference in 
FA, MD, AD, and RD between the cortex and medulla. Independent paired 
tests were made to compare parameters between healthy volunteer and HF 
groups for Group 1 versus 2, Group 2 versus 3, and Group 3 versus 4. Pearson 
correlation coefficients were calculated to analyse the relationship between FA 
and MD of the cortex and medulla with eGFR. A correlation value of p<0.05 
indicated a statistically significant difference for paired and independent tests. 
4.5.4 Results                                                                                                                                                                           
The two healthy volunteer groups differed primarily in age, while the two HF 
groups differed in renal function. As expected, cardiac function was 
significantly different between healthy volunteers and HF patients. Systolic 
blood pressure was higher in HF patients with impaired renal function (144 ± 
26 mmHg) compared to HF patients with preserved renal function (120 ± 17 
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mmHg) (p=0.04). Cardiac output was higher for healthy volunteers compared 
to HF patients. 
 
Phase contrast MRI and volume adjusted global kidney 
perfusion 
Renal cortex volume and renal flux parameters were similar in the left and 
right kidneys for the overall population and within the groups. Consequently, 
left and right kidney values were averaged for further calculations.  Figure 4.8 
shows renal artery flux and global perfusion across the four groups. Renal 
artery flux was significantly deceased (p=0.025) between Group 1 and 2, 
however there was no significant difference in global perfusion. In Group 4, 
renal artery flux (2.98 ± 1.02 ml/s vs. 4.58 ± 1.78 ml/s; p=0.035) was 
significantly decreased compared to Group 3. In Group 2, global perfusion was 
significantly higher compared to Group 3 (p=0.019).and 4 (p=0.003). 
 
Figure 4.8: Renal artery flux of the kidney and global perfusion of kidney cortex for 
the four groups: (1: younger healthy volunteer, 2: older healthy volunteer, 4: HF 
patient without RDF, and 4: HF patient with RDF). *p<0.05. 
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ADC versus IVIM model parameters 
An example of the diffusion decay curve and corresponding mono-exponential 
and bi-exponential fit are shown in Figure 4.9. For all data, the diffusion signal 
was better fit using the bi-exponential IVIM model (R2=0.999) as compared to 
a mono-exponential ADC model (R2=0.983). Figure 4.10 shows example 
ADC, D, D*, and f colour maps for a HF patient with RDF.  
 
 
Figure 4.9: Example of a logarithm plot of relative signal intensity (raw data) against 
b-values, data taken from the left kidney cortex of a young healthy volunteer. The raw 
data can be seen to fit well to the bi-exponential model (R2=0.999). 
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Figure 4.10: Mono-exponential (ADC) parameter colour maps and bi-exponential (D, 
D*, and f) parameters colour maps of a HF patient with RDF. The unit for ADC, D, 
and D* is (x10-³mm²/s). Note the large variance in the D* map. 
 
Comparison between renal cortex and medulla 
 Table 4.1 and Figure 4.11 show the ADC, D, D* and f values in the cortex and 
medulla for all groups. Generally, ADC was higher in the medulla than cortex, 
with ADC in the medulla being significantly higher than in the cortex for HF 
patients (Group 3 and 4) (p<0.02). For all groups, D in the medulla was higher 
than in the cortex, but this difference was not significant (p>0.1). D* in the 
medulla of Group 1 and Group 2 was significantly higher than in the cortex 
(p<0.05). D*f in the medulla was significantly higher than the cortex for 
Groups 1, 3 and 4 (p<0.05). Renal medulla T1 was significantly higher than the 
cortex (p<0.00001) for all groups. 
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Comparison between healthy volunteer and HF groups 
  The difference in ADC, D, D* and f of the cortex and medulla between 
groups is shown in Figure 4.11. There was a significant reduction in ADC for 
both the cortex and medulla, with Group 1 (< 40 years, eGFR 101 ± 17 
mL/min) being higher than Group 2 (> 50 years, eGFR 75 ± 16 mL/min) 
(p<0.02). In the cortex there was a significant decrease in ADC (p<0.02) 
between Group 2 and 3, and between Group 2 and 4 for both cortex (p< 0.001) 
and medulla (p<0.005). In the medulla, there was no significant difference 
between Group 2 and 3 in all values (p>0.1). There was no significant 
difference in D, D* and f between Groups 2, 3 and 4 (p>0.5). Between the HF 
patients (Group 3 and 4), there was no significant difference in any diffusion 
parameter in the cortex (D, D* and f (p>0.1). Although D* and f independently 
did not show a significant difference between renal function, D*f between 
Group 1 and 2 was significant was significant (p<0.03) for both the cortex and 
medulla. Between Group 2 and 4, there was significant reduction in D*f for the 
cortex (p<0.005). The only significant difference between Group 3 and 4 was a 
reduction in ADC of the medulla of Group 4 compared to Group 3 (p=0.048). 
In summary, results suggest that ADC and D*f in both cortex and medulla 
decrease with age and CRS. T1 relaxation time was significantly increased 
between Group 3 and 4 (p=0.047), and was prolonged in HF patients with renal 
dysfunction compared to HF patients with normal renal function [32] 
 
  
 
 
 
 
 
 
 
 
Group1:Younger healthy volunteer, Group 2: Older healthy volunteer, Group 3: HF patients without RDF, Group 4: HF patients with RDF.
CORTEX Mean ± SD 
Group ADC D D* f D*f T1 
 
1 
 
2.70 ± 0.16 
 
1.67 ± 0.21 
 
12.90 ± 3.63 
 
0.31 ± 0.08 
 
3.78 ± 0.89 
 
1080 ± 68 
2 2.50 ± 0.26 1.35 ± 0.19 9.11 ± 3.90 0.32 ± 0.11 2.79 ± 0.64 1030 ± 55 
3 2.14 ± 0.23 1.37 ± 0.20 8.24 ± 4.78 0.27 ± 0.10 2.04 ± 1.05 1067 ± 79 
4 1.93 ± 0.21 1.32 ± 0.23 8.10 ± 5.91 0.23 ± 0.08 
 
1.65 ± 0.76 1169 ± 100 
 
MEDULLA Mean ± SD 
Group ADC  D  D* f D*f  T1                      
 
1 
 
2.74 ± 0.15 
 
1.72 ± 0.22 
 
22.11 ± 16.17 
 
0.28 ± 0.08 
 
5.63 ± 2.94 
 
1357 ± 88 
    2 2.45 ± 0.29 1.42 ± 0.22 11.58 ± 5.23 0.31  ± 0.11 3.18  ± 1.09 1346 ± 80 
3 2.27  ± 0.24 1.44 ± 0.11 10.64 ± 7.01 0.27 ±  0.07 2.73 ± 1.63 1332 ± 101 
    4 2.01 ± 0.17 1.32 ± 0.34 12.64  ± 7.31 0.28 ± 0.10 3.04  ± 1.37 1383 ± 146 
 
Table 4.1: Mean ADC, D,D*,f , D*f ,and T1 values and standard deviation (± SD) in the cortex and medulla for Group 1,2 3, and 4. The units of 
ADC, D, and D* are x10-3 mm²/s and for T1 is ms. 
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Figure 4.11: (a) ADC, (b) D, (c) D*f, and (d) T1 of the kidney cortex and medulla for 
the four groups: (1: younger healthy volunteer, 2: older healthy volunteer, 4: HF 
patient without RDF, and 4: HF patient with RDF). **p<0.01, *p<0.05.  
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Correlation of diffusion, T1 and flow parameters with eGFR 
 In the cortex, there was a strong correlation between ADC and D*f with eGFR 
(R=0.650, p<0.0001 and R=0.721, p<0.0001) (Figure 4.12 (a) and (c)). D and 
D* also highly correlated with eGFR (R=0.497, p=0.003 and R=0.498, 
p=0.003). D*f in the cortex was highly correlated with eGFR (R=0.721, 
p=0.0001). In the medulla, there was a strong correlation between ADC and 
eGFR (R=0.621, p<0.0001) and a good correlation of D and D*f with eGFR (R 
=0.391, p=0.024 and R=0.409, p=0.018). T1 relaxation time in both the cortex 
and medulla negatively correlated with eGFR, though the correlation was not 
significant. There was also no significant correlation of ADC with T1 (Figure 
4.13) or D with T1 (data not shown). Renal artery flux positively correlated 
with eGFR (R=0.718, p<0.0001), Figure 4.14(a), and there was a significant 
correlation between renal artery flow with D*f in the cortex (R=0.553, 
p=0.001) and medulla (R=0.413, p=0.019), as shown in Figure 4.14b. 
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Figure 4.12: Variation in (a) ADC, (b) D, (c) D*f, and (d) T1 and eGFR in kidney 
cortex (dashed line) and medulla (solid line) for all groups (1:younger healthy 
volunteers, 2:older healthy volunteers, 3: HF patients without RDF, and 4: HF patients 
with RDF). There was a significant correlation of eGFR with ADC, D, and D*f for 
cortex and medulla. The four groups can be clearly distinguished on each of the 
graphs. 
 
Figure 4.13: Variation in ADC with T1 in kidney cortex (dashed line) and medulla 
(solid line) for all groups (1: younger healthy volunteers, 2: older healthy volunteers, 
3: HF patients without RDF, and 4: HF patients with RDF). There was no significant 
correlation of ADC with T1. 
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Figure 4.14: Correlation of (a) Renal artery flux with eGFR and (b) with D*f in kidney 
cortex (dashed line) and medulla (medulla) for all groups (1:younger healthy 
volunteers, 2:older healthy volunteers, 3:HF patients without RDF, 4:HF patients with 
RDF).  
Assessment of accuracy of ADC and IVIM parameters 
The fitted diffusion parameters (D, D*, f, ADCIVIM, and ADCmono) and 
standard deviation (±) for the cortex and medulla are shown in Table 4.2.   
  CORTEX 
 
  
 
D      
 (x10-³mm/s) 
D*              
(x10-³mm/s) 
f ADCIVIM 
(x10-³mm/s) 
ADCmono   
(x10-³mm/s) 
Fitted  1.77 ±0.16 14.65 ±3.99 0.32 ±0.05 3.17 ±0.08 2.40 ±0.05 
Simulated 1.8 14.2 0.31 - 2.4 
  MEDULLA 
 
  
 
D             
(x10-³mm/s) 
D*              
(x10-³mm/s) 
f ADCIVIM 
(x10-³mm/s) 
ADCmono   
(x10-³mm/s) 
Fitted  1.49 ±0.18 11.94 ±3.36 0.35 ±0.06 2.86 ±0.08 2.10 ±0.05 
Simulated 1.5 11.3 0.34 - 2.1 
 
Table 4.2: Simulated and fitted diffusion parameters obtained from mono-exponential 
and bi-exponential fits for cortex and medulla.  
Table 4.3 shows the accuracy (%) and standard deviation (%) in these 
measures for renal cortex.  
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 D D* f ADCmono D*f  
Accuracy (%) 1.5 5.9 3.0 -0.1 2.3 
Stdev (%) 9 31 18 2.6 12 
 
Table 4.3: The accuracy (%) and standard deviation (%) of fitted diffusion parameters 
obtained from mono-exponential and bi-exponential fits for renal cortex.  
 
The good accuracy and low standard deviation obtained from the results shows 
the data fits well, with both mono-exponential and bi-exponential equations 
with low errors (Table 4.3). For ADCmono the stdev of fit is ~ 2-3 %. The 
largest error is found for D* at ~ 30 % for cortex and medulla (as reflected in 
the map), whilst D and f yield errors of ~ 9 % and 18 %. It can be seen that the 
value of ADCIVIM yields a higher value than for D due to the contribution of 
the perfusion fraction using this diffusion scheme with low b-values.   
 
Stretched-exponential and Kurtosis Model 
     An example of diffusion decay curve and the corresponding stretched-
exponential (R2=0.983) and kurtosis (R2=1.000) fit are shown in Figure 4.15. 
Figure 4.16 shows DDC and α (stretched-exponential model), and Dapp and 
Kapp (Kurtosis model) colour maps of a HF patient with RDF. The cortex and 
medulla can be clearly differentiated in DDC and α maps. 
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Figure 4.15 : Logarithm plot of relative signal intensity (raw data) versus b-value from 
the left cortex of the kidney of a young healthy volunteer 
 
 
                   
 
 
               
Figure 4.16:  Stretched-exponential (DDC and α) and kurtosis (Dapp and  Kapp) maps 
for a HF patient with RDF. The units of DDC and Dapp are (x10-3 mm²/s). 
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Comparison between healthy volunteer and HF groups 
           Table 4.4 shows DDC and α (stretched-exponential model), and Dapp 
and Kapp (Kurtosis model) in the cortex and medulla for Groups 1 to 4. There 
was no significant difference in any parameters between medulla and cortex. 
There was a significant difference in DDC and α , and Dapp and Kapp between 
Group 1 and 2 in both medulla (DDC: p= 0.0005, α: P = 0.003; Dapp: 0.012, 
Kapp: p = 0.031) and cortex (DDC: p= 0.005, α: P =0.063; Dapp: 0.019, Kapp: P 
= 0.013), Figure 4.17. There was also a significant difference in α  between 
Group 2 and 3 (p = 0.019) for the cortex. In the medulla, α, DDC, and 
Dapp decrease with age and eGFR, while Kapp increased with age and eGFR. 
There was no significant difference between Group 3 and 4 for any measure in 
either cortex or medulla.  
 
Group 1: Younger healthy volunteers, Group 2: Older healthy volunteers, Group 3: HF 
patients without RDF, and Group 4: HF patients with RDF. 
CORTEX Mean ± SD 
Group DDC α Dapp Kapp 
1 2.41± 0.10 1.15± 0.07 3.43± 0.17 0.86± 0.06 
2 2.28± 0.08 1.10± 0.07 3.06± 0.43 0.94± 0.07 
3 2.18± 0.16 0.99± 0.08 2.71± 0.34  0.89± 0.14  
4 2.17± 0.16 1.03± 0.10 2.80± 0.56 0.97± 0.06 
 
MEDULLA Mean ± SD 
Group DDC  α Dapp Kapp 
1 2.45± 0.06 1.16± 0.04 3.46± 0.23 0.87± 0.08 
2 2.27± 0.12 1.07± 0.07 3.06± 0.41 0.95± 0.06 
3 2.25± 0.07 1.00 ± 0.08 3.05± 0.40 0.97±  0.05 
4 2.24± 0.13  0.99 ± 0.08 2.80± 0.41 1.00± 0.09 
 
Table 4.4 : Mean and standard deviation (± SD) in DDC and α (stretched-expoential 
model), and  Dapp, and Kapp (Kurtosis model) in the cortex and medulla for Group 1,2 
3, and 4. The unit for DDC and Dapp is (x10-3 mm²/s). 
The application of MRI measures to study Kidney Disease 
 
106 
 
 
 
 
Figure 4.17:  Comparison of stretched exponential model (a) DDC, (b) α, and kurtosis 
model (c) Dapp, and (d) Kapp in cortex and medulla for the four groups: (1: younger 
healthy volunteers, 2: older healthy volunteers, 3: HF patients without RDF, and 4: HF 
patients with RDF). **p<0.01, *p<0.05. 
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Correlation of Stretched-exponential and Kurtosis diffusion 
parameters with eGFR 
The correlation of DDC, α, Dapp, and Kapp with eGFR are shown in Figure 4.18. 
In the medulla, there was a significant positive correlation of eGFR with α for 
stretched exponential model (R = 0.433, P = 0.012), and a significant negative 
correlation of eGFR with Kapp for the kurtosis model (R = -0.422, P = 0.014). 
No significant correlation was found for the cortex. While for DDC and Dapp, 
there was a significant correlation with eGFR for both medulla and cortex. 
 
 
                                                                  
Figure 4.18:Variation in (a) DDC (b) α, (c) Dapp,, and (d) Kapp with eGFR in the 
cortex(dash line) and medulla (solid line) for all groups (1: younger healthy 
volunteers, 2: older healthy volunteers, 3: HF patients without RDF, and 4: HF 
patients with RDF). The four groups can be clearly distinguished on each of the 
graphs. 
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DTI Directionality parameters 
The mean and standard deviation (SD) of FA, MD, axial diffusivity (AD), and 
radial diffusivity (RD), for the four groups are shown in Table 4.5. Maps of FA 
and MD are shown in Figure 4.19. FA was significantly higher in the medulla 
than cortex in Group 1 (p<0.0001), Group 2 (p=0.004), and Group 4 (p=0.037). 
AD in the medulla was significantly higher than cortex in Group 1 (p=0.033) 
and 2 (p=0.022). No significant difference between medulla and cortex in MD 
and RD was found for all groups. RD in the cortex and medulla was significant 
lower (p<0.00001) than AD for the four groups. 
 
 
                    
Figure 4.19: DTI measures in the kidney of a HF patient without RDF. Map of (a) FA 
reflects the anisotropic structure of the tissue, and (b) MD map shows the degree of 
diffusivity of the tissue.  
 
     Figure 4.20 shows FA and MD in the medulla and cortex decrease across 
Groups 1, 2 and 3. FA, MD, AD and RD of Group 1 was significantly higher 
than Group 2 in both medulla (FA: p=0.003; MD: p=0.0003, AD: p=0.002, 
RD: p=0.0002) and cortex (FA: p=0.04; MD: p= 0.0002, AD: p<0.001, RD:  
p<0.001). There was also a trend for higher values of RD in Group 2 than 
0  1.2 
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Group 3 for the cortex (p = 0.08). There was no significant difference in values 
between Group 3 and 4.   
Figure 4.21 shows the correlation between FA with eGRF, and MD with 
eGFR. FA and MD increase as eGFR increases, with a weak correlation of 
eGFR for FA (medulla: R = 0.49, P = 0.003; cortex: R = 0.43, P = 0.014), and 
a significant positive correlation for MD (medulla: R = 0.42, P = 0.015, cortex: 
R = 0.46, P = 0.007).     
CORTEX Mean ± SD 
Group FA MD  AD       RD 
1 0.39 ± 0.04 1.95 ± 0.15 2.80 ± 0.28 1.52 ± 0.02 
2 0.35 ± 0.07 1.55 ± 0.29 2.16 ± 0.38 1.21 ± 0.07 
3 0.34 ± 0.07 1.40 ± 0.22 2.05 ± 0.33 1.06 ± 0.05 
4 0.36 ± 0.04 1.50 ± 0.25 2.16 ± 0.25 1.16 ± 0.01 
 
MEDULLA Mean ± SD 
Group FA MD AD       RD 
1 0.43 ± 0.02 1.95 ± 0.17 2.86 ± 0.28 1.48 ± 0.01 
2 0.38 ± 0.06 1.55 ± 0.30 2.22 ± 0.38 1.18 ± 0.01 
3 0.35 ± 0.07 1.43 ± 0.26 2.10 ± 0.38 1.09 ± 0.07 
4 0.38 ± 0.06 1.55 ± 0.20 2.25 ± 0.20 1.19 ± 0.03 
 
Group 1: Younger healthy volunteers, Group 2: Older healthy volunteers, Group 3: HF 
patients without RDF, and Group 4: HF patients with RDF. 
 
Table 4.5 : Mean FA, MD, AD, and RD values and standard deviation (± SD) in the 
cortex and medulla for Group 1,2 3, and 4. The unit for MD, AD, and RD is          
(x10-³mm²/s). 
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Figure 4.20:  Comparison of (a) FA, (b) MD, (c) AD, and (d) RD of kidney cortex and 
medulla for the four groups: (1: younger healthy volunteers, 2: older healthy 
volunteer, 4: HF patients without RDF, and 4: HF patients with RDF). **p<0.01, 
*p<0.05. 
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Figure 4.21:  Variation in (a) FA values and (b) MD with eGFR in the cortex (dashed 
line) and medulla (solid line) of kidney for all groups (1: younger healthy volunteers, 
2: older healthy volunteers, 3: HF patients without RDF, and 4: HF patients with 
RDF). There was a significant correlation of eGFR with MD for both the cortex and 
medulla. The four groups can be clearly distinguished on each of the graphs. 
 
4.5.5 Discussion  
ADC and IVIM models 
Comparison between cortex and medulla  
      In this study, ADC in the renal medulla was generally higher than the 
cortex. Some previous studies report the opposite finding of ADC in the cortex 
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to be significantly higher than in the medulla [30, 33-35], attributing this to 
higher perfusion of the renal cortex compared to the medulla [33, 36, 37] and 
higher blood volume and larger tubular diameters in cortex [34], while other 
studies are in-line with these study findings [16].  Namimoto et al. [16] for 
example, showed renal medulla has a higher ADC than the cortex, which they 
attributed to the fact that the medulla has more water content per unit tissue 
mass than the cortex. D* in the medulla was also higher than in the cortex for 
healthy volunteers, as reported in Sigmund et al. [34], similarly this effect was 
found for D*f. This finding appears reasonable due to higher flow rate in the 
tubular loops of Henle. However, there was no significant difference in D* 
between medulla and cortex in HF patients with and without RDF. D*f was 
found to be higher in the medulla than cortex for all groups, likely reflecting 
that the medulla contains the loops of Henle (Figure 4.3) with a lot of capillary 
networks and collecting ducts to carry the filtration substances to the pelvis. It 
was also found that there was no significant difference in f between the cortex 
and medulla, though f was larger for Group 1, 2, and 3, likely as 90% of the 
renal blood volume is distributed to the cortex [37, 38].  
The finding that T1 relaxation time in the medulla is significantly higher than 
the cortex reflects the high water contents in the medulla, whilst a lower f 
indicates a decrease in blood volume due to low reabsorption of water [38].  
Comparison between healthy volunteer and HF groups 
      ADC and D in the renal cortex and medulla was significantly shorter in 
healthy volunteers for the older healthy volunteer group compared to the 
younger healthy volunteer group. This may be due to weak filtration and 
reabsorption of water into tissue and blood in the older healthy subjects who 
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have lower eGFR. In [35], the authors showed that D in the cortex of patients 
with eGFR>80 mL/min was significantly higher than for patients with 
30<eGFR<60 mL/min, although there was no significant differences in f for 
cortex and medulla. This result is consistent with the results of this study.  
     ADC in the cortex of the older healthy volunteer group was significantly 
higher than HF patients without RDF with a similar eGFR. Low GFR in kidney 
patients is due to reduced blood perfusion, loss of nephron, interstitial fibrosis, 
tubular atrophy, and scarring of glomeruli. This is probably due to structural 
changes of the proximal and distal tubule membrance in the cortex limiting 
water to reabsorb into tissue and blood. Breidthardt et al. [32] analysed the 
result of ASL perfusion and T1 measures from subjects in this study, and  
found renal impairment in HF patients was not related to ASL renal  perfusion, 
as these measures were similar in HF patients with or without RDF. Ichikawa 
et. al. [35] suggested that diffusion and perfusion of the renal medulla is less 
influenced in cases of renal dysfunction than the renal cortex. However, the 
only significant difference between HF patients with and without RDF found in 
this thesis was in the ADC of the medulla, with a lower ADC in HF patients 
with RDF likely due to less reabsorption of water. Moreover, ADC in the 
cortex and medulla between older healthy subjects and HF patients with RDF 
was significantly different, along with D*f in the cortex. Renal artery flux  was 
also found to be significantly lower in HF patients with RDF compared to 
without RDF, and renal artery artery flux significantly correlated with D*f in 
the cortex (R=0.553, p=0.001).  
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Correlation with eGFR 
     GFR is generally considered the best biomarker of renal function, and 
typically estimated clinically from serum level or renal clearance of 
endogenous filtration marker. There are a small number of studies that have 
investigated the correlation between diffusion parameters and eGFR [9, 11, 12, 
16, 35, 39]. In this study, ADC, D, and D*f all correlate with eGFR (all p < 
0.024). The linear correlation between ADC and eGFR in patients suggests that 
pathological changes cause a decrease of renal water content and/or restricted 
diffusion [16, 39]. 
Accuracy of ADC and IVIM parameters 
The accuracy of the ADC fit has shown to be good, whilst the IVIM model also 
fits parameters with reasonable accuracy, though D* has a large variance. In 
previous studies, ADC was calculated separately in the kidney for low and high 
b-values to enable the differentiation of the relative influence of the perfusion 
fraction and true diffusion [40, 41]. Thoeny et. al [40] used the combination of 
low and high b-values (b=0, 50, 100 s/mm² and 500, 750, 1000 s/mm² 
respectively) to evaluate the morphology of kidney abnormalities. In agreement 
with simulations, Bilgili et. al. showed that low b-values lead to an 
overestimation of the ADC due to the contribution of perfusion to the diffusion 
measurement, whereas large b-values underestimate ADC due to increasing 
contributions from the low ADC component and SNR [42]. Zhang et al. 
investigated various sets of b-values used in 10 published studies to assess the 
varaiability in ADC, D, D* and f of normal kidney parenchyma. [30]. Wittsack 
et. al.[37] investigated whether a mono-exponential or bi-exponential fit is the 
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best to describe diffusion characteristic in the kidney. The signal of the renal 
cortex was simulated from a bi-exponential using D, D*, and f values and 16 b-
values (0, 50, 100, to 750 s/mm2) at SNR levels of 1- 50%. The standard 
deviation of ADCmono was found to be lower than that of D, D*, as shown in 
simulations in this chapter. Wittsack et. al. [37] also analysed the relation 
between the DWI data fit with mono-exponential and bi-exponential models, 
and showed that high SNR is needed in analysing IVIM parameters, else the 
additional information on the two fractions of pure diffusion and pseudo-
diffusion may be disturbed by noise-related fluctuations [37].  
Stretched-exponential and Kurtosis models analysis  
      To investigate the heterogeneity in water diffusion and structural change in 
tissues, the stretched-exponential and kurtosis models were used. In the 
stretched-exponential model, information about the distribution of diffusion 
can be obtained. A continuous distribution of diffusion coefficient deviating 
from a mono-exponential decay, representing an increase in intravoxel 
heterogeneity in tissue, is characterized by α. A small number of studies have 
used the stretched-exponential model, these have generally been applied in the 
brain, because the cerebral cortex contains considerable heterogeneity in 
diffusion [28, 43]. The non-Gaussian behaviour of diffusion-related signal 
decay can also be characterized in liver fibrosis [44], where DDC has been 
shown to be strongly correlated with the degree of liver fibrosis, conversely 
there was no significant correlation between α and degree of liver fibrosis. In 
theory, the higher α value, the closer ADC and DDC should agree, such that if 
α≈1 then DDC≈ADC. The results from this study show that α in the cortex and 
medulla were high (>0.99), suggesting that cortex and medulla has low 
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intravoxel diffusion heterogeneity, leading to agreement of DDC to ADC 
values. Hence, DDC decreases with eGFR in a similar manner to ADC. In 
addition, the result from stretched-exponential analysis shows a reduction in 
DDC and α with ageing and with Cardiorenal Syndrome.  
    Water diffusion in tissues is a random process, and the time for water 
molecules to diffuse from one point to another is governed by a probability 
distribution. This distribution has a Gaussian form with its standard deviation 
proportional to the diffusion coefficient. However, tissues with complex 
structure consisting of various types of cells and membranes can cause the 
diffusion displacement probability distribution to deviate substantially from 
Gaussian. This deviation from Gaussian behaviour can be quantified using the 
kurtosis model and can be regarded as a measure of a tissue’s degree of 
structure. In the kidney, these results proved a decrease in Dapp in the medulla 
and cortex with ageing and Cardiorenal Syndrome, and a corresponding 
increase in Kapp reflecting an increase in the non-Gaussian behaviour that can 
arise due to structural changes.  
       In this study, Kapp was found to be higher in the medulla than Kapp in the 
cortex, but the difference was not significant. Similarly, previous studies have 
found the mean kurtosis in the medulla to be significantly higher than in the 
cortex [45], because the medulla has a more complex structure and water 
diffusion restricted by the collection tubules/ducts wall and deviates the 
diffusion distribution from the Gaussian form. The relationship between the 
microstructural changes in medulla with kidney function was revealed, with a 
negative significant correlation of Kapp with renal eGFR in the medulla. 
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Diffusion Tensor imaging analysis 
      DTI is a promising technique for functional assessment of the kidney. DTI 
assesses directionality of diffusion and yields a FA measure of directionality, 
with a value of 0 reflecting perfectly isotropic diffusion. In renal medulla, 
diffusion properties are expected to show anisotropy as a consequence of the 
radial orientation of tubules, collecting tubules, and blood vessels [21, 33, 46]. 
        The DTI results show that FA in the medulla is higher than in the cortex 
in healthy volunteers and HF patients with renal dysfunction. This result agrees 
with the other previous studies [47-50]. Moreover, medulla anisotropy may be 
caused by two distinct factors which are vascular or tubular flow, both of 
which are very important to renal function[38]. AD in the medulla was higher 
than in the cortex in young and old heathy subjects. RD in medulla and cortex 
was significantly lower than AD for all groups. The low RD and high AD 
reflect the anisotropic directionality in the cortex and medulla, and suggest 
coherent flow along the axial direction and restricted diffusion in the radial 
direction [22]. DTI parameters of FA, MD, AD, and RD was higher in younger 
healthy volunteers than older healthy subjects in both the cortex and medulla. 
RD in the cortex reduced form the old healthy volunteers to HF patients 
without RDF, reflecting less anisotropic structure of the cortex. The reduction 
of FA in cortex suggests that the diffusion in the renal cortex can be coherent 
in direction but relatively isotropic in magnitude. Moreover, the reduction of 
FA in both medulla and cortex with ageing and eGFR, and the corresponding 
reduced MD, is likely to be a result of structural changes such as fibrosis. HF 
patients without renal dysfunction with a eGFR > 60 mL/min have a lower FA 
compared to the HF patients with RDF with <60 mL/min, but the difference 
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was not significant. In contrast, Lazman et. al showed that the FA in the 
medulla and cortex with eGFR> 30 mL/min were significant higher than those 
in a group with GFR<30 mL/min [47]. However, we did not split our HF with 
RDF group into a eGFR lower and higher than 30 mL/min.  
The FA of medulla was found to correlate significantly better with renal 
function compared to the cortex and ADC values [47]. 
        Most DTI protocols use multiple diffusion gradients that are subsequently 
averaged to minimize the effect of anisotropy [21]. However, averaging 
multiple gradients might also decrease information on anisotropic structures 
due to the radially oriented tubular structure of kidney [20, 33]. DTI involves a 
longer scanning period since it requires several (usually six or more) gradient 
pulses to assess tissue anisotropy and it is more difficult to apply on abdominal 
organs than DWI such as kidney, spleen and liver [51]. DTI of abdominal 
organs has proven to be challenging due to respiratory motion. Kido et. al [46] 
first evaluated the FA of the kidney using 3.0 T MRI and a respiratory 
triggered acquisition, and showed the image quality of the FA and ADC map to 
be superior to that at 1.5 T, due to the high SNR. Ries et al. [33] and Wu et. al 
[22] obtained DTI sequences using the single breath-holding technique and 
demonstrated the anisotropic structure of the kidney on FA maps. This method 
reduces misregistration caused by motion but it has a limited acquisition time 
during one breath-holding. From their study, FA in cortex was slightly lower 
than FA in medulla (less than 10%) compared to the result from previous 
studies (more than 45%) [21, 34]. This difference might be due to the size of 
ROI used on the cortex and medulla. The ROI masking was done the whole 
cortex and medulla, while mostly small ROIs were drawn on both cortex and 
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medulla in the previous studies. Other than that, mis-registration of the kidney 
during respiratory-triggered acquisition might still exist owing to movements 
of the kidney during respiration [21].   
     
There are some limitations to this study. Firstly, renal biopsies were not 
performed and so the association of ADC, IVIM parameters, and T1 relaxation 
time with histopathology cannot be investigated. Secondly, the sample size in 
each group was small, and so further studies need to be performed with a large 
sample size building on this work. Finally, the number of diffusion directions 
implemented was small at 6 and there warrants greater investigation of 
diffusion tensor imaging using a larger number of directions. 
 
4.5.6 Conclusion 
       In this chapter, diffusion weighted and tensor imaging, T1 relaxation time 
mapping and PC-MRI flow to the kidney, have been used to assess 
haemodynamic and structural measures in the kidney and to determine whether 
these parameters impact on the pathophysiology underlying Cardiorenal 
Syndrome.  
This work has explored different diffusion models, with the monoexponential 
model used to estimate the ADC, and a bi-exponential IVIM model used to 
separate water diffusion, D, and perfusion/flow effects (D*, f, D*f). A 
stretched-exponential model of diffusion has been presented to characterize the 
intravoxel heterogeneity in the distribution of diffusion coefficients. While the 
kurtosis technique has provided a measure of tissue structure by identifying the 
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degree to which water diffusion is non-Gaussian. The directionality in the 
kidney for both cortex and medulla was associated with diffusion parameters 
using DTI. The combination of these four models provides a comprehensive 
method to assess the structural change and perfusion/blood flow related 
changes in the renal cortex and medulla.  
Overall, the effect of renal dysfunction on HF patients was more predominant 
in the medulla, where ADC can differentiate between HF patients with and 
with RDF. Furthermore, this finding is strengthened when a high α in the 
medulla shows that the medulla tissue is homogeneous and gives a strong 
agreement of DDC with ADC. More importantly, the decreasing in ADC with 
renal dysfunction is accompanied by a decrease in the degree of tissue structure 
of the medulla, as proved by a decreasing Kapp. There were anisotropy 
characteristics in the medulla shown by a high FA. In HF patients with RDF, 
there was significant low D*f as a flow marker in the cortex, and this was 
strongly correlated with renal artery flow, suggesting D*f could be a marker to 
differentiate HF with and without RDF. T1 measures in the cortex were shown 
to be increased in HF patients with RDF compared to those without. Based on 
this small sample, renal dysfunction in HF appears to be mediated by decreased 
renal flow and prolonged T1 relaxation time reflecting chronic reno-
parenchymal damage and should be validated further in future studies. 
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Chapter 5  
T1 Relaxation in Colon 
 
5.1 Introduction 
This chapter uses T1 measurements to study the characteristics of the chyme 
within the ascending colon (AC) as a marker of water absorption and health. 
Firstly, the gastrointestinal tract and anatomy and physiology of large intestine 
are described. The colonic contents at different positions in the AC were 
characterised by using mono and biexponential T1 measurements after a liquid 
challenge, and the reliability of these T1 measurements were assessed. Finally, 
the heterogeneity of the measurements in the ascending colon (AC) were 
investigated by considering different ROI sizes and locations in different 
physiological situations. 
 
5.2 Gastrointestinal Tract 
The gastrointestinal (GI) tract consists of the mouth, pharynx, oesophagus, 
stomach, small (duodenum, jejunum, and ileum) and large intestines, and anal 
canal. The GI tract is responsible for the breakdown, digestion and absorption 
of food, and removal of solid waste in the form of faeces from the body. The 
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food passes through each section of the GI tract and interacts with various 
digestive fluids and enzymes. This chapter will focus on the anatomy and 
physiology of the large intestine. 
5.2.1 Anatomy and physiology of large intestine 
The large intestine lies below the stomach and liver and almost completely 
frames the small intestine in a coronal view as shown in Figure 5.1. It is 
designed to absorb water from the contents of small intestine that pass into it. 
Although the small intestine absorbs some water this process is intensified in 
the large intestine until the semisolid consistency of faeces is achieved. The 
main functions of the large intestine are, (1) the reabsorption of water and 
compaction of faeces, (2) absorption of important vitamins liberated by 
bacterial action, and (3) storage of faecal material prior to defecation. The large 
intestine also called large bowel, has an average length of approximately 1.5 m 
and a width of 7.5 cm, and is divided into three portions, (1) the cecum, (2) the 
colon, and the rectum.  
The colon is divided into four regions: (1) The ascending colon, which ascends 
along the right side of the peritoneal cavity until it reaches the inferior margin 
of the liver, (2) transverse colon, which passes below the stomach horizontally 
toward the left side following the curve of the body wall, (3) descending colon, 
which continues along the left side until it curves and forms (4) the S-shaped 
sigmoid colon, that empties into the rectum. 
The reabsorption of water is an important function of the large intestine. About 
1500 ml of watery material arrives in the colon each day, and some 1300 ml of 
water is recovered from it, so that only about 200 ml within the faeces are 
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ejected. The large intestine also absorbs a variety of useful compounds (eg; bile 
salts and vitamins), organic waste products (eg; bilirubin products derived from 
the breakdown of haemoglobin), and various toxins generated by bacterial 
action. The average composition of faeces is 7 5% of water, 5 % of bacteria, 
and the rest a mixture of indigestible materials, small quantities of inorganic 
matter, and the remains of epithelial cells. 
The large intestine contains of a variety of bacteria, known as commensals, 
which in general, do not cause any problems. In fact, they play an important 
part in digestion, fermenting carbohydrates and releasing hydrogen, carbon 
dioxide and methane gas. The bacteria synthesize a number of vitamins such as 
vitamin K and some B vitamins and are responsible for breaking down the 
bilirubin into urobilinogen, which gives the faeces its characteristic brown 
colour.  
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                                Figure 5.1: The gastrointestinal (GI) tract [1]. 
 
Figure 5.2 : The diagram of colon. (This image is modified from Essentials of 
Anatomy & Physiology, Third Edition by Martini and Bartholomew, 2003)[1]. 
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5.2.2 Definition of ascending colon region 
In this work, quantitative analysis was performed on the different regions of 
the ascending colon (AC). The AC was divided into three ROIs; (1) top, (2) 
middle, and (3) bottom (Figure 5.3).  
 
 
Figure 5.3:  The region of the ascending colon for quantitative analysis, top, middle, 
and bottom ROIs . 
 
 
5.3 Study of T1 measurement in the ascending colon 
5.3.1 Introduction 
The measurement of T1 is fundamental to understand the properties of the 
colon contents and to measure changes in physiology due to disease. We know 
that a single compartment T1 fit can provide a robust and useful way to assess 
colonic contents but we also know that in reality the system is often clearly 
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multi-compartmental (heterogeneous) and furthermore the recovery curves are 
clearly multi-exponential. The overall goal of this work is to determine if 
biexponential fitting can be used to characterise the colonic contents. There 
were three subsidiary aims; (1) To measure the properties of the colonic 
contents using mono and biexponential T1 after a liquid challenge, (2) to assess 
the reliability of T1 measurement of colonic contents, and, in the light of the 
observed sensitivity to exact location of the ROI (3) to evaluate the effect of 
heterogeneity by considering different ROI sizes and locations. The data set in 
this work was acquired as a part of the ‘Moviprep Study’ which was performed 
at the SPMMRC in collaboration with the NIHR Nottingham Digestive 
Diseases Biomedical Research Unit at the Nottingham University Hospitals 
NHS Trust. 
5.3.2 Agreement and Reliability  
Agreement quantifies the closeness between two measurements made on the 
same subjects. It is measured on the same scale as the measurements 
themselves. Inherent variability which exists in all measurement methods will 
result in a variation in measured values. A bias between the average measured 
value and good standard deviation can also be quantified.  
The term reliability refers to the consistency of repeated measures with respect 
to the mean value of all the measurements [2].  A reliable method could signify 
that measurements are reproducible over time (test-retest reliability), that a 
single observer conducting repeated measurements would obtain similar results 
each time (intra-observer reliability) or that the result of a measurement made 
by different observers on the same subjects’ data is similar (inter-observer 
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reliability) [3]. Reliability can be evaluated using several parameters, such as 
intra-class correlation coefficient (ICC), limit of agreement (LOA) and the 
Bland Altman plot [2,4,5]. 
ICC describes the consistency of measurements made by different observers. It 
depends on the relationship between group variance and total variance. ICC 
can range from 0 to 1 and can be classified as poor (CC < 0.20),  fair (0.21-
0.40), moderate (0.41-0.60 ), good (0.61-0.8) and very good (0.81-1.00) [6].  
The LOA is computed from the differences between measurements obtained 
from two different methods, and provides the range in which 95% of values 
should lie [2]. LOA can be calculated using the Equation (5.1). 
LOA	 = d	 ±	 1.96	×SD 																																															(5.1) 
where d is mean difference and SD is the standard deviation of the differences 
between the measurements [7]. Outliers can be observed graphically on the 
Bland-Altman plot, which is plotted by drawing the mean of two measurements 
on the x-axis and the differences between the two measurements on the y-axis. 
The horizontal line of mean difference, upper, and lower LOA are drawn to 
illustrate graphically the bias between the measurements and LOA. The plot 
also provides information in the size of the differences between two variables, 
distribution around the absolute zero and distribution with increasing mean 
values.  
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5.3.3 Method 
 Study population 
This study was conducted with approval from the National Research Ethics 
Service (approval 10/H0906/50), the NHS Trust R&D (approval 10GA018), 
and by the Medicines and Healthcare products Regulatory Agency (MHRA 
Clinical Trial Authorization CTA 03057/0045/001-0001, protocol 10050). All 
volunteers gave written and informed consent before participating and the 
studies were carried out to Good Clinical Practice standards. Study product 
supplies and dispensing was organized by the Clinical Trials Pharmacy of 
Nottingham University Hospitals. 
Twenty-three healthy volunteers were recruited from the general campus 
population by advertisement. The inclusion criteria were male or female, 18–65 
years of age, body mass index (BMI) between 18 and 28 kg/m2. The exclusion 
criteria were pregnancy, any history of serious acute or chronic illness 
especially gastrointestinal, use of medication known to affect gastrointestinal 
transit, such as opiates and constipating ion drugs, substance abuse, and 
unsuitability for MRI scanning (such as having any contra-indicated metal 
implants or pacemakers). Subjects were asked to avoid alcohol for 24 h before 
the study day. Volunteers were grouped into two groups. 
All volunteers fasted overnight before the study day. Group 1 (11 volunteers) 
was given 1 L of Polyethylene glycol (PEG) electrolyte solution twice, at 1 pm 
one day before the ‘Study Day’ and at 8 am on the ‘Study Day’. They were 
allowed to drink the 1 L solution over a period of 1 hour on each occasion. 
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Group 2 (12 volunteers) was given a single dose of 2 L of PEG electrolyte 
solution at 8 am on the ‘Study Day’ and allowed to drink it in 2 hours.  
For both groups ‘Baseline’ data was acquired on their first visit before any 
PEG electrolyte solution had been consumed. Group 1 were also scanned on 
the morning of the ‘Study Day’ before consuming the second dose of solution 
(‘Part-treated’).  Both groups underwent the same MRI scanning procedure 
again in subsequent visits on the mornings of Day 1, 3, 14, and 28. All subjects 
attended for all visits except one subject who did not come for their last visit 
(Day 28). Figure 5.4 shows the experimental timeline and indicates the number 
of usable measurements for each group at each session . Subjects were also 
scanned after they received the PEG electrolyte solution on the ‘Study Day’ 
(Group 1: 4 hours, Group 2: 6 hours), but the MRI data for this day were only 
used in Section 5.3.3.3.3. 
 
Figure 5.4: The timeline of study with the usable measurement, as some data was not 
suitable for analysis. Baseline corresponded to the ‘Study day’ for group 2 and the day 
prior to the ‘Study day’ for group 1. Part-treated corresponded to the start of the study 
day for group 2. All the MRI data were taken in the morning after overnight fasting.   
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  MRI procedures 
All volunteers were scanned on a 1.5T MRI scanner (Achieva Philips 
Healthcare Systems, Best, Netherlands). Each volunteer was positioned supine 
in the scanner with a body transmit coil and four-channel SENSE body coil 
wrapped around the abdomen. Coronal, sagittal and transverse localisers were 
acquired to plan the position of the slice for the T1 measurements to maximise 
coverage through the ascending colon. 
T1  relaxation times 
MRI data were acquired using an inversion-recovery balanced fast field echo 
(IR-bFFE) sequence in the sagittal plane to image the ascending colon with a 
single slice (10 mm), matrix size of 256 x 256, FOV of 400 x400 mm2 , in-
plane resolution of 1.56 x 1.56 mm2 , FA 45 ° an TR/TE = 3/1.5 ms. Images 
were acquired with eight different inversion times (TI) of 100, 250, 500, 1000, 
1500, 2000, 3000, and 5000 ms. Each different TI data set was acquired during 
a separate breathhold with 15 s of free breathing between each to allow for full 
MRI signal recovery. 
 
  Data analysis 
5.3.3.3.1   T1 measurements 
ROIs were defined using a graphical user interface custom written IDL® 6.4 
(Research Systems Inc, Boulder CO, USA). An ROI was drawn in three 
different regions of the ascending colon: top, middle, and bottom, avoiding the 
bowel walls. These were copied to each different TI image, and then adjusted 
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at each TI, if the ascending colon had moved between images due to a different 
diaphragm position for the breathhold. The signals from these three regions 
were averaged to obtain mean signal for each TI. The mean signal then fitted 
for a single T1 to a model of signal evolution from all RF pulses applied during 
the bFFE sequence using Powell minimisation algorithm written in C. Data 
were also fitted to a simple 2-compartment model (Equation 5.2) which 
allowed for both ‘long’ and ‘short’ T1 components (T2 and M0 were assumed to 
be the same for both T1 components to reduce the number of parameters to fit): 
 
S23 TI = 	fS2 TI + 1 − f S3 TI 																																		(5.2) 
where 
S:(TI) = 		 S; 1	 −	<= >?>@A 																																										(5.3. a) 
and 
SD(TI) = 		 S; 1	 −	<= >?>@E 																																										(5.3. b) 
where SL is the signal from long T1 component, Ss signal form short T1 
component, and f is fraction of long T1 component. For the monoexponential 
fit (T1single) the signals were fitted to a standard inversion recovery curve 
similar to Equation 5.3. The signals were plotted against TI for 1 and 2-
compartment models. Independent-test were done between the T1 measures at 
baseline and part-treated, baseline and Day 1 for both group accordingly. The 
test was also done on T1 measures between Group 1 and 2. The correlation of 
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T1 measure at Day 1 with Day 28 were calculated using Spearman rank 
correlation test. 
 
5.3.3.3.2   Reliability assessment  
Three observers performed analysed the T1 recovery data for the colonic 
contents: the author (observer 1), Dr Caroline Hoad (observer 2), and Dr 
Kathryn Murray (observer 3). 15 T1 data sets were randomly selected from 
across all volunteers at any visit for repeated analysis. Each observer repeated 
the placement of the colon ROIs twice for all 15 data sets.  All ROI data sets 
were then fitted to Equation (5.3) and a simple monoexponential recovery 
curve. The analyses were performed blind to the other observer’s results (inter-
observer) and the observer’s own previous results (intra-observer).  
The reliability results were computed using the Statistical Package for the 
Social Sciences (SPSS: Version 22; Chicago, IL, USA), Reliability was 
assessed using two-way random ICCs with absolute agreement and 95% 
confidence intervals. LOA and the Bland-Altman plots were calculated to 
express the differences as the percentage of the mean of the measurements 
made by the three observers. The intra-observer reliability was assessed by 
comparing the differences in the two measurements made by the same observer 
of each data set. Inter-observer reliability test was assessed by comparing the 
first measurements of each observer against the first measurement of the other 
observers. These reliability estimates were made for single T1, short T1 short, 
and long T1. 
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5.3.3.3.3   The heterogeneity of T1 measures in the AC as 
assessed by ROI size and location. 
These measurements were conducted by a single observer (the author). Two 
datasets from volunteers in Group 2 were selected as showing no movement of 
the colon due to change in breathholding position. ROIs with different sizes 
(small, medium, and large) were drawn on a single TI image in each region of 
the colon (top, middle, and bottom) as shown in Table 5.1 and Figure 5.5. The 
signals from the ROIs for each region were averaged to obtain mean signals for 
each ROI. This was then fitted to the 1-compartment and 2-compartment 
models to obtain single T1, short T1, and long T1 as above. Mean of single T1, 
short T1 and long T1 were also calculated from all ROIs in each region of the 
colon and plotted to indicate the heterogeneity within the colonic contents. 
 
ROI size No. ROI No. Pixel in a ROI 
Top Middle Bottom 
Small 5 8 5 8 
Medium 4 27-30 17-23 20-35 
Large 3 64-71 31-33 56-66 
 
Table 5.1: Information of ROIs on three different size ( small, medium, and large), 
number of ROIs, and number of ROI pixels , which were drawn on the colon MRI 
image at three different regions of the colon (top, middle, and bottom). 
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Figure 5.5:  Example of ROIs drawn on the ascending colon with different size, small 
(yellow), medium (red), and large (blue) on three region (top, middle, and bottom). 
 
This was then repeated considering a watery content in the colon. Two good 
images of the colon were chosen from Group 1. Figure 5.6 (a) shows an image 
from a volunteer from Group 1 on the ‘Study Day’ after taking 1 L of PEG 
electrolyte solution, and shows brighter and darker regions within the colon at 
this TI, suggesting a wash-in of watery ileal fluid which had not mixed well 
with thicker colonic contents. Small ROIs were drawn on the bright and dark 
region of the colon at the top, middle and bottom as shown in Figure 5.6(a). 
Figure 5.6 (b) shows an image from a different volunteer of Group 1 after 
taking 1 L of PEG electrolyte solution on ‘Study Day’, showing that in this 
case the colonic contents are relatively uniform throughout the region. In this 
case only, small ROIs also were drawn on the top, middle and bottom region of 
the colon. The mean signal from each ROI then fitted to the 1- compartment 
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and 2-compartment models to obtain single T1, short T1, and long T1. and 
average over all ROIs. 
 
         
Figure 5.6: Small ROIs drawn on the ascending colon with three region (top, middle, 
and bottom). (a) Images of water and faecal matter separation in ascending colon. (b) 
The image of water and faecal matter mixture in ascending colon. 
 
(a) (b) 
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5.3.4 Result 
T1 measurements  
 
 
Figure 5.7: An example of signal intensity data fitted to the two models, 1-
compartment and 2-compartment. The curves show examples of where the single 
compartment model (a) did fit the data well and (b) did not. 
 
Figure 5.7 (a) shows example T1 recovery curves for 1-compartment and 2-
comparment models, for datasets that fitted well with 1-component (R2=0.990) 
and 2-component (R2= 0.991) models. However, Figure 5.7(b) shows some of 
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the data is not fitted well with 1-compartment  model  (R2=  0.974), while was 
fitted well with 2-comparment model (R2=0.994). 
Figure 5.8 shows single T1, short T1, long T1, and fraction of long T1 
component of ascending colon at the different experimental time points for 
Group 1 and 2. Figure 5.9 shows single T1 value of ascending colon of each 
volunteer in both group. There was a significant increase in single T1 and short 
T1  between the baseline and part-treated cases (p≤0.003 and p=0.008 
respectively, one tail student t-test unequal variances). No similar trend was 
seen for long T1 or Fraction of long T1. There was no different between 
baseline and day 1 for either group or both groups combined. There was no 
difference between groups for day 1 results. No trends were apparent between 
day 1 and day 28, (spearman rank correlation coefficient p>0.25 in all cases). 
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Figure 5.8: Single T1, short T1, long T1, and fraction of long T1 component of 
ascending colon for Group 1 and 2. Values are mean ± standard deviation. Group 1 
were also scanned on the morning of the ‘Study data’ before consuming the second 
dose of solution (‘Part-treated’).   
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Figure 5.9:  Single T1 of ascending colon at baseline, part-treated and Day 1 for each 
volunteer in Group 1 and Group 2. 
 
Reliability of T1 measurements 
Table 5.2 shows the ICC for the intra-observer repeatability and Table 5.3 
shows the ICC for the inter-observer repeatability. The corresponding LOA 
and Bland Altman plots are shown in Figure 5.10. For both intra and 
interobserver studies the repeatability was better for the single T1 than for the 
long and short T1 component fit. The performance of the different observers 
was similar.  
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Intra-observer ICC 
(95% Confidence Interval) 
 
 T1 value Obsv 1 Obsv 2 Obsv 3 
Single T1 0.91 0.616 0.958 
  (0.749 - 0.969) (-0.094 -0.889) (0.881 - 0.986) 
Short T1  0.794 0.733 0.57 
  (0.503 - 0.925) (0.333 -0.905) (0.127 -0.829) 
Long T1  0.788 0.247 0.502 
  (0.472 -0.924) (-0.287 -0.663) (0.005 -0.8) 
 
Table 5.2: Reliability results (ICC) from single T1, short T1, and long T1 from two 
measurements made by each observer (Obsv) for the intra-observer experiment. 
 
 
Inter-observer (ICC) 
(95% Confidence Interval) 
 
Obsv 1 vs 2 
 
Obsv 1 vs 3 
 
Obsv 2 vs 3 
 
Single T1 0.873 0.896 0.963 
 
(0.671 - 0.955) (0.67 - 0.966) (0.896 - 0.987) 
Short T1  0.513 0.368 0.826 
 
(0.06 - 0.8) (-0.089 - 0.719) (0.556 - 0.938) 
Long T1 0.622 0.379 0.587 
 
(0.18 - 0.855) (-0.178 - 0.742) (0.131 - 0.839) 
 
Table 5.3 : Reliability results (ICC) for T1 single, T1 short and T1 long from two 
measurements made between two observers for inter-observer experiment. 
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Figure 5.10: Bland Altman plots of single T1, short T1 and long T1, showing the intra-
observer or inter-observer mean difference (%) based on measurements made by three 
observers. The solid lines refer to the mean difference (%), whereas dotted line refer to 
LOA for inter and intra observers experiments. 
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The heterogeneity of T1 measures in the AC according to 
different size of ROI and location. 
Figure 5.11 and Figure 5.12 show the results of T1 measurements in the AC 
before a liquid challenge. It shows that for volunteer 1 the mean single, short, 
long T1s, and fraction of long T1 component do not depend on the size of ROI 
at the top (0.05<SD<0.24) and middle (0.06<SD< 0.55) locations in the colon. 
However, the results are more scattered with high standard deviation, SD 
(0.1<SD<1.32), in the bottom region compared to the top and middle regions. 
This particular colon had a high fraction of long T1 component compared to the 
most other data (see figure 5.8).  For volunteer 2, mean single and short T1s are 
not particularly dependent on the size of ROI and locations for all regions 
(0.06<SD<0.23). However, T1 long, and fraction of long T1 component are 
more scattered with high SD (0.18<SD< 1.43 and 0.07<SD<0.29), in all 
regions. This colon had a lower fraction of Long T1 component, similar to the 
mean values. In both cases for the single T1 fit the standard deviation between 
the ROIs tended to decrease with increasing ROI size suggesting that the 
heterogeneity was occurring on a scale similar to the size of the largest ROI. 
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Figure 5.11: T1 measurement of 1 and 2-compartment fit for Volunteer 1. The data 
were obtained based on different sizes of ROI drawn at three locations (Top, middle, 
and bottom) in the ascending colon. Mean values of all parameters shown as 
horizontal lines. 
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Figure 5.12 :  T1 measurement of single and two-compartment fit for Volunteer 2. The 
data were obtained based on different sizes of ROI drawn at three locations (Top, 
middle, and bottom) in the ascending colon. Mean values of all parameters shown as 
horizontal lines. 
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Figure 5.13 shows the results of T1 measures in the AC after a liquid challenge. 
Figure 5.13(a) shows the results for a region likely to correspond to liquid ileal 
content (dark region) and one for residual colonic content (bright region). 
Single T1 and long T1 of the dark region in the middle and bottom colon are 
close to T1 of free water. Both dark and bright regions have high fraction of 
long T1 component. Single and long T1 of bright regions are lower than that of 
dark regions. In general the spread of the results was greater in the bottom ROI.  
In Figure 5.13(b) the single T1 and long T1 are close to T1 of free water 
suggesting that the colon contents have become liquid. However, it still 
contains a mixture with a T1 short contribution, although the fraction of long 
T1 component is very high and is the dominant parameter. The distribution of 
single T1 and long T1 in top region are less scattered compare to those in the 
middle and bottom regions of the colon.  
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Figure 5.13:  Single T1, short T1, long T1, and fraction of long T1 component of 
ascending colon after a liquid challenge. The data were measured in small ROIs at the 
top, middle and bottom of the AC. Mean values shown as horizontal lines. (a) The 
data was measured in two regions of free water and faecal matter (dark and bright 
regions in the MRI image) separately. While in (b), The data was obtained from the 
mixture of water and faecal matter in the AC. 
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5.3.5 Discussion  
It proved to be feasible to fit T1 recovery curves from the colonic contents to 
multiple exponentials and it was found that this gave a better fit to the data in 
some cases but not all.  An increase in single T1 and short T1 was observed 
after consuming 1L of the electrolyte solution, suggesting that the effect of 
electrolyte solution caused an increase in the colonic fluid after 18 hours.  
However, the colonic fluid decreased to baseline on the following day and the 
2L dose did not have a similar effect.  
        The study of the reliability and reproducibility of T1 measurements of the 
colonic contents was conducted to allow the value of the results in future 
clinical studies to be investigated and to understand whether biexponential 
fitting was particularly sensitive to the choice of ROI by the operator. The data 
from this study showed that the single T1 was a more reliable parameter, than 
either of the T1s from the 2-component fit. The wider of LOA for short and 
long T1s  and the lower of ICC demonstrated poor reliability. Overall, observer 
1 showed the best intra-observer reliability with narrowest LOA for short and 
long T1s, whiles the second narrower is for single T1. However, the inter-
observer reliability test showed that narrower range of LOA for single and 
short T1s between measurements made by observer 2 and 3. The inconsistency 
in intra and inter- observer reliability occurs because of inheterogeneity of 
signal. Every observer may have drawn ROIs with different sizes and at 
different different locations. Therefore, the heterogeneity of results for the AC 
for different ROI sizes and ROI location (top, middle, and bottom regions) was 
investigated [8]. 
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          Figure 5.11 and Figure 5.12 shows that average T1 results were not 
particularly affected by the size of ROI, but Figure 5.13 shows that the results 
were affected by the location of ROI in different regions of AC, where the 
distribution of T1 measurements produced higher standard deviation between 
the ROI locations at the bottom of colon region. The higher variability in T1 
values imply greater heterogeneity of the colonic content in the bottom of the 
AC. This data need to be extended for all volunteers to evaluate the constancy 
in the result but has implications for how the colonic contents should be 
analysed in future. This is also illustrated in Figure 5.6 (a). Figure 5.6 (b) 
shows the water gets absorbed from the AC leaving the colonic contents dark. 
The liquid ileal (dark region) contents in AC consists of more free water, 
proved by the single T1 being high and close to the T1 of free water. The 
residue colonic contents which have not diluted illeal contents has lower single 
and long T1s. This suggests that T1 assessment by two models can be used to 
identify illeal contents arriving in the AC. The colonic content of the bright 
region in the top of colon has small variance compared to other dark and bright 
regions in the middle and the bottom of AC. In term of location of ROI, top of 
the colon was also the best region to measure T1 values, where the variance in 
T1 value distribution was small. This suggests that the top region of the AC is 
the best region to measure a consistent T1 value, after some mixing has 
occurred.  
5.3.6 Conclusion 
T1 values provide a robust method for characterising the colonic contents. 
Single and short T1s measurements are affected by the liquid challenge and the 
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characteristic of colonic content varies day by day. T1 measurements provide 
reliable information for in vivo study of the AC. The size of ROI does not 
effect the T1 measurement of the AC, but it is affected by the location of ROI 
of the AC, where the heterogeneity of the colonic contents at the bottom of the 
AC is high compared to those at top and middle regions.  
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Chapter 6    
The application of MRI measures to the study of 
Chronic Liver Disease 
 
 
6.1 Introduction 
This chapter addresses the application of Diffusion Weighted Imaging (DWI) 
and T1 relaxation time measures to assess changes in liver function associated 
with Chronic Liver Disease (CLD). Initially, a description of liver structure and 
function, and the known changes which occur in liver disease related to fibrosis 
are outlined. This is followed by a brief review of current MRI measures to 
assess liver fibrosis, including DWI and longitudinal relaxation time (T1) 
mapping. Specific studies that were conducted are then described. The first is a 
study of fibrosis in Chronic Liver Disease using DWI and longitudinal 
relaxation time mapping at 1.5 Tesla. With the push to higher field strength 
scanners, a liver imaging protocol is then developed at 3 Tesla for the 
assessment of structural and haemodynamic changes in the liver. The 
repeatability and reproducibility of this protocol is tested in a cohort of healthy 
subjects. Finally, an assessment of the influence of diffusion b-values on the 
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measured apparent diffusion coefficient (ADC) and intravoxel incoherent 
motion (IVIM) parameters is performed for consideration in future studies. 
6.2 Liver structure and function 
6.2.1 Liver structure and blood supply 
     The liver is a vital organ in the human body, performing many critical 
functions related to digestion, metabolism, immunity, and the storage of 
nutrients and removal of harmful substances within the body. The liver is 
located in the right upper quadrant of the abdomen cavity, just below the 
diaphragm, to the right of the stomach and overlying the gallbladder (Figure 
6.1). The liver contains four lobes and is the largest organ in the body, 
contributing to approximately 2 percent of the total body weight ~ 1.5 kg in the 
average adult human.  
 
Figure 6.1: The human abdomen showing the liver (adapted from 
http://www.merckmanuals.com/home/fundamentals/the_human_body/tissues_and_org
ans.html) 
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The liver is unique in that blood is delivered to it via two blood vessels, the 
hepatic artery and the portal vein (Figure 6.2). The hepatic artery carries 
oxygenated blood (oxygen saturation ~ 0.98) from the heart via the aorta. The 
portal vein carries deoxygenated (oxygen saturation ~ 0.75) nutrient rich blood 
draining the blood from the small intestine (gastrointestinal tract), spleen and 
pancreas. Within the liver, these blood vessels subdivide into small capillaries 
known as liver sinusoids which then lead to a lobule (Figure 6.3).  
 
 
Figure 6.2: Liver anatomy showing the feeding vessels and structure (adapted from 
http://anatomylist.com/liver-anatomy-common-bile-duct.html)  
 
Lobules are the basic functional unit of the liver. Each lobule is a cylindrical 
structure several millimetres in length, and 0.8 to 2 millimetres in diameter. It 
is made up of millions of hepatic cells called hepatocytes which form the basic 
metabolic cells in the liver. Figure 6.3 shows a cross sectional view of a liver 
lobule that is constructed around a central vein, and which joins to the hepatic 
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vein to carry blood from the lobule out of the liver to the heart. On the surface 
of the lobule are branches of the hepatic artery, portal vein and bile duct. 
Branches of the hepatic artery carry oxygenated blood from the heart to each 
lobule through small arteries, while branches of the portal vein deliver nutrient-
filled blood from the small intestine to each lobule through small veins. Bile 
duct branches deliver the bile, a digestive fluid which is made by the liver cells 
form waste products of the blood into the gallbladder, which stores the bile. 
 
Figure 6.3: Branches of the portal vein, hepatic artery, and bile duct surround each 
lobules. A central vein carries blood to the heart (Adapted from the 2010 revision of 
the Complete Home Medical Guide © Dorling Kindersley Limited). 
 
6.2.2 Liver function 
        The blood which flows from the portal vein contains many bacteria that 
grow in the intestine. When a bacterium comes into contact with a Kupffer cell, 
the large phagocytic macrophages that line the hepatic venous sinuses, it 
efficiently cleanses the blood as it passes through the sinuses. The liver is also 
responsible for immunological effects, with the reticuloendothelial system of 
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the liver containing many immunologically active cells, acting as a ‘sieve’ for 
antigens carried to it via the portal system. 
The liver performs a number of roles in metabolic function. Firstly, the 
liver performs a role in carbohydrate metabolism including (1) storage of 
glycogen, (2) conversion of galactose and fructose to glucose, (3) glycogenesis 
(the synthesis of glyocogen) and (4) the formation of chemical compounds 
from intermediate products of carbohydrate metabolism. The liver acts to 
maintain a normal blood glucose concentration; when blood glucose 
concentration begins to fall too low, glycogen stored in the liver allows the 
excess glucose to be removed, and return it to the blood. Gluconeogenesis, the 
synthesis of glucose from large amount of amino acids and lactate or glycerol, 
is also important in maintaining a normal blood glucose concentration. 
          The liver also has a number of roles in fat metabolism. These include (1) 
oxidation of fatty acids to supply energy for other body functions, (2) synthesis 
of large quantities of cholesterol, phospholipids, and most lipoproteins, and (3) 
synthesis of fat from proteins and carbohydrates. Almost all fat in the body is 
synthesized from carbohydrates, proteins and dietary fat. The synthesized fat is 
transported in the lipoproteins to adipose tissue to be stored. The liver 
synthesizes about 80 percent of cholesterol which is converted into bile salts, 
and secreted into bile. The rest of the cholesterol is transported in lipoproteins 
and carried by the blood to the tissue cells in the body. Cells use both 
cholesterol and phospholipids to form membranes, intracellular structures, and 
multiple chemical substances that are important to cellular function. 
          The liver plays an important role in protein metabolism for (1) 
deamination of amino acids, (2) formation of urea for removal of ammonia 
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from the body, (3) formation of plasma proteins, and interconversions of the 
various amino acids and synthesis of other compounds from amino acids. 
Deamination of amino acids is required before they can be used for energy or 
converted into carbohydrates or fats. Ammonia is removed from the body 
fluids when urea is formed by the liver. Large amounts of ammonia are also 
formed by the deamination process, and additional amounts are continually 
formed in the gut by bacteria and then absorbed into the blood.   
         The liver stores vitamins, such as vitamin A, D, and B12. Sufficient 
quantities of vitamin A can be stored for as long as 10 months, vitamin D for 3 
to 4 months, and enough vitamin B12 for at least one year. The highest 
proportion of iron in the body is stored in the liver in the form of ferritin. When 
there is an excess quantity of iron in the body, hepatic cells containing the 
protein apoferritin combine with iron to form ferritin. 
         The liver forms blood substances that are used in the coagulation process 
such as fibrinogen, prothrombin, accelerator globulin, and insulin-like growth 
factor 1 (IGF-1). The liver is a major site of thrombopoietin production, a 
glycoprotein hormone that regulates the production of platelets by the bone 
narrow, and synthesizes angiotensinogen, a hormone responsible for raising the 
blood pressure when activated by renin. The liver also removes or excretes 
drugs, hormones and other substances.  
          One of the functions of the liver is to secret bile, normally between 600 
and 1000 ml/day.  Bile helps to emulsify large fat particles of food into many 
particles and helps the absorption of vitamin K from the diet. It also aids in the 
absorption of digested fat end products through the intestinal mucosal 
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membrane. Bile excretes several important waste products from blood, such as 
bilirubin, an end product of haemoglobin destruction, and excess cholesterol.                                                            
6.3 Liver Fibrosis 
        Liver disease is the fifth most common cause of death according to the 
Office for National Statistics (ONS) in the UK [1]. At the early stage of liver 
disease, the liver can become inflamed. If left untreated, the inflamed liver will 
start to scar, with scar tissue (a kind of fibrous tissue) replacing healthy liver 
tissue - this process is called fibrosis of the liver. As scar tissue builds up, liver 
function declines, and the remaining healthy liver tissue has to work harder to 
compensate for the scarring. 
        If liver disease is diagnosed and treated successfully at this stage, the liver 
can heal itself. If left untreated, the liver may become so seriously scarred that 
the damage cannot be reversed – this process is called cirrhosis. The stage of 
liver fibrosis can be described using several scoring systems for fibrosis 
(METAVIR, Ishak, NASH-CRN). The METAVIR score (F0 ¼ no fibrosis, F1 
¼ stellate enlargement of portal tracts without septa, F2 ¼ stellate enlargement 
of portal tracts with few septa, F3 ¼ septal fibrosis without cirrhosis, F4 ¼ 
cirrhosis), has been used in several studies. The recently published histological 
scoring scheme of the NASH Clinical Research Network (NASH CRN) is 
increasing in popularity by both clinical and research communities, and is used 
in Section 6.5. A normal liver is of stage F0 and F1, stage F2 denotes light 
fibrosis, and F3 is severe fibrosis. Cirrhosis is defined as stage F4 (or stages 5 
or 6 in the Ishak scoring system) [2]. During the decade from 1992–2001 in the 
UK, there was a 45% increase in cirrhosis [3], with 30,000 people now 
The application of MRI measures to the study of Chronic Liver Disease 166 
estimated to be living with cirrhosis and at least 7,000 new cases being 
diagnosed each year. In developed countries, cirrhosis is the 14th most common 
cause of death [4]. Fibrosis disorganises the architecture of the liver both 
anatomically and functionally. When fibrosis reaches the cirrhotic stage, it is 
initially completely asymptomatic; this is the compensated cirrhosis stage, i.e. 
not complicated. Cirrhosis then decompensates, and liver complications appear 
including (1) portal hypertension, which impedes venous circulation and causes 
the pressure in the portal vein to rise which can promote haemorrhaging by 
bursting oesophageal varicose veins; (2) ascites, the formation of a liquid 
effusion in the abdominal cavity, which can become infected; (3) hepatic 
encephalopathy, a neurological disorder resulting from the accumulation of 
toxins that are not broken down by the liver; and (4) cancer of the liver, 
hepatocellular carcinoma, a final complication. 
Liver fibrosis occurs when there is excessive accumulation of 
extracellular matrix (ECM) proteins including collagen, which is a 
characteristic of most types of chronic liver disease [5]. The major collagen-
producing cells such as activated hepatic stellate cells, portal fibroblasts, and 
myofibroblasts of bone marrow origin are activated by fibrogenetic cytokines 
in the injured liver. Cirrhosis produces hepatocellular dysfunction and 
increases intrahepatic resistance to blood flow, which results in hepatic 
insufficiency and portal hypertension. Advanced liver fibrosis results in liver 
failure, portal hypertension and as an end-point often requires liver 
transplantation. The main causes of liver fibrosis are chronic hepatitis C virus 
(HCV) infection, alcohol abuse, and non-alcohol steatohepatitis (NASH). In 
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addition, liver fibrosis is also influenced by both genetic and environmental 
factors [5].  
Advanced liver fibrosis is potentially reversible. Early detection or 
diagnosis of liver fibrosis in chronic liver disease (CLD) patients is important 
for therapeutic and prognostic purposes, such as antifibrotic therapies to inhibit 
the accumulation of fibrogenetic cells or prevent the deposition of extracellular 
matrix proteins. Histopathology of the disease is typically performed by a 
biopsy which is still the gold-standard method to determine fibrosis stage, 
necroinflammatory grade, and to identify the underlying cause of liver disease. 
The degree of fibrosis can be quantified from staining of the ECM protein (e.g. 
with Sirius red) using computer-guided morphometric analysis. However, an 
invasive liver biopsy  procedure has a risk of complications [6], and the small 
sample size leads to intra-observer and inter-observer variability and sampling 
errors. Non-invasive methods to assess liver fibrosis using routine laboratory 
tests, such as scoring the serum level of proteins related to the hepatic 
fibrogenetic process,  has been proposed as a surrogate marker of liver fibrosis. 
However, such levels are not effective for differentiating intermediate grades 
of fibrosis. MRI provides a non-invasive modality to assess liver disease, and is 
now being explored as a method to validate markers of liver fibrosis which 
could reduce biopsy related risks and cost.  
6.4  Previous MRI studies to assess liver fibrosis. 
A number of MRI techniques have been used in the assessment of liver 
fibrosis. These include conventional contrast-enhanced MRI, double contrast-
enhanced MRI, MR Elastography (MRE), DWI, perfusion imaging and MR 
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spectroscopy, and more recently longitudinal relaxation time (T1) mapping [7]. 
The work in this chapter focuses primarily on the use of DWI and longitudinal 
relaxation time measures (T1) to assess liver disease.  
6.4.1  Using Diffusion Weighted Imaging (DWI) to assess Liver 
fibrosis  
         DWI has been used to assess and stage liver abnormalities such as 
chronic liver disease (CLD) and chronic hepatitis C virus [6, 8, 9]. Koinuma et 
al.[6] showed that the ADC value is potentially useful to evaluate the stage of 
liver fibrosis in chronic hepatitis patients with cirrhosis. ADC in the liver was 
compared between patients with cirrhosis, chronic hepatitis, and normal liver 
as measured using the histology activity index (HAI) stage, a stage derived 
from the combination of scores of necrosis, inflammation, and fibrosis. They 
showed a significant (P < 0.0001) decrease in ADC as the fibrosis stage 
assessed by the HAI increased and as the stage of liver disease progressed 
(ADC of 3.45, 2.45, 1.98 x 10-3 mm2/s for normal, chronic hepatitis, and 
cirrhosis respectively). Lewin et al.[8] diagnosed liver fibrosis in patients with 
chronic HCV infection using DWI in comparison to other non-invasive 
methods including FibroScan, aspartate aminotransferase to platelets ratio 
index (APRI), the Forns index, serum hyaluronate concentration, transient 
elastography and liver fibrosis stage from biopsy.  Patients with moderate-to-
severe fibrosis (F2-F3-F4) had liver ADC values lower than those without or 
with mild fibrosis (F2-F3-F4: 1.10 +/- 0.11 versus F0-F1: 1.30 +/- 0.12 x 10-3) 
mm2/s) and healthy volunteers (1.44 +/- 0.02 x 10-3 mm2/s). In discriminating 
patients with stage F3-F4, the areas under the receiving operating characteristic 
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curves (AUCs) were 0.92 (+/-0.04), higher than any other method assessed. 
Taouli et al. [9] quantified liver fibrosis assessed from biopsy against ADC. 
Again, significantly lower (p < 0.001) liver ADC was found in stage (F2-F3-
F4) (1.47 +/- 0.11 x 10-3 mm2/s) versus F1-F0 (1.65 ± 0.10 x 10-3 mm2/s), as 
well as stage (F3-F4) (1.44 ± 0.07 x 10-3 mm2/s) versus F0-F1-F2 (1.66 ± 0.10 
x 10-3 mm2/s). Liver ADC was a significant predictor of stage > F2 and > F3, 
with AUCs of 0.896 and 0.896, sensitivity of 83.3% and 88.9%, and specificity 
of 83.3% and 80.0%. Wang et al. [10] used histopathology as the reference 
standard to detect and characterise chronic hepatitis and liver fibrosis in 
patients with chronic liver disease and showed that ADC had lower 
discriminatory capability in staging fibrosis. Bonekamp et al. [11] investigated 
whether the combination of CT-derived arterial enhancement fraction (AEF), 
ADC measurement and serum biomarkers (the aspartate aminotransferase 
(AST)/alanine aminotransferase (ALT) ratio, and AST-to-platelet ratio index 
(APRI)) could provide a more accurate assessment of liver fibrosis. This study 
revealed that an increase in hepatic AEF and decrease in ADC was associated 
with the presence of mild, moderate and advanced liver disease. They reported 
ADC could distinguish between hepatic fibrosis at stage > F1, > F2, F3 and F4. 
Since fibrosis progression can be reversed in early stages, DWI was thought to 
potentially provide a method to distinguish between liver fibrosis at early and 
intermediate stage. However, Bakan et al. [12] showed that DWI can be used 
to distinguish fibrosis only at later stage, and not at the early to intermediate 
stages (i.e. between F0 and F1, and F0 and F2, but not between F1 and F2). 
They showed significant differences in ADC between all groups except 
between stage F0 and F1, and between stage F1 and F2. Sandrasegaran et 
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al.[13]  determined the severity of liver fibrosis by evaluating the ADC in 
patients with high-stage fibrosis (F3 and F4), with hepatitis C, hepatitis B, 
alcohol, non-alcoholic steatohepatitis and primary biliary cirrhosis. However, 
no significant differences in ADC were found between patients with and 
without viral hepatitis. They found that ADC values in patients with moderate 
to severe fibrosis was lower than in patients without or with mild fibrosis and 
healthy liver. However, no significant differences were found between stage F1 
and F2, stage F2 and F3, and stage F3 and F4 [13], with the ADC value 
overlapping substantially in each group except between stage F0 and stage F3 
or F4.  
        Several  studies have reported the ADC of cirrhotic livers is lower than 
that of the healthy liver [6, 14], likely due to the presence of a larger amount of 
connective tissue in the liver, narrowed sinusoids, and decreased blood flow [6, 
14, 15] leading to restricted water diffusion in the fibrotic liver [10]. However, 
an overlap has been reported between the ADC values for normal and cirrhotic 
liver [16]. In summary, ADC has generally been found to decrease with 
increasing fibrosis stage [6, 8, 9, 11, 12, 14], and correlate with fibrosis stage 
[6, 9-12, 14]. Though  some studies such as Wang et al. [10] report that ADC 
does not consistently decrease with increasing fibrosis stage, aligned with a 
number of studies reporting inconsistent results for staging liver fibrosis with 
DWI [6, 8, 9, 13, 14, 16]. For example, Boulanger et al. [16] found no 
significant difference between hepatitis C virus patients and controls, with 
ADC values of hepatitis patients even being higher than those of normal liver. 
         Critically, the choice of b-values used in a DWI scheme affects the 
calculated ADC [8, 10, 17] and thus may effect reported results. Higher b-
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values that are used to obtain ADC values are more sensitive to diffusion, 
whilst low b-values are more sensitive to perfusion. In prior studies, some 
groups have used just  two [6, 11, 13, 14] or three b-values [7, 12], while others 
use multiple b-values [8, 9] to obtain ADC values. Taouli et al. [9] used b-
values of 0, 50, 300, 500, 700 and 1000 s/mm2 to obtain ADC values in chronic 
hepatitis patients and healthy volunteers, but also assessed ADC values 
obtained using just two pairs of b-values individually (0 /50, 0/300, 0/500, 
0/700, and 0/1000 s/mm2). There was a considerable range of ADC values 
obtained, for example for stage F0 patients, ADC values of 3.21 ± 0.98, 1.95 
± 0.25, 1.60 ± 0.18, 1.42 ± 0.14, 1.19 ± 0.12 x 10-3 mm2/s were computed for 
b-value pairs of 0 /50, 0/300, 0/500, 0/ 700, and 0/1000 s/mm2 respectively, 
compared to and ADC value of 1.66 ± 0.12 x 10-3 mm2/s  for the combination 
of b-values of 0, 50, 300, 500, 700, and 1,000 s/mm2. Multiple b-values 
enabled more precise calculation of ADC with less perfusion contamination 
[18] and less regional ADC variation. The authors suggested that ADC values 
measured with DWI can be used to quantify liver fibrosis when the b-value is 
500 s/mm2 or greater, and that staging of fibrosis cannot be detected at small b-
values (< 300 s/mm2), for which there is likely an increase in the amount of 
perfusion contamination in the ADC measurement [16]. Importantly, the ADC 
is determined not only by molecular diffusion in tissue but also by 
microcirculation in vessels i.e. perfusion. Perfusion-related effects are not 
negligible due to the liver being a highly vascularized organ.  
         The IVIM technique has been applied in liver imaging to estimate both 
perfusion-related and pure molecular diffusivity [18, 19]. Luciani et al. [20] 
showed that ADC values were significantly higher than D values in the healthy 
The application of MRI measures to the study of Chronic Liver Disease 172 
liver (ADC = 1.39 ± 0.2 x 10-3 mm2/s versus D = 1.10 ± 0.7 x 10-3 mm2/s) and 
in the cirrhotic liver  (ADC = 1.23 ± 0.4   x 10-3 mm2/sec vs D = 1.19 sec ± 0.5 
x 10-3 mm2/s). ADC and D* were reported to be significantly reduced in the 
cirrhotic liver compared to the healthy liver, with the observed ADC reduction 
in cirrhotic livers being linked to the decrease in D* values related to reduced 
perfusion in cirrhotic livers. Ichikawa et al. [21] suggested D* may potentially 
be a surrogate marker of liver perfusion. There was a strong negative 
correlation (R=0.71) between D* and fibrosis stage, while f and ADC had a 
weak negative correlation (R=0.19, and R=0.23) with fibrosis stage. In 
contrast, no significant correlation was observed between D and fibrosis stage. 
From these results, it was concluded that a decrease in perfusion in micro-
vessels is reflected by the decrease of ADC associated with fibrosis rather than 
restricted molecular diffusion in the tissue. In another patient based study, it 
was found that D, f and D* were significantly lower in fibrotic than healthy 
livers, and decreased with severity of fibrosis [22].  
         In an animal model study, liver fibrosis was induced in mice using a 
carbon tetrachloride (CCl4) injection, and fibrosis was established after 2 - 4 
weeks [23]. It was shown that D and D* decreased as liver fibrosis developed, 
however there was no change in f. Similarly, a CCl4 injection of different doses 
was injected into rats to induce various fibrotic stages [24]. Significant inverse 
correlations were found between fibrosis stage and D, f, D*, ADC, suggesting 
IVIM is a useful technique to assess early detection and diagnosis of liver 
fibrosis. 
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6.4.2 Using Longitudinal Relaxation time (T1) to assess Liver 
fibrosis  
           Recently, the longitudinal (T1) relaxation time has been suggested to 
provide a marker for detection and characterision of inflammation and fibrosis 
at early stage [25]. Heye et al [26] evaluated liver T1 on a 1.5 T MR scanner, in 
order to distinguish between healthy subjects and patients with liver cirrhosis. 
The T1 value in the cirrhotic liver was significantly higher (852 ± 132 ms) than 
in the healthy liver (678 ± 45 ms). The potential of MR relaxometry as a non-
invasive test to assess fibrosis can be evaluated by comparing T1 values with 
histopathology of the liver. A high T1 value is reflected by the presence of 
elevated water in the extracellular cells. However, the T1 value can also be 
affected by the accumulation of iron in the liver, with a decrease in T1 value 
with increased iron level in the liver [27-29]. The accumulation of iron can be 
determined accurately from a T2* map where hepatic iron content has shown a 
strong negative correlation with T2* [28]. With the elimination of iron, 
Banerjee et al. found T1 with T2* > 2 ms strongly correlated with increasing 
liver fibrosis.  In the recent MRker study, T1 has been shown to be a simple 
marker of fibrosis, and was found to increase with advanced fibrosis [27]. 
Hoad et al. [27] suggested T1 values might be combined with other MR 
parameters or non-invasive markers such as serum panel markers or transient 
elastography in order to estimate liver fibrosis stage.  
           The remainder of this chapter is divided into three sections of distinct 
studies which aim to i) Assess the use of diffusion parameters (ADC, and D*, f 
and D) and T1 measures collected at 1.5 Tesla for staging of liver fibrosis in 
patients with chronic liver disease (CLD) - Section 6.5; ii) Assess the reliability 
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and reproducibility of a liver MR examination for use at 3 Tesla and to enable 
future patients studies - Section 6.6; and iii) Optimise diffusion parameters to 
assess ADC and IVIM parameters of D*, f and D in liver fibrosis – Section 6.7.   
 
6.5 STUDY 1: The assessment of liver fibrosis using Diffusion 
Weighted Imaging and Relaxometry (Mrker study) 
Clinical decision making and prognosis in chronic liver disease depends 
upon the degree of necroinflammation and fibrosis. Liver biopsy is currently 
the primary tool used in this evaluation, but since a liver biopsy samples only 
1/50,000th of the liver volume, it is prone to sampling errors and intra- and 
inter-observer variability. Furthermore, the procedure can cause bleeding and 
pain. Therefore the development of non-invasive tests to evaluate both 
necroinflammation and fibrosis is highly desirable.  
 In the scope of DWI, there is a wide variation and inconsistency in the 
values of ADC and IVIM parameter estimates to assess the severity of liver 
fibrosis in Chronic Liver Disease (see section 6.3). To overcome this, a recent 
study [30] has proposed normalizing liver ADC values using the spleen as a 
reference organ to reduce variability in the ADC measurement, the spleen was 
chosen due to its size and similar position relative to the diaphragm as to the 
liver. This normalization procedure assumes values in the spleen remain 
relatively constant across patients even in liver disease. Do et al. [30] found 
that normalisation of the liver ADC with spleen ADC improved the accuracy in 
detecting liver fibrosis and cirrhosis. MRI can also be used to detect the 
longitudinal (T1) relaxation time (see section 6.3), which has been suggested to 
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provide a marker for detecting and characterising inflammation and liver 
fibrosis at early stage [25].   
          This current study aims to investigate in the liver the use of the diffusion 
weighted imaging ADC and IVIM parameters, liver ADC normalised by the 
spleen, and the longitudinal T1 relaxation time measures to distinguish liver 
fibrosis stage in chronic liver disease. This data was acquired as an extension 
of the ‘MRker Study’ [27] which was performed at the SPMMRC in 
collaboration with the NIHR Nottingham Digestive Diseases Biomedical 
Research Unit at the Nottingham University Hospitals NHS Trust. 
6.5.1 Methods and analysis 
6.5.1.1 Patient population 
         This data was collected with approval from the Nottingham NHS Ethics 
Committee at Nottingham University Hospitals NHS Trust and Royal Derby 
Hospital between May 2009 and September 2012; all patients gave written and 
informed consent (National Research Register Document NCT01572064). 
Patients were recruited through the NHS Trust by Dr Naaventhan 
Palaniyappan, Dr Martin James, Dr Indra Guha, and Prof Guruprasad Aithal. 
53 patients with chronic liver disease (CLD) participated in this study and at 
the time of enrolment all participants underwent a liver biopsy core length ≥ 25 
mm. MRI was performed within three months of biopsy and patients received 
no therapeutic interventions between biopsy and imaging. 14 patients were 
excluded from analysis due to inadequate biopsy (2), incomplete MRI 
acquisition (3), incomplete relaxometry data (2), poor quality DWI data (7).  
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6.5.1.2 Biopsy and histopathology procedures 
       The biopsy procedure was performed by Dr. Martin James. Liver biopsies 
were either obtained via percutaneous or transjugular route. Patients were 
fasted overnight before the procedure and biopsies were carried out by 
experienced operators. The majority of the biopsies acquired were 
percutaneous and these were all carried out with ultrasound guidance, with 
samples taken from the right lobe of the liver. No major complications from the 
liver biopsy were reported in this cohort.    
        Biopsies were stained with Hematoxylin and Eosin (H&E), PicroSirius 
Red (PSR) and Perls Prussian Blue stains prior to assessment by one 
pathologist, blinded to the MR data. Due to the varied aetiologies, a composite 
grading system was used to categorise biopsies based on necroinflammation 
(none/mild, moderate, severe) and fibrosis was defined according to the 
Clinical Research Network (NASH-CRN) scoring from F0 to F4.  
6.5.1.3 MR data acquisition 
All patients were scanned once on a 1.5T whole body scanner (Achieva Philips 
Healthcare Systems, Best, Netherlands) with a body transmit coil and five-
channel SENSE cardiac receive coil placed over the liver. Coronal and 
transverse localisers were acquired to plan the position of slices for the DWI 
and T1 measures, such that these maximised coverage of the left lobe of the 
liver and ensured that the right lobe was present in all slices.   
Diffusion Weighted Imaging (DWI) data 
 Respiratory triggered Spin-Echo Diffusion Weighted Imaging (SE-DWI) was 
performed with an EPI readout (7 axial slices per volume, 3x3x8 mm3 voxel, 
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96 x 96 matrix, slice gap 4 mm, half scan factor 0.692, SENSE factor 2, and 
TE/TR = 67/2500 ms, SPIR fat saturation scheme). Nine b values (b = 0, 25, 
50, 100, 200, 300, 500, 650, 800 s/mm²) were used, and data were acquired in 
six orthogonal directions.  
T1 and T2* relaxation times 
MRI data were acquired using a respiratory triggered acquisition with 7 axial 
slices per volume, 3x3x8 mm3 voxel size, 96x96 image matrix, 4 mm slice gap 
(33%), and SENSE factor 2. For T1 measurement, an inversion-recovery spin-
echo echo-planar imaging (IR SE-EPI) sequence was used with fat saturation 
pulse (water only excitation). A minimum TR of 8000 ms and ten TI values 
(100, 200, 300, 400, 500, 600, 700, 800, 900, 1000 ms) were acquired twice 
with ascending and descending slice ordering acquisition to provide a larger 
range of inversion times for a given slice, resulting in slices being acquired at 
20 TI values ranging from 100 to 1484 ms. Each inversion time (TI) was 
collected at the same point in the respiratory cycle by introducing an additional 
delay following the respiratory trigger and prior to the TI. TI provides the 
inversion time for the first slice in the multi-slice data scheme for which there 
was a temporal slice spacing of 48 ms. For T2* measurement, a gradient-echo 
echo-planar imaging (GE-EPI) sequence was used with saturated pulse 
inversion recovery (SPIR) for fat saturation. Five TEs (12, 15, 20, 30, 40 ms) 
were acquired, each with three repetitions, and the TR of the scheme was set to 
a minimum of 8000 ms. 
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6.5.1.4 MR Data Analysis 
Diffusion Weighted Imaging (DWI) data 
The data were analysed using a programme developed in MATLAB (R2010a; 
MathWorks Inc, Natick, MA, USA). All images were first inspected for poor 
image quality affected by motion and low signal, and any images where bulk 
motion was apparent were discarded before fitting. The signal intensity for 
each b-value was averaged across the six directions to form an average image. 
An ROI was drawn of the whole liver and spleen using the DWI image 
collected at b = 0 s/mm² at each slice (for liver) and one slice (for spleen) to 
create a binary mask, as shown in Figure 6.4. For the liver, a binary mask 
without small and large vessels was created by excluding those pixels with 
intensity higher than the mean intensity of the liver (Figure 6.4 (b)). 
 
            
                               
Figure 6.4: An ROI was drawn around the liver on a b = 0 s/mm² DWI image (a) to 
create a binary mask whilst excluding small and large vessels in the liver (b). An ROI 
drawn on b = 0 s/mm² DWI image of the spleen(c) to create a binary mask (d).  
 
(a) (b) 
(c) (d) 
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The binary mask was applied to the average images at each b-value to measure 
the mean signal intensity for the whole liver. The mean signal intensity was fit 
to (i) a mono-exponential ADC model (Equation (3.6), Chapter 3) and (ii) a 
full bi-exponential IVIM model fit (Equation (3.7), Chapter 3) using a ‘least-
square’ fitting algorithm to obtain a value of  (i) ADC, (ii) D, D*, and f for the 
liver. For the spleen, a value of ADC only was obtained and used to calculate a 
normalised liver ADC from the ratio of liver ADC to spleen ADC.   
T1 and T2* relaxation time mapping 
A mask was drawn around the liver image from each slice of the TI = 1000 ms 
image for the T1 data, and the TE = 12 ms image for the T2* data. Data were fit 
on a voxel-by-voxel basis to generate T1 and T2* maps (Figure 6.5 (a)and (b)) 
using a least squares non-linear curve fitting algorithm in Matlab® (The 
MathWorks Inc., Natick, MA). A weighted linear least squares fit was used 
with 1/TE (in ms) as the weighting factor in order to avoid noise bias in the T2* 
fitting. 
  
          
Figure 6.5 : (a) T1 and (a) T2* maps of  a chronic liver disease stage F4 patient, the 
colour bar shows T1 and T2* values respectively in unit of ms. Maps taken from Hoad 
et al [27]. 
 
(a) (b) 
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Histogram analysis was used to assess the distribution of relaxation times (T1 
and T2*) across the whole liver. Each histogram of voxel values was fit to a 
Gaussian function, and T1 and T2* values were obtained from the position of 
the peak of the histogram (the mode of the distribution). This analysis provided 
an automated method to eliminate those voxels containing blood in vessels 
without having to draw detailed masks to exclude these voxels. The T1 and T2* 
data fitting maps and all the calculations were performed by Dr. Caroline L. 
Hoad and are published in [27]. 
6.5.1.5 Statistical Analysis 
Statistical analysis was performed using SPSS (version 21.0, IBM SPSS 
Statistics, USA). Patients were separated based on their fibrosis stage (F0-F4), 
and can be classified into those without advanced fibrosis (F0-2), and those 
with advanced fibrosis and cirrhosis (F3-4). The distribution of fibrosis stage of 
all patients is shown in Figure 6.6, note the small sample size for F4. In 
addition to other histological factors, a T2* cut-off value of 22.6 ms was used 
to define patients without iron accumulation in their liver [27]. The fibrosis 
stages were then also sub-divided into patients with T2* >0 ms (all patients) 
and T2* > 22.6 ms (patients without iron accumulation) to determine whether a 
lower T2* contributed to variance in diffusion measures, which could arise due 
to lower signal-to-noise ratio of the SE-EPI based DWI data. A Shapiro-Wilk 
normality test was performed to assess that the normality of the data. Data were 
compared using analysis of variance (ANOVA) with Independent-paired test 
for two comparison if normally. The DWI parameters (ADC, D, D*, and f) and 
T1 values for the liver, spleen ADC and normalised liver ADC were recorded, 
with normal data expressed as mean (SD) and non-normal as median 
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(interquartile range, IQR) across each group. All parameters were plotted 
against fibrosis stage. The relationship between liver ADC, D, D*, f, and 
normalised liver ADC with T1 was plotted and tested using a Pearson 
correlation. To assess the effect of inflammation on parameters, the two patient 
groupings of patients without advanced fibrosis (F0-F2) and with advanced 
fibrosis and cirrhosis (F3-F4) were sub-divided into those with (none or mild) 
or (moderate or severe) inflammation. Independent paired tests were made to 
compare the DWI and T1 parameters between patients in both groups with 
inflammation factor.  
 
 
Figure 6.6: (a) Distribution of fibrosis stage across the Chronic Liver Disease patient 
group in this study. (b) Distribution of patients subdivided according to patients with 
(T2* < 22.6 ms) and without (T2* > 22.6 ms) iron accumulation.  
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6.5.2 Results 
Table 6.1 shows the measured ADC and IVIM parameters and T1 values in the 
liver, together with ADC of the spleen and normalised liver ADC, as a function 
of fibrosis stage for all patients (T2* > 0 ms).  
Fibrosis 
Stage (F) 
ADC 
 
D 
 
D* 
 
f 
 
T1 
 
                      
0 1.93  ± 0.72 1.04  ± 0.11 56.  4 ± 8.3 0.26  ± 0.12 634  ± 48 
1 1.84  ± 0.18 1.01  ± 0.10 71.0  ± 11.6 0.25  ± 0.04 646  ± 19 
2 1.76  ± 0.26 0.98  ± 0.07 61. 8  ± 20.8 0.24  ± 0.05 647  ± 34 
3 1.97  ± 0.45 1.03  ± 0.09 61.1  ± 10.5 0.26  ± 0.07 675  ± 59 
4 1.71  ± 0.71 1.06  ± 0.19 72.6  ± 21.5 0.22  ± 0.07 707  ± 78 
                      
 
 Fibrosis 
Stage (F) 
ADC Spleen Normalized ADC liver 
          
0 0.92 ± 0.18 2.38 ± 0.87 
1 1.12 ±  0.20 1.66 ± 0.27 
2 0.96 ± 0.14 1.86 ± 0.34 
3 1.04 ± 0.26 1.94 ± 0.51 
4 0.96 ± 0.16 1.88 ± 0.41 
          
 
Table 6.1 : Mean and standard deviation of ADC, D, D*, f, and T1 values for the liver, 
ADC of the spleen, and normalised liver ADC for all patients (T2*> 0 ms) at each 
stage of fibrosis 0, 1,2 3, and 4. Units of ADC, D, and D* x10-3 mm²/s and T1 is in ms. 
 
Figure 6.7 plots this data for all patients (T2* > 0 ms) and also shows data for 
those patients with a T2* cut-off > 22.6 ms, previously validated as the cut-off 
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value to define patients without iron accumulation (sensitivity 0.89, specificity 
0.71) [27]. A reduction in ADC is seen between F0 and F1-F4 for patients 
without iron accumulation (with T2* >22.6 ms ), with a general decline in ADC 
across F0-F1-F2-F3 for these patients (note this is not continued for F4, but 
may relate to the low sample size of this group), though  there was no 
significant difference in ADC found across fibrosis stages F1-F4 for patients 
with T2* > 22.6 ms (p=0.527). There were also no significant differences in D, 
D*, and f values across fibrosis stages (F0-F4) for all patients (T2* > 0 ms) or 
those with T2* >22.6 ms. 
  
  
Figure 6.7: ADC and IVIM (D and D* x10-3 mm/s2 and f) parameter values as a 
function of fibrosis stage shown for all patients (T2*>0 ms) and patients without iron 
accumulation (T2* > 22.6 ms).  All data is shown as mean and standard error.  
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Figure 6.8 shows the normalised liver ADC value, with a reduction seen 
between F0 and F1-F4 for all patients with T2*> 0 ms and T2*> 22.6 ms 
(p=0.03). However, no significant difference in normalised liver ADC value 
was found across F1-F4 (p=0.149, p=0.256). 
 
 
Figure 6.8: Liver normalised ADC (ratio of liver ADC to spleen ADC) as a function of 
fibrosis stage for all patients (blue) and those patients without iron accumulation (T2* 
> 22.6 ms). The difference of liver normalised ADC across all fibrosis stage are not 
significant. 
 
Figure 6.9 shows the longitudinal relaxation time (T1) as a function of fibrosis 
stage. An increase in T1 with fibrosis stage can be seen, with a significant 
difference (p=0.02) between F0 and F4 for all patients (T2* > 0 ms), as well as 
between both stage F1 and F4 (p=0.045) and F2 with F4 (p=0.04).  
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Figure 6.9: Longitudinal relaxation time (T1) as a function of fibrosis stage for all 
patients and those patients with liver T2* > 22.6 ms only. The T1 value between 
fibrosis stage F0 and F4 for all patients is significantly different (p=0.02). 
 
To assess this data further, and improve sample size limitations, the data was 
also binned into groups of no fibrosis F0, early to intermediate fibrosis (F1 and 
F2) and severe fibrosis (F3 and F4), and differences assessed for all patients 
(T2* > 0 ms) and those without iron accumulation (T2* > 22.6 ms). For all 
patients, a significant reduction in ADC was found between F0 versus F1-F2 
(p=0.05), with normalised liver ADC showing a significant reduction for both 
F0 versus F1-F2 (p=0.013) and F0 vs F3-F4 (p=0.048). T1 was found to 
increase between both F0 versus F1-F2 (p=0.028), and F1-F2 versus F3-F4 (p 
=0.028). For those patients without iron accumulation (T2*> 22.6 ms), 
significant differences were found in ADC for F0 versus F3-F4 (p=0.03), T1 
for F1-F2 versus F3-F4 (p=0.027), and normalised Liver ADC for F0 versus 
F2-F3) (p=0.049). 
Figure 6.10 (a) shows liver ADC plotted against T1, with data points shown for 
patients with T2* < 22.6 ms and T2* > 22.6 ms. When combining all patients’ 
data (all T2* values) a significant correlation of R = 0.488 (p = 0.002) between 
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ADC and T1 was found. For patients with T2* < 22.6 ms, a correlation of R= 
0.486 and p=0.041 was seen, with a large variance in ADC. Including only 
those patients with T2* > 22.6 ms a stronger correlation of R = 0.59, p = 0.005 
was found. Figure 6.10 (b) shows the correlation of ADC value and T1 for 
those subjects with T2* > 22.6 ms plot as a function of fibrosis stage (F0-F4). 
 
 
Figure 6.10 (a): Correlation of liver ADC (x10-3 mm2/s) with longitudinal relaxation 
time (T1( ms)) for patients with T2* values < 22.6 ms (red) and > 22.6 ms (green). R 
and p values are indicated for ADC values for all patients (T2* > 0 ms) in black, and 
associated correlations for subgroups in red and green. (b) Correlation of liver ADC 
value with longitudinal relaxation time (T1) for patients with T2* > 22.6 ms shown in 
terms of fibrosis stage (F0-F4).  
 
Figure 6.11 shows the correlation of normalised liver ADC value and T1 for all 
subjects (T2*>0 ms), there was a significant correlation of normalised liver 
ADC with T1 (R=0.321, p=0.047).  
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Figure 6.11: Correlation of liver normalised ADC with longitudinal relaxation time 
(T1) for patients with T2* < 22.6 ms (red) and > 22.6 ms (green). R and p values are 
indicated for liver normalised ADC for all patients (T2* > 0 ms) in black, and 
subgroups in red and green. 
 
Figure 6.12 shows the IVIM diffusion parameters of D, D* and f as a function 
of longitudinal relaxation time T1. No significant correlation was found for D 
or D*, with a large variance in D* values (see Section 6.6 and 6.7). In contrast, 
a strong significant correlation of reduced perfusion fraction, f, with increased 
T1 was found, suggesting a reduction in perfusion fraction associated with 
increased T1, linked to increased fibrosis and scarring (Figure 6.12 (c) and (d)). 
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Figure 6.12: Correlation of (A) D (x10-3 mm2/s), (b) D* (x10-3 mm2/s).and (c) f as a 
function of T1 (ms) for all patients with T2* > 22.6 ms and T2* <22.6 ms respectively. 
R and p values are indicated for D, D*, and f for all patients (T2* > 0 ms) in black, and 
subgroups in red and green. (d) f versus T1 for those patients with T2* > 22.6 ms plot 
showing fibrosis stage (F0-F4). 
 
Figure 6.13 shows a box plot of ADC, D, D*, f , and T1 for patients with and 
without inflammation grouped into F0-F1-F2 (no-intermediate fibrosis) and 
F3-F4 (severe fibrosis) stage, such grouping was performed due to low subject 
numbers. There was no significant difference between patients with (none or 
mild) inflammation and patients with (moderate or severe) inflammation at 
fibrosis stage (F0-F2) for any parameters. However, f and T1 values between 
patients with (none or mild) and (moderate or severe) inflammation at fibrosis 
stage (F3-F4) were significantly different (p=0.003 and p=0.041 respectively).  
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Figure 6.13: Box plots showing the additional histological influences of inflammation 
on ADC, D, D*, f and T1 values without advanced fibrosis (F0-F2) and with advanced 
fibrosis and cirrhosis (F3-F4). The difference between patients (without or with mild) 
inflammation and (moderate or severe) inflammation at fibrosis stage F3-F4 are 
significant for f and T1. Filled circles and grey star represent outliers in the data. 
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6.5.3 Discussion and conclusion 
           This study has investigated DWI parameters and longitudinal relaxation 
time in the liver of patients with Chronic Liver Disease. Liver ADC tends to 
decrease with fibrosis stage and T1 significantly increased with fibrosis stage. 
Here data were also divided between patients without and with iron 
accumulation (defined as subjects with liver T2* values < 22.6 ms). This 
limited the subject number in each group, but indicated that variability in 
underlying T2* value may mask underlying changes in DWI parameters with 
fibrosis stage. The DWI data from liver tissue with significant iron (T2* < 22.6 
ms) were understandably noisier due to lower signal-to-noise ratio of the DWI 
SE-EPI data, which was collected with an echo time of 67 ms. This was 
assessed further in the correlation of diffusion and T1 measures. There was a 
significant correlation between liver ADC and T1 (p < 0.05), and a higher 
correlation when including only those patients without iron accumulation. This 
data highlights that iron score should be taken into consideration when 
comparing data across fibrosis staging, else this may mask correlations. A 
simple non-invasive measurement of T2* can be used to identify these datasets 
as shown in this study. For IVIM parameters of D and D* no significant trend 
with fibrosis was found, whilst the perfusion fraction, f, showed a significant 
reduction with increasing T1 value. It will be of interest to compare these 
findings with other MR measures which assess perfusion, such as the use of 
arterial spin labelling (ASL) in the liver. 
           Previous DWI studies show that liver fibrosis and inflammation exhibit 
similar ADC correlations. Here, the perfusion fraction was found to 
significantly decrease with inflammation at a severe stage of fibrosis (F3-F4), 
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while T1 value significantly increased with inflammation. This very 
preliminary data suggests that the combination of IVIM diffusion and T1 
parameters may be complementary and could be used to distinguish 
inflammation from fibrosis. 
             In summary, this study has presented preliminary findings of the 
association between liver diffusion and T1 measures with fibrosis stage and 
inflammation. For a more complete study a larger patient cohort is required to 
fully explore these relationships with sufficient power. To do this a future 
study may be better performed at higher field strength of 3 Tesla where 
changes associated with liver disease staging may be more apparent. Prior to 
such a study, MR protocols must first be optimised at 3 Tesla. Section 6.6 aims 
to perform a study of reproducibility of DWI and relaxometry measures in 
healthy subjects at 3 Tesla. The IVIM data presented in this study highlights 
the potential errors in the measurement of D* for fibrosis staging, Section 6.7 
then follows, which aims to understand the variance in the IVIM parameters, 
and optimise DWI b-value parameters for more accurate assessment of liver 
D* and f measures in future studies.  
6.6 STUDY 2: The assessment of liver reproducibility MR 
measures at 3 Tesla 
         MRI parameters must be robust and reliable to be clinically useful for 
disease characterization, development of potential imaging biomarkers, and the 
prediction and monitoring of therapeutic effect. Reproducibility is a type of 
reliability that describes how repeatable measurements made on subjects are 
under different conditions: measurements made by different observers, 
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measurements conducted using different measuring methods or measurements 
made over a period of time that can be indirectly influenced. The measurement 
of reproducibility reflects observer errors such as ROI placement, biological 
variation and instrumental errors. In this study, the reproducibility of diffusion 
weighted imaging and relaxation time measures, as well as phase contrast 
blood flow measures of the liver are assessed at 3 Tesla, to reflect the move of 
clinical systems to higher field strength for studies of Chronic Liver Disease. 
          Adam et al. assessed the short and midterm reproducibility of ADC in 
the liver of healthy subjects [31]. ADC values were found to be not 
significantly different between the two sessions. Chen et al. compared the 
reproducibility of ADC in normal healthy liver for different respiratory motion 
compensation techniques (multiple breath-hold, free breathing, respiratory 
triggered and navigator-triggered DWI) and for different locations in the liver, 
right and left lobes [32]. They found that the ADC value of the liver had good 
reproducibility for intra- and inter- observer agreement tests (ICC of 0.982 and 
0.952 respectively) when using a free-breathing DWI technique. ADC of the 
middle right lobe of the liver was shown to have the best reproducibility (limits 
of agreement (LOA) = 0.02 ± 0.33 x 10-3mm2/s) for free breathing measures. 
The reproducibility of IVIM parameters to assess colorectal liver metastases 
and normal healthy liver in two scan sessions one hour apart was assessed in 
patients in [33]. ROIs were drawn within the outer border of selected 
metastases and over an adjacent area of normal liver parenchyma. The 95 % 
confident limits for agreement reproducibility for ADC and D were smaller in 
normal liver (-6% to + 8%) than in liver metastases (-21 % to +25 %). f and D* 
had poor reproducibility, with the 95% confidence limits for f and D* values in 
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liver metastases of -89% to + 120%, wider than those in normal liver of -31 to 
59 %. 
         Hoad et al. evaluated the repeatability of T1 measures in healthy 
volunteers between two imaging sessions at 1.5 T and found that T1 was 
repeatable with a very small coefficient of variance (CV) of 1.8 ± 1.8 %. [27].  
In another repeatability study, a CV of 1.3 % was found for liver T1 maps, and 
8.4 % for liver T2* maps [28].  
         Following on from Study 1 performed at 1.5 Tesla to assess liver fibrosis 
in Chronic Liver Disease, here I investigate the reproducibility of liver MR 
parameter measures (diffusion parameters of ADC and IVIM, longitudinal T1 
relaxation time, phase contrast based blood flow) at 3 Tesla. For DWI analysis 
methods, the reproducibility of ADC and IVIM parameters that are obtained 
using both average signal intensity and liver mapping methods are investigated. 
I also assess the reproducibility of the liver characteristics determined by MR 
relaxometry (specifically T1, T2, and T2* relaxation time values) in the liver, 
blood flow to the liver through the portal vein and hepatic artery, and volume 
assessment of the liver. These measures define the basis of future studies using 
multi-parametric MR assessment of the liver at 3 Tesla.  
6.6.1 Methods and analysis 
6.6.1.1 Subjects 
This study was performed at Sir Peter Mansfield Imaging Centre (SPMIC), 
University of Nottingham. Ten healthy volunteers (age 23-37 years) were 
recruited to the study between June 2014 and October 2014 during which they 
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were scanned for their first session. Each volunteer then underwent the same 
MRI scanning procedure on a second session at least one week later, and 
within four weeks of their first MR session. Subjects fasted overnight and were 
allowed to drink water only prior to each scan session, both scan sessions were 
collected at the same time of day. 
 
6.6.1.2 MRI data acquisitions 
This study was performed on a 3T (Achieva Philips Healthcare Systems, Best, 
Netherlands) with a multi-transmit body coil and 16-channel SENSE torso 
receive coil. Balanced TFE axial, coronal and sagittal localisers were acquired 
from which to plan the slices positioned over the liver.  
Diffusion Weighted Imaging Data 
Respiratory triggered Spin Echo Diffusion Weighted Imaging (SE-DWI) was 
performed using an EPI readout (9 slices, 3x3x8 mm voxel, 96 x 96 image 
matrix, no slice gap, and TE/TR = 54/1800 ms, SENSE factor 2, NSA 1). DWI 
data were collected at nine b-values (b = 0, 25, 50, 100, 200, 300, 500, 650, 
800 s/mm²) and six orthogonal directions. First these six directions were 
averaged to generate a single b-value image. To avoid the influence of liver fat 
on the DWI measurements, fat saturation using a SPIR scheme was 
implemented. 
T1, T2 and T2* relaxation time data 
T1 data were acquired using a respiratory triggered acquisition with 9 slices per 
volume, 3x3x8mm3 voxel size, 96 x 96 image matrix, 4 mm slice gap, half scan 
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0.843 and SENSE factor of 2. An inversion recovery spin-echo echo-planar 
imaging (IR SE-EPI) sequence was used with fat saturation pulse (SPIR). Data 
was collected at 10 inversion times (TIs) (100, 200, 300, 400, 500, 600, 700, 
800, 1000, and 1200 ms) with images acquired twice using both ascending and 
descending slice ordering, to improve the dynamic range of inversion times as 
in [27]. Each inversion time (TI) was collected in the same point in the 
respiratory cycle by altering the delay time between the respiratory trigger and 
the inversion pulse. The TI provides the inversion time for the first slice in the 
multi-slice data scheme for which there was a temporal slice spacing of 59 ms.  
For the T2 measurement, a spin echo-echo planar imaging (SE-EPI) sequence 
was acquired with SPIR fat saturation pulse, six echo times of TE 27, 35, 42, 
50, 60, and 70 ms were collected in a TR of 10000 ms. 
T2* data was acquired using a mFFE (multiecho fast field echo) sequence with 
nine slices per volume, a 3x3x8 mm3 voxel size, 96 x 96 image matrix, FA of 
30°, TR of 410 ms, 12 echoes were collected with an initial echo time of 2.5 
ms and echo spacing of 2.5 ms. Data were acquired with fat saturation (SPIR). 
Each measurement was acquired in a single breath hold of ~ 20 s. 
Phase contrast Imaging 
Phase-contrast (PC) MR images with through-plane velocity encoding and 
VCG gating were used to measure blood flow in the portal vein and hepatic 
artery. Data was acquired using a single slice Turbo Field Echo (TFE) pulse 
sequence with the slice positioned perpendicular to each vessel. Image 
acquisition parameters were: slice thickness 6mm, FA 25º, number of 
excitations (NEX) 2, reconstructed resolution 1.17 x 1.17 mm2, TFE factor 
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dependent on subjects’ heart rate (range 4 - 6). For the portal vein (PV), 20 
phases per cardiac cycle were acquired with TE/TR = 3.6/5600 ms and velocity 
encoding (VENC) = 50 cm/s. For the hepatic artery (HA), 30 phases per cardiac 
cycle were acquired with TE/TR =3.4/7600 ms and VENC = 100 cm/s). Each PC 
MR measurement was acquired in approximately a 20 s breath hold. 
 
6.6.1.3 MRI data analysis 
Data were analysed using MATLAB (R2010a; MathWorks Inc, Natick, MA, 
USA), with scripts written to assess motion, determine the diffusion parameters 
(ADC, D, D*, and f) and relaxation (T1, T2, and T2*) values, and perform 
histogram analysis to a Gaussian fit to each parameter.  
Diffusion Weighted Image (DWI) analysis 
First, images were inspected for poor image quality as a result of motion, any 
images displaying bulk motion were discarded prior to fitting the data. The 
signal intensity for each b value was averaged across six directions at each 
pixel to form an averaged data image. An ROI was drawn to define the liver 
and an ROI to define the spleen using the DWI data with b = 0 s/mm² at each 
slice to create a binary mask of the liver and spleen. For the liver, a binary 
mask without vessels was created as shown in Section 6.5. The ADC, D, D*, 
and f values were assessed using three analysis methods.  
Analysis method 1: The binary mask was applied on the averaged data at each 
b-value to measure the mean signal intensity for the whole liver. The average 
signal intensity was fitted to (i) mono-exponential (equation (3.6), Chapter 3), 
and (ii) bi-exponential models (Equation (3.7), Chapter 3), at nine b-values (0, 
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25, 50, 100, 200, 300, 500, 650, 800 s/mm²) using a ‘least-square’ algorithm 
fitting to obtain values of (i) ADCav, (ii) Dav, D*av, and fav for the liver and 
ADCav for the spleen. Normalised liver ADCav was calculated as the ratio of 
liver ADCav to spleen ADCav.  
Analysis method 2: ADC, D, D*, and f maps were generated from the voxel-
by-voxel fit to models using a least-square fitting logarithm. The liver binary 
mask was applied to ADC, D, D*, and f maps, and the spleen binary mask was 
applied to the ADC map to obtain the mean value of liver ADCmap, Dmap, 
D*map, fmap, and spleen ADCmap. Normalized liver ADCmap was also measured 
as the ratio of liver ADCmap to spleen ADCav. 
Analysis method 3: Histogram analysis was used to assess the distribution of 
ADC, D, D*, and f values at each pixel across the whole liver by applying the 
binary mask on the maps. The histogram of each parameter was fit to a 
Gaussian function and the peak (mode) of the histogram was assessed to yield 
ADChist, Dhist, D*hist, fhist. 
T1, T2, and T2* mapping 
For the T1, T2 and T2* weighted data, each slice of MR images was inspected 
for any residual motion, and any images displaying motion were excluded 
before being fit. To map T1, the image intensities were fit on a voxel-by-voxel 
basis to Equation (6.1) using a least squares non-linear curve fitting algorithm.  
M =	M$ 	 1 − 2exp	 −TIT- 																															(6.1) 
For T2 /T2*mapping, the data were fit to Equation (6.2). 
M =	M$ exp −TET3 																																				(6.2) 
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T1, T2, and T2* values were assessed by histogram analysis of the maps in 
Matlab® (The MathWorks Inc., Natick, MA)(Analysis Method 3), as this was 
shown to be the most robust method in [27]. Since DWI and relaxometry data 
were collected in the same space, the ROI drawn on the whole liver to create a 
binary liver mask could be applied to all maps, as shown in Figure 6.14. 
 
      
                     
               
Figure 6.14: Maps of (a) ADC, (b) D, (c) D*, (d) f, (e) T1,  (f)T2 , and (g) T2* of a 
healthy volunteer. Maps were subsequently interrogated to determine average signal in 
the mask, or to perform a histogram analysis.  
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Phase-contrast  
An ROI was drawn over the vessel on the PC images using Scanner 
manufacturer’s software (Q-flow, Philips Healthcare, Best, NL) to calculate 
mean vessel area (mm2), velocity (cm/s) and flux of blood (ml/s) over the 
cardiac cycle. This was computed for the portal vein and hepatic artery. 
Volume 
Liver volume was measured using Analyze 9.0 software (Biomedical Imaging 
Resource, Mayo Foundation, Rochester, MN). An ROI was drawn on the axial 
localizer image at each slice, and total liver volume was determined by 
summing across all slices. 
 
6.6.1.4 Statistical analysis 
Statistical analysis was performed using SPSS (version 21.0, IBM SPSS 
Statistics, USA).  For all parameters, a Bland-Altman plot was formed and 
limits of agreement (LOA) calculated from: 
LOA	 = d	 ±	 1.96	×SD 	                            (6.3) 
where d is the mean difference and SD is the standard deviation of differences. 
Intraclass Correlation Coefficient (ICC) and Coefficient of variance (CV (%)) 
were also calculated using SPSS to evaluate the reproducibility of parameters. 
ICC is a relative measurement of reliability in which variation due to 
measurement error in the same subject is compared with the variation between 
all measures and subjects. CV is a measure of reliability expressed as the 
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variation between two duplicate measurements, x1 and x2, in relation to the 
mean value of measurements (Equations (6.4.a-c)).  
SD = 	 (	x- −	x3)32n 																																					(6.4. a) 
Mean = 	 x- +	x32n 																																							 6.4. b  
CV	 % = 100	×	 SDMean																																				(6.4. c) 
 
6.6.2 Results 
One subject was excluded from analysis of T2 measures due to poor image 
quality, and one subject from phase contrast measures due to difficulty in 
localising the portal vein and hepatic arteries. 
 
Diffusion Weighted Image (DWI) measures 
Figure 6.15 shows the Bland-Altman plots for ADC, D, D* and f, and 
normalised liver ADC for each of the three analysis methods to compute av, 
map, hist values of each parameter. 
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Figure 6.15: Bland-Altman plots of (a) ADC (x10-3 mm/s2), (b) D (x10-3 mm/s2), (c) 
D* (x10-3 mm/s2), (d) f and (e) normalised liver ADC. BA plots show the % difference 
between the two scan sessions plot against the mean measurement of the two visits. 
This is shown for each of the three analysis methods (av, map and hist). Solid lines 
show the mean differences, and the dotted line shows the LOA. 
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Comparing parameters obtained from each of the analysis methods, the average 
of the map (map) tended to give the best reproducibility (LOA of ADCmap: -26 
to 20 %, D*map: -63 to 69 %, fmap: -26 to 20 %, and normalized liver ADCmap: -
36 to 36 %). This is also evident by the lowest CV for analysis method 2 
(map), shown in Table 6.2. The Bland-Altman plot shows that D* has poor 
reproducibility for all analysis methods, with LOA of between 91 to 231 %, 
though av and map values of D and D* have narrower LOA compared to hist 
values. This is evident from the low CV values, though the ICC for all is 
moderate (Table 6.2). ADC and f for all analysis methods demonstrate very 
good CV and ICC values. Normalised ADC can be seen to have a larger CV 
compared with ADC. The low ICC and high CV of D* show that this variable 
is not a reproducible measure. 
Analysis method 1 (av) 2 (map) 3 (hist) 
 CV (%) ICC CV (%) ICC CV(%) ICC 
ADC 10.2 0.84 7.0 0.87 7.3 0.85 
D 7.3 0.57 8.4 0.61 8.5 0.56 
D* 35.8 0.18 22.7 0.31 45.3 0.02 
f 8.2 0.86 7.8 0.73 8.1 0.76 
Normalized liver 
ADC 
16.6 0.78 12.2 0.86 - - 
 
Table 6.2: CV and ICC values for ADC, D, D*, f and normalised ADC for analysis 
method 1 (av), 2 (map), and 3 (hist). 
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T1, T2, and T2* mapping 
Figure 6.16 shows the Bland-Altman plots for T1, T2, and T2* using the 
histogram analysis method, and Table 6.3 provides CV and ICC values. 
 
  
 
Figure 6.16: Bland Altman plots of (a) T1 (ms), (b) T2 (ms), and (c) T2* (ms). Solid line 
is the mean difference (%), dotted line is the LOA. 
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 CV (%) ICC 
T1 1.5 0.95 
T2 6.7 0.55 
T2* 4.9 0.92 
 
Table 6.3:  CV and ICC values for T1, T2 and T2* for histogram analysis. 
 
For the relaxometry measures, the LOA of T1 is small (-4 to 5 %), and lower 
than for T2 (-16 to 21 %) and T2* (14 to 16%). T1 also has a very small CV 
(1.54 %) and very good ICC (0.95) along with T2* (0.92) (Table 6.3). 
Comparing T1 values with DWI parameters, T1 shows the best reproducibility 
as illustrated by the comparison of histogram distributions of T1 values 
between Session 1 and Session 2 for two different volunteers (Figure 6.17 and 
Figure 6.18 respectively). This was found to be consistent for every volunteer 
for T1, but not for ADChist, Dhist, D*hist and f, for which the distribution of D*hist 
is poor, and explains the poor Gaussian fit and thus broad LOA of D*hist.  
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Figure 6.17: Histogram plot of ADChist (x10-3 mm2/s), Dhist (x10-3 mm2/s), D*hist (x10-3 
mm2/s)., fhist and T1 (ms) between two scan sessions (Visit 1 and Visit 2) of a volunteer 
in which all measures are consistent. Solid line (red and green) represents the fitting 
data to a Gaussian for Visit 1 and 2.  
 
0
200
400
600
800
1000
1200
1400
0 1 2 3 4
C
ou
nt
ADChist
Visit 1
Visit 2
0
500
1000
1500
2000
2500
3000
0.0 0.5 1.0 1.5 2.0 2.5
C
ou
nt
Dhist
Visit 1
Visit 2
0
2
4
6
8
10
12
14
16
18
0 100 200
C
ou
nt
D*hist
Visit 1
Visit 2
0
1
2
3
4
5
6
7
0 0.2 0.4 0.6
C
ou
nt
f hist
Visit 1
Visit 2
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
400 900 1400
C
ou
nt
T1
Visit 1
Visit 2
The application of MRI measures to the study of Chronic Liver Disease 206 
 
 
Figure 6.18: Histogram plot of ADChist (x10-3 mm2/s), Dhist (x10-3 mm2/s), D*hist (x10-3 
mm2/s)., fhist and T1 (ms) between two scan sessions (Visit 1 and Visit 2) of a volunteer 
in which measures are less consistent. Solid line represents the fitting data to a 
Gaussian. Solid line (red and green) represents the fitting data to a Gaussian for Visit 1 
and 2. Note poor Gaussian fit to D* in Visit 1 data compared to Visit 2 data. 
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Phase contrast MRI to assess blood flow 
Figure 6.19 shows the Bland-Altman plots for the PC-MRI measures of flux, 
velocity and area for portal vein (PV) and hepatic artery (HA). 
 
 
 
Figure 6.19: Bland Altman plot of (a) mean flux (ml/s), (b) mean velocity (cm/s), and 
(c) cross-section area of portal vein (PV) and hepatic artery (HA). Solid lines refer to 
mean differences (%), dotted line represents LOA. 
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 CV (%) ICC 
 PV HA PV HA 
Flux           
(Blood flow)  
18.6 22.7 0.21 0.71 
Velocity 15.5 25.0 0.32 0.22 
Cross-section 
area 
13.3 9.5 0.57 0.90 
  
Table 6.4:  CV and ICC values for flux (ml/s), velocity (cm/s), and cross-section area 
of portal vein (PV) and hepatic artery (HA).  
 
From the Bland-Altman plot, the LOA is quite broad. CV’s are between 9.5 
and 25 %, with the HA demonstrating the highest ICC.  
Liver volume measurements 
Figure 6.20 shows the Bland-Altman plot for liver volume with a narrow LOA 
(-8 to 15 %). The volume of the liver is reproducible and highly correlated, 
with a low CV (4.6 %) and very high ICC (0.93) (Table 6.4).  
 
Figure 6.20 : Bland Altman plot of volume (cm3) of the liver shows the mean and 
difference (%) between measurements of two scan sessions. Solid lines refer to mean 
difference (%), dotted line refers to LOA. 
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 CV (%) ICC  
Liver volume  4.62 0.93 
 
             Table 6.5: CV and ICC of the liver volume between two scan sessions. 
 
6.6.3 Discussion  
           Three analysis methods were explored for the assessment of diffusion 
data.  Analysis method 2, which calculated the mean parameters within the 
diffusion map, was shown to be the best method to evaluate the reproducibility 
of DWI parameters. All DWI parameters were shown to be reproducible, 
except D* which was shown to have large LOA, a high CV and poor ICC. 
These results for LOA of ADC are similar to previous studies, for example [34] 
reported LOA of (-30 to +30 %) for ADC. But LOAs reported for D, D* and f 
are lower than in [34], who found values of (-63 to +70 %), (-200 to +184 %), 
and (-77 to +69 %). CV values are similar to those in [34] for ADC of 8.2 %, 
whilst they also found higher values of CV for D, D* and f at 15.2 %, 51.6 % 
and 20.4 % respectively. Haemodynamic measures of the velocity of the portal 
vein and hepatic artery had a reasonable CV but low ICC, this is possibly due 
to the need to correct these measures for body surface area (BSA). Others have 
demonstrated similar reproducibility for flow measurements with PC-MRI [34-
36].  
            T1 shows the best reproducibility of all measures in the liver (CV  1.5 
%, ICC 0.95) compared to ADC, IVIM parameters, haemodynamic parameters, 
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and liver volume measures, although liver volume was also found to be highly 
reproducible for healthy liver (CV 4.6 % and ICC 0.93).   
           The poor reproducibility of D* value suggests the need to further 
optimise IVIM parameters prior to its use at 3 Tesla. Thus the focus of Study 3 
(Section 6.7) is to optimise IVIM parameters by investigating the best scheme 
of b-values for liver diffusion measures.  
 
6.7 STUDY 3: Optimisation of DWI acquisition parameters 
for ADC and IVIM measures in the liver.  
         This final section aims to understand the variability in diffusion 
parameters reported in the literature for the liver that may arise from the use of 
different b-values across studies, and the associated errors found in Study 1 and 
2 of this chapter. A similar methodology to that described in Chapter 4 for the 
kidney is used to optimise diffusion parameters for the assessment of ADC 
using a mono-exponential decay model, and for the bi-exponential IVIM model 
fitted for D, D*, and f.  
6.7.1 Methods and Analysis 
All simulations were performed in a programme developed in MATLAB 
(R2010a; MathWorks Inc, Natick, MA, USA). The MRI signal in the liver was 
first simulated and a Monte-Carlo simulation then performed to estimate both 
the accuracy and error in the fitted parameters. The signal intensity in the liver 
was simulated using a mono-exponential ADC model (Equation (3.6), Chapter 
3)  and bi-exponential IVIM model (Equation (3.7), Chapter 3) of D, D*, and f 
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using values previously published in the literature in liver disease [20] as show 
in Table 6.6. 
Simulated diffusion parameters                   Values 
ADC (x10¯³mm²/s) 
D (x10¯³mm²/s) 
1.39 ± 0.2 
1.1 ± 0.7 
D* (x10¯³mm²/s) 79.1 ± 18.1 
f 0.27 ±0.5 
 
Table 6.6: ADC values and IVIM (D, D*, and f) values used in the mono-exponential 
and bi-exponential models to simulate the DWI signal in a fibrotic liver. 
 
Data was simulated for four DWI schemes listed in Table 6.7. These four DWI 
schemes were chosen in order to represent the effect of b-value variation on 
DWI parameters. The maximum b-value used in Scheme A, C (b-values used 
in MRker study in Section 6.5) and D was 800 s/mm², while the maximum b-
value used in Scheme B was 500 s/mm². Each scheme consists of a variable 
number of b-values ranging from 9 to 19. The Schemes can be divided into two 
categories. The first category with a number of low b-values (Scheme A and B) 
and the second category with few low b-values (Scheme C and D). Figure 6.21 
shows a mono-exponential and bi-exponential curve of the liver of a patient 
with stage F3 collected in the MRker study using b-values in Scheme C.    
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Scheme b-values (s/mm²) No. of b-values 
A  0,10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 
200, 300, 400, 500, 600, 700, 800 
19 
B  0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 
150, 200, 300, 400, 500 
16 
C  0, 25, 50, 100, 200, 300, 500, 650, 800 9 
D  0, 50, 100, 200, 300, 400, 500, 600, 700, 800 10 
 
        Table 6.7: Four b-value schemes used in the simulation of liver DWI data. 
 
 
 
Figure 6.21: Logarithmic plot of relative signal intensity (raw data) of the liver of a 
patient with stage F3 with increasing b-values.  
 
Noise was added to the simulated DWI signals, computed from random 
numbers generated in Matlab and multiplied by 1/ signal to noise ratio (SNR). 
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A low SNR of 10 was applied to account for the long TE used, as a result of a 
high maximum b-value (800 s/mm2). The signal from the IVIM model was fit 
to a bi-exponential equation using a ‘least-squares’ method to estimate a 
predicted value of D, D* and f. While, the signal simulated from the one 
compartment (mono-exponential) model was fitted to a mono-exponential 
equation to estimate a predicted value of ADCmono. To obtain ADCIVIM from 
the two compartment IVIM model, the simulated IVIM signal was fitted to a 
mono-exponential equation. All data schemes were simulated and fit 1,000 
times to estimate a mean fitted value and standard deviation.  
 The SNR in the liver is low due to the short T2* of the liver (typically 35 ms at 
1.5 T and 25 ms at 3 T, but lower if iron deposition is present), as Schemes 
with a high b-value of 800 s/mm², necessitate a long echo time of at least 67 
ms. For improved SNR, the echo time (TE) can be reduced, at the cost of 
employing a smaller maximum b-value (bmax). Thus for Scheme B, which used 
a maximum b-value of 500 s/mm², the Monte Carlo simulation was repeated 
for two levels of SNR, to observe the effect on the accuracy and error on fitted 
values of ADC, D, D* and f. 
The mean and standard deviation in the fitted values for ADCmono, ADCIVIM, D, 
D*, and f were calculated and compared across the four schemes in Table 6.7. 
The accuracy (%) and standard deviation percentage (STDEV %) in parameters 
were calculated using Equation (6.5) and (6.6).  
Accuracy	%	 = VsimulatedJVpredicted Ksimulated 	×100																												(6.5)                                                                                                                            
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MTDEV	% = Standard	Deviation	Vsimulated 	×100																		(6.6) 
 
6.7.2 Results 
         The fitted diffusion parameters (D, D*, f ADCIVIM, and ADCmono) and 
standard deviation (±) are shown in Table 6.8, whilst Figure 6.22 shows the 
accuracy and standard deviation (STDEV). 
 
b-value 
Scheme 
D D* f ADCIVIM ADCmono 
A 1.04 ±0.28 68.0 ±25.3 0.29 ±0.06 2.37 ±0.33 1.39 ±0.15 
B 0.99 ±0.42 67.7 ±24.7 0.29 ±0.06 3.02 ±0.44 1.38 ±0.20 
C 1.01 ±0.36 65.0 ±29.1 0.31 ±0.09 2.06 ±0.32 1.39 ±0.18 
D 0.98 ±0.35 58.6 ±33.8 0.32 ±0.10 1.92 ±0.24 1.40 ±0.15 
Simulated 1.1 79.1 0.27  - 1.39 
 
Table 6.8: Fitted D, D*, and f values, ADCIVIM and ADCmono, and associated standard 
deviation (± SD) for Schemes A-D. The units for ADC, D, and D* is x 10-3 mm²/s. 
Simulated values are shown for comparison, these values are provided in Table 6.6. 
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Figure 6.22: (a) Accuracy (%) and (b) STDEV % for the bi-exponential fit of D, D*, f 
and mono-exponential fit of ADCmono, for each of b-value Schemes A, B, C, D.  
 
           Comparing schemes, as expected, it can be seen that Scheme A and B 
(with highest number of low b-values) most closely match the IVIM simulated 
parameters. The fitted value of D* for those schemes with low b-values 
(Scheme A and B) are higher than for those schemes without low b-values 
(Scheme C and D), while f is lower for Scheme A and B than Scheme C and D. 
Figure 6.22 (a) and (b) show Scheme A has the best accuracy % and lowest 
STDEV % compared to other schemes, with accuracy % and STDEV % of D, 
D*, and f increasing (i.e. poorer precision) from Scheme A, B C, to D. The 
accuracy % and STDEV % of ADCmono in all schemes is low (i.e. precise 
measure with low error) compared to those of D, D*, and f. The fitted value of 
ADCIVIM from the simulated bi-exponential IVIM model can be seen to be 
highest for Scheme B, with a number of low b-values and low maximum b-
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value, lower for Scheme A with low b-values, and is lowest for Schemes C and 
D which have few low b-values. 
          The predicted diffusion parameters (D, D*, f, ADCIVIM, and ADCmono) 
and standard deviation (±) for the liver at two SNR levels are shown in Table 
6.9. As expected, D, D*, and ADCmono at an SNR of 20 fit closer to simulated 
values than for an SNR of 10. The graphs in Figure 6.23 (a) and (b) show the 
gain in accuracy % and STDEV % of ADCmono, D, D* and f at an SNR of 20 
compared to an SNR of 10. 
 
SNR D D* F ADCIVIM ADCmono 
10 0.99 ±0.42 67.7 ±24.7 0.29 ±0.06 3.02 ±0.44 1.38 ±0.20 
20 1.08 ±0.20 74.2 ±17.7 0.28 ±0.03 3.00 ±0.22 1.39 ±0.10 
           
 
Table 6.9: Fitted D, D*, and f values, ADCIVIM and ADCmono, and standard deviation 
(± SD) at SNR 10 and SNR 20 for the liver. Values obtained from fitting data to bi-
exponential and mono-exponential equation using b-values of Scheme B. Unit of 
ADC, D, and D* is (x10¯³mm²/s). 
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Figure 6.23: (a) Accuracy (%) and (b) STDEV % of bi-exponential and mono-
exponential fitting for predicted D, D*, f and ADCmono at SNR 10 and SNR 20 in the 
liver.  
 
6.7.3 Discussion  
            Simulations have been performed to understand the effect of choice of 
b-value in DWI of the liver on the fitted value of ADC, and IVIM parameters 
of D, D* and f. There was an increase in precision error and standard deviation 
in D, D*, and f from Scheme A, to Scheme C and D, using fewer low b-values 
with the same maximum b-value. By using a lower maximum b-value and a 
high number of low b-values (Scheme B) the value of ADCIVIM was high, and 
decreased as fewer low b-values were used. Girometti et al. [17] suggested that 
ADC depends on the maximum b-value, and that ADC in a cirrhotic liver can 
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be better differentiated from ADC in a healthy liver by using a maximum b-
value of 400 s/mm²	rather than 800 s/mm² [17]. Additionally, the maximum b-
value may also cause a difference in D measured in the liver [20]. Maximum b-
values of larger than 400 s/mm² have been recommended for use in DWI in 
order to reduced T2-shine through effects and to ensure measured ADCs 
approach closer to the true diffusion coefficient [37, 38].  
           Lemke [39] used the IVIM model to simulate DWI signal using 16 b-
values with added Gaussian noise for three ranges of D, D*, and f i.e. low, 
medium, and high to represent brain, kidney and liver respectively. Optimum 
b-values were obtained and they suggested that simulations can be used to find 
the optimum b-values for DWI experiments in order to obtain an acceptable 
image quality. However, the assumption of SNR in simulations may not be the 
same in real organs where the SNR will also be influenced by physiological 
effects such as subject movement, which is influenced by magnetic 
susceptibility and gradient swithching eddy currents [40]. 
           Some studies have measured the overall error in the fit, from the 
summation of the error in D, D*, and f from the bi-exponential IVIM model, in 
order to choose the optimum b-values scheme [39, 40]. However, in our study 
the errors from data fitting to obtain all parameters were observed individually. 
Interestingly, it is shown that the error in D* can be reduced by using a lower 
b-value max (500 s/mm2). However, D* has a high STDEV% compared to D, 
f, and ADCmono and his was similarly reported in Lemke et. al [39] where the 
contribution of D* to the overall error  was three times higher than the error in 
D and f. Overall, the use of a sequence containing a few number of low b-
values together with some high b-values provides better data fitting in the 
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predicted values of D, D* and f in the liver.  Dyvorne et. al [41] used a number 
of lower b-values (0, 15, 30,45, 60, 75, 90, 105, 120, 135, 150, 175, 200, 400, 
600, and 800 s/mm2) to improve the accuracy of f and D*. However, it is 
challenging to perform this scheme for in vivo human imaging because this 
number of b-values requires a long scanning time. Hence, the choice of b-
values needs to be optimized to a reasonable number to reduce the scanning 
duration. Dyvorne et al. reported that the scan time can be reduced by up to  
75% by using four b-values compared to 16 b-values without affecting the 
precession of IVIM parameters calculated [40].  
 In DWI, image SNR is an important factor, error in the estimation of 
parameters can increase by using low quality images. The decrease in accuracy 
and standard deviation percentage of D, D* and f at SNR 20 show that DWI of 
the liver should be modelled biexponentially under the precondition of 
sufficient SNR [41]. Lemke et al. suggested that SNR should be much higher 
than the critical level to achieve reliable fitting of all IVIM parameters [42].  
           In conclusion, simulations can be used to define errors of IVIM and 
ADC parameters using scheme of variable b-value distributions. The optimum 
number of b-value should be chosen to minimize the errors of IVIM parameters 
acquired in DWI experiment within a reasonable scanning time. The accuracy 
of predicted diffusion values can be improved and the error reduced by using a 
few low b-values with sufficient high maximum b-value in the bi-exponential 
data fit.  
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6.8 Conclusion 
           In conclusion, this chapter has assessed the use of diffusion weighted 
imaging and T1 mapping in chronic liver disease, studied the reproducibility of 
liver MR measures at 3T and determined the effect of choice of b-value of 
fitted DWI ADC and IVIM parameters. The liver MRker study has compared 
T1 mapping with diffusion ADC and IVIM parameters for staging of liver 
fibrosis.	It was found that ADC, normalised liver ADC and IVIM parameters 
had limited ability to distinguish fibrosis stage, as reported in previous studies 
[10, 13, 16]. However, a decrease of ADC of the liver significantly correlated 
with increasing T1 with and without iron accumulation. Further, the IVIM 
perfusion fraction, f, showed a significant reduction with increasing T1 value. 
In contrast, D and D* have been found to decrease with fibrosis stage in select 
other studies [20, 22]. The high standard deviation of D* and poor 
reproducibility between repeat measurements, as shown in healthy volunteers 
(Section 6.6) and simulations (Section 6.7), can explain the lack of significant 
change in this parameter. Furthermore, IVIM parameters were found to show 
most significant correlations with T1 in patients without iron accumulation 
(T2*>22.6 ms), reflecting the need for sufficient SNR for IVIM fits. Results 
obtained in the MRker study have some limitations. Firstly, there is a bias in 
the distribution of patient numbers across fibrosis score (Figure 6.6), with a 
very small number of patients with fibrosis stage F4. The choice of b-values 
used may also effect results, as outlined in Section 6.7, with nine b-values and 
few low b-values used in the MRker study for ADC and IVIM measurement. 
From simulations, it is shown that the use of a larger number of small b-values 
can reduce the error in D*. In contrast to DWI, there was an increase of T1 with 
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fibrosis stage. These results parallel the result found in a previous study [28]. 
Moreover, T1 was shown to provide the best reproducibility compared to ADC 
and IVIM parameters, as evidenced from data collected in repeat measures in 
healthy volunteers (Section 6.6). There was a very poor reproducibility of D* 
values in healthy subjects, and this finding is consistent with the result of other 
studies, [33], while the reproducibility of blood flow data was also explored 
and found to have reasonable CV values but low ICC values , however this 
may have been due to the data not being BSA corrected [34].  
All IVIM data in this chapter was fit with the full bi-exponential IVIM 
model to generate IVIM measures of D, D*, and f. In future, this will be 
compared to a more simple second approach to fit the IVIM data, by 
performing an initial estimation of D using a reduced set of high b-values (> 
200 s/mm2), and subsequently using the value of D as a fixed a parameter for 
the fit to f and D*.  This method has been suggested to provide a more robust 
fit, if sufficient SNR at high b-values, but does rely on the assumption that D* 
can be neglected at high b-values.  
           For future studies, collecting data at 3 Tesla will provide better SNR, 
and this coupled with larger patient numbers will improve power. Results 
suggest that a DWI scheme with more low b-values and a maximum b-value 
higher than 500 s/mm2 should be used in a future study to obtain a better fit of 
IVIM parameters to distinguish liver fibrosis stage. This data should be 
combined with T1 measures, T2* measures, and also other MR data to validate 
perfusion fraction estimates, such as arterial spin labelling (ASL).  
            In summary, using an optimised b-value scheme, the combination of 
IVIM diffusion and T1 parameters may provide complementary information, 
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and potentially help separate inflammation effects from fibrosis non-
invasively, using a simple non-invasive measurement of T2* to account for iron 
score when comparing data across fibrosis staging.  
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Chapter 7  
Conclusions 
This thesis has presented the application of MR diffusion imaging and 
relaxometry measurements in abdomen organs of the kidney, colon, and liver.  
         Chapter 4 investigated the pathophysiology change in cardiorenal 
syndrome (CRS) kidney assessed by ADC and IVIM parameters diffusion 
obtained using mono-exponential and bi-exponential full IVIM model fit, the 
relationship between diffusion parameters and renal function was assessed, and 
T1 measurements were also observed. Structural changes in the kidney were 
assessed by diffusion parameters obtained using two other models, the 
stretched-exponential and kurtosis models. DTI measurements were 
implemented to assesses directionality of diffusion in the kidney. The CRS data 
were compared with the healthy younger and older kidney. Results show that 
renal dysfunction causes structural change in the medulla, where ADC and 
degree of tissue structure decrease with renal dysfunction. While in the cortex, 
D*f as an indicator of flow could separate CRS as it decreases with renal 
dysfunction. In conclusion, the combination of these four analysis models can 
be used to assess the structural change and blood flow in the cortex and 
medulla of CRS patients. DTI also has potential value to evaluate the 
individual renal function and can be used to assess renal changes in CRS, the 
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directionality in the kidney for both cortex and medulla can be associated with 
diffusion parameters.  
            Chapter 5 presented the robustness of the biexponential of the T1 model 
to study the colonic contents properties of ascending colon (AC) as a marker of 
water absorption and health. From the result showed, a single and short T1s 
measurements are affected by the liquid challenge and the characteristic of 
colonic content is varies day by day for every single normal day. Prior to 
investigation of the T1 properties within the AC, T1 measurements provide 
reliable information for this work. Also, it was found that the size of ROI does 
not effect the T1 measurement of the AC, however it is affected by the location 
of ROI placement at the bottom region of the AC. Hence, the heterogeneity of 
the colonic contents at the bottom of the AC is high compared to top and 
middle regions. Overall, multiple compartment of T1 values can be used to 
perform a completely non-invasive investigation of the characteristics of the 
colon.  
             In Chapter 6, the changes in liver function associated with Chronic 
Liver Disease (CLD) were assessed using ADC, IVIM parameters, and T1 
measurements at 1.5 Tesla. Result show that ADC of the liver with and without 
iron accumulation decreased with fibrosis and significantly correlated with 
increasing T1. For IVIM measurement, f also showed a significant reduction 
with increasing T1 value in patients both with and without iron accumulation. 
In addition, the decrease of f with increasing T1 is not only caused by fibrosis 
and cirrhosis, but also due to inflammation in the liver. A liver imaging 
protocol was implemented at 3 Tesla to assess the reproducibility of structural 
and haemodynamic measures in the healthy liver. The high standard deviation 
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of D* and poor reproducibility between repeat measurements can explain the 
lack of significant change in this parameter in Chronic Liver Disease. While, 
T1 is shown to have the best reproducibility compared to ADC and IVIM 
parameters as well as T2 and T2*. The mean velocity and blood flow of the 
portal vein and mean velocity of hepatic artery demonstrated poor 
reproducibility. Finally, it was shown that the error in IVIM measurement, 
especially in D*, can be reduced by using few low b-values with a sufficiently 
high maximum b-value in bi-exponential data fitting. In conclusion, the 
combination of IVIM diffusion and relaxometry parameters may provide 
complementary information, and potentially help separate inflammation effects 
from fibrosis non-invasively. Iron score should be taken into consideration 
when comparing data across fibrosis staging, else this may mask correlations. 
Moreover, a simple non-invasive measurement of T2* can be used to identify 
these datasets. 
             In summary, this thesis has demonstrated the utility of DWI and 
relaxometry measures which can be applied for assessing disease, function and 
properties of the abdominal organs. In future studies it is apparent that larger 
cohorts are required and multiparametric data should be collected at 3T with 
optimised b-values for diffusion weighted imaging.  
 
 
 
 
